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Abstract 
In their natural environment, bacteria are often found as sessile populations, known as 
biofilms, typified by surface adherence and extracellular matrix production. This growth 
phase confers broad spectrum antibiotic recalcitrance, through undefined mechanisms. 
This work sought to investigate a role for increased mutability ofstaphylococci in biofilms, 
as a contributing mechanism in biofilm antibiotic recalcitrance. 
Initially, a novel biofilm model for use with staphylococci was established that 
utilised cellulose disks and incorporated human plasma to promote bacterial surface 
adherence. This system was validated by demonstrating antibiotic recalcitrance, 
dissemination by D-amino acids, and similarities with transcriptional profiles of other 
biofilm models. 
Using this novel biofilm model, and the Sorbarod flow system, mutation 
frequencies (MFs) were determined for Staphylococcus aureus and Staphylococcus 
epidermidis in biofilms and compared with those in planktonic cultures. This revealed 
increases in MF of up to 68-fold compared with planktonic cultures. The role of oxidative 
stress in biofilm mutability was investigated by addition of antioxidants to biofilms. 
Here, MFs were reduced up to 5-fold, suggesting a role for oxidative damage. 
Transcriptional profiling of biofilms revealed upregulation of several genes involved in DNA 
repair, compared with planktonic cultures. Genes encoding antioxidant activity were also 
investigated; of these only sodA was upregulated. Staphyloxanthin biosysthetic genes, 
however, were downregulated. 
During these studies, S. aureus biofilms were found to generate phenotypic 
variants. White variants (WVs) and large pale variants (LPVs) were mostly found amongst 
cells shed from biofilms. WVs had lost biofilm forming capacity and had mutations in the 
iv 
alternative sigma factor, SigB. LPVs retained biofilm forming capacity, but the genetic basis 
of their variation remains undefined. 
In summary, I have shown that staphylococci exhibit enhanced mutability in 
biofilms, accelerating the emergence of antibiotic resistance and morphological variants. 
This may result from oxidative stress, causing the enhanced accumulation of mutations 
within the genome. 
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CHAPTER 1 
1. Introduction 
1.1. Bacterial biofiims 
This thesis deals with mutability and oxidative stress within staphylococcal biofilms. In 
addition, the emergence of morphological variants from S. aureus biofilms and their role in 
biofilm dissemination have been investigated. Therefore, it is relevant to consider the 
literature on microbial biofilms. 
In the mid-1800s, Robert Koch and colleagues helped generate the familiar 
microbiological techniques that allowed the isolation of pure bacterial cultures from 
complex mixed species environments. These cultures of free floating, or planktonic, cells 
have since proven invaluable for investigations concerning bacterial genetics, structure and 
metabolism, and elucidating the connection between pathogens and infectious disease. 
However, it is becoming increasingly apparent that the behaviour of planktonic cultures is 
not necessarily representative of that demonstrated by bacteria in their natural 
environments. Indeed, in their ecosystems, the vast majority of bacteria are found 
associated with surfaces as multicellular communities, or biofilms (Zobell, 1943; Zong et al., 
2005). These surface-attached communities are phenotypically differentiated from 
planktonic cultures by the formation of cellular aggregates, known as microcolonies, 
extracellular matrix production, which is often an exopolysaccharide (EPS) matrix, and a 
markedly slower growth rate (Lindsay & von Holy, 2006). Biofilms are found ubiquitously 
throughout the environment, from those lining the human gastrointestinal tract 
(Macfarlane, 2008) to those found in extreme climates such as deep-sea vents and 
hydrothermal springs (Taylor et a!., 1999; Yim et al., 2006). Furthermore, evidence for their 
1 
existence has been identified in early fossil records, exemplified by the 3.2 billion year old 
hydrothermal rocks found to harbour fossilised filamentous biofilms (Rasmussen, 2000). 
Biofilm structures were first observed on tooth surfaces by Van Leeuwenhoek, by 
utilising simple microscopes (Donlan, 2002). Zobel) (1943) observed that the number of free 
floating microorganisms in seawater was significantly less than in the adherent population 
found on submerged surfaces . The advent of electron microscopy then allowed the 
visualisation of biofilms, from wastewater treatment plants, at high resolution (Jones et al., 
1969). Subsequently in 1978, following investigations into dental plaque and adherent 
populations in mountain streams, Costerton put forward the idea of "biofilms" as a 
mechanism to allow microorganisms to adhere to biotic and abiotic surfaces (Costerton et 
al., 1978). The advent of biofilm studies then ensued, and as a result there has been 
increasing evidence for the presence of biofilms in the human host. Recent years have seen 
a profound increase in biofilm investigations, reflecting increasing reports of their 
involvement in infectious disease, with the National Institutes of Health now estimating 
that >80% of all infections in the developed world involve a biofilm component (NIH, 2002). 
It is important to state, however, that biofilms also form a protective part of human natural 
defences. In many cases biofilms formed by the resident microbiota provide colonisation 
resistance, to prevent colonisation by exogenous pathogens. For example, the 
polymicrobial biofilms attached to the intestinal epithelial lining in the human digestive 
tract, provide protection against food and waterborne pathogen infection (Lee et al., 2000). 
2 
I. I. I. Biofilm development 
1.1.1.1. Attachment 
Bacteria undergo complex changes during the transition from a free-living lifestyle into a 
biofilm. This process occurs by several sequential steps (Figure 1.1). Prior to initial 
attachment of the cells, 'surface conditioning' is often required, whereby surfaces become 
coated with adsorbed bridging molecules (Lindsay & von Holy, 2006). For example, large 
cellular aggregates of Pseudomonas aeruginosa are formed on surfaces coated with mucin, 
a phenomenon not observed on surfaces coated with DNA or actin (Landry et al., 2006). 
Similarly, the adherence of S. epidermidis to surfaces may be increased by the presence of 
surface-activated platelets (Wang et al., 1993). 
To bring about initial attachment, the bacterial cells must be in close proximity with 
the conditioned surface. This can be achieved by active motility via the use of flagella, a 
process demonstrated in P. aeruginosa. Indeed, mutants lacking a flagellum are unable to 
initiate surface colonisation, suggesting that these structures may be necessary for 
adherence (O'Toole & Kolter, 1998). Alternatively, the cells may be transported to the 
surface by processes such as liquid flow or Brownian motion (van Loosdrecht et al., 1990). 
The initial attachment of bacteria is reversible, such that the adhering cells are in 
continuous exchange with the surrounding planktonic cells and continue to exhibit 
Brownian motion or self-propulsion. This is followed by irreversible binding due to the 
production of EPS and cell-to-cell bridges (Lindsay & von Holy, 2006). EPS production is 
necessary for the irreversible attachment of organisms such as P. aeruginosa and 
S. epidermidis (Davies & Geesey, 1995). Other organisms, however, may use specific 
receptors to anchor themselves to the surface. Vibrio cholerae, for example, utilises a 
mannose-sensitive haemagglutinin to achieve attachment on abiotic surfaces (Watnick et 
al., 1999). 
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1.1.1.2. Maturation and Dispersion 
Maturation of the immature biofilm results in a complex multicellular structure surrounded 
by an extracellular matrix, commonly composed of EPS (Lawrence et al., 1991). Indeed, the 
microcolonies within complex biofilms are surrounded by water channels, which transport 
water, nutrients and waste products (Massol-Deya et al., 1995). Mature biofilm can also 
shed cells that revert to the planktonic phase, allowing colonisation of new surfaces, a 
process referred to as dispersion or dissemination (Parsek & Fuqua, 2004). The mechanism 
of which is dependent on the organism. Proteus mirabilis, a causative organism of urinary 
infections associated with catheters, forms swarmer cells. The significant increase in the 
number of flagella on these cells allows rapid spread of the organism over catheters and 
other medical devices (Sabbuba et al., 2002; Rather, 2005). By contrast, P. aeruginosa 
synthesises an alginate Iyase (AIgL) that functions to degrade alginate, the P. aeruginosa 
EPS, resulting in the release and spread of peripheral biofilm cells (Boyd & Chakrabarty, 
1994). Furthermore, it has recently been established that the production of D-amino acids 
in mature biofiims of Bacillus subtilis, P. aeruginosa and S. aureus, may contribute to their 
disassembly (Kolodkin-Gal et al., 2010). Specifically, in B. subtilis D-amino acids such as 
D-tyrosine become incorporated into the peptide side chains of the cell wall instead of the 
terminal D-alanine, disrupting the biofilm matrix by preventing anchoring of TasA amyloid 
fibres to the peptidoglycan (Kolodkin-Gal et al., 2010). Other mechanisms of dispersion 
include alteration of cell surface components, such as an increase in cell surface 
hydrophobicity, demonstrated by Escherichia coli (Allison et al., 1990b) and P. aeruginosa 
(Allison et aL, 1990a), gliding motility, exemplified by Myxococcus xanthus (Wolgemuth et 
al., 2002) and quorum sensing mechanisms employed by Xanthomonas campestris (Dow et 
al., 2003). 
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1.2. Staphylococci 
Some of the most extensively studied organisms, in terms of biofilm formation, are the 
staphylococci. The staphylococci are Gram positive cocci, many of which form part of the 
natural flora of mammals. Coagulase negative staphylococci (CNS) such as S. epidermidis, 
for example, colonise the skin of the majority of the population, whilst the primary 
ecological niche for S. aureus is the anterior pares, where it permanently colonises 
approximately 20% of the population (Kluytmans et al., 1997; O'Gara & Humphreys, 2001). 
In addition, S. aureus is a major cause of human infection in both the clinical and the 
community setting (Lowy, 1998). The severity of these infections may be partly attributed 
to the production of a variety of virulence factors in S. aureus, including coagulase, catalase, 
adhesins, toxins and capsule (Tenover & Gorwitz, 2006). Furthermore, the impact of this 
organism in the hospital setting is compounded by its propensity to develop antibiotic 
resistance. Meticillin-resistant S. aureus (MRSA), for example, gained notoriety in the 
hospital and other healthcare settings, where it has proven difficult to treat due to its 
resistance to ß-lactams (David & Daum, 2010). Furthermore, the incidence of CA-MRSA 
(community acquired meticillin-resistant S. aureus) infections is on the increase, with these 
strains often affecting otherwise healthy individuals with no prior exposure to the 
healthcare setting (David & Daum, 2010). CA-MRSA infections are mostly of the skin and 
soft tissue, but necrotizing pneumonias and abscesses have also been reported (Fridkin et 
al., 2005; Kaplan et al., 2005; Purcell & Fergie, 2005; Thomas et al., 2011). Efforts to 
elucidate the pathogenesis of CA-MRSA found that the majority of isolates harbour 
Panton-Valentine leukocidin and a variety of enterotoxins on several mobile genetic 
elements (Baba et al., 2002; Vandenesch et al., 2003). Furthermore, epidemic strains of CA- 
MRSA also secrete high levels of cytolytic peptides, known as phenol-soluble modulins, 
capable of lysing human neutrophils (Wang et al., 2007). 
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S. aureus causes a broad range of infections, many of which are pyogenic and 
toxigenic in nature, including abscesses, food poisoning, impetigo, infective endocarditis 
and septicaemia (Tenover & Gorwitz, 2006). By contrast, CNS, such as S. epidermidis, are 
much less aggressive pathogens which rarely cause pyogenic infections in the healthy host, 
and the infections they do cause are not mediated by toxins (Heilmann & Peters, 2006). 
However, in the immunocompromised host, or those with indwelling medical devices (heart 
valves, shunts, plastic lines, etc. ), S. epidermidis can become a frequent cause of infection 
(Raimundo et al., 2002). 
The majority of infections caused by staphylococci include a biofilm component. 
Staphylococcal biofilm formation is a multifactorial process that may differ between species 
and strains. For the purposes of this work, only biofilm formation by S. epidermidis and S. 
aureus will be discussed here. 
1.2.1. Staphylococcal biofilm formation 
1.2.1.1. Primary attachment 
Primary attachment of cells to surfaces is the first step in biofilm formation, and in S. 
epidermidis and S. aureus this process is often achieved through interaction with host 
components via adhesins (Figure 1.2) (Arrecubieta et al., 2007; Corrigan et al., 2007; O'Neill 
et al., 2008; Corrigan et al., 2009). Furthermore, initial adhesion may also be influenced by 
surface chemistry, For example, hydrophobic surfaces promote biofiim formation in S. 
epidermidis (MacKintosh et al., 2006; Patel et al., 2007) 
EPS of S. epidermidis biofilms, previously termed PS/A, polysaccharide intercellular 
adhesin (PIA) or Poly-ß-(1,6)-N-acetylglucosamine, first isolated from rich cultures of S. 
epidermidis, is important for adherence, as antibodies raised against it prevent biofilm 
formation on silastic catheters by biofilm-positive strains (Tojo eta!., 1988). 
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Figure 1.2 A summary of the bacterial, host and environmental components that influence biofilm 
formation in staphylococci. Adapted from Cramton & Götz (2004). 
Staphylococci utilise a broad range of surface proteins that interact with host 
extracellular matrix molecules and serum proteins. These proteins, termed MSCRAMMs 
(microbial surface components recognising adhesive matrix molecules), interact with host 
components to bring about surface adhesion (Patti et al., 1994). The most common host 
cellular components bound by MSCRAMMS are fibronectin, fibrinogen, collagen and elastin 
(Patti et al., 1992; Greene et al., 1995; McDevitt et al., 1995; Keane et al., 2007). However, 
binding of vitronectin, haemoglobin, antibodies and cellular lipids by some MSCRAMMs has 
also been demonstrated (Uhlen & Abrahmsen, 1989; Hussain et al., 2001a; Huesca et al., 
2002; Mazmanian et al., 2003). S. aureus, in particular, expresses many different 
MSCRAMMs that are usually covalently attached to the cell wall via a LPXTG motif (Navarre 
& Schneewind, 1994). Specifically, a membrane-anchored transpeptidase, known as 
sortase, cleaves the LPXTG sorting signal between the threonine and glycine residues. 
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Attachment to the cell wall then occurs by amide bond formation between the carboxyl 
group of the threonine residue and the amino group of residues within the peptidoglycan 
cross bridge (Perry et al., 2002). 
Some of the best characterised MSCRAMMs are the S. aureus fibronectin binding 
proteins A and B (FnBPA and FnBPB) (Greene et al., 1995; Clarke et al., 2002). These 
proteins have been shown to primarily bind fibronectin, a large glycoprotein present on the 
surface of mammalian cells, in extracellular fluids and in connective tissue matrices 
(Yamada & Olden, 1978; Greene et al., 1995). However, FnBPA has also been shown to bind 
fibrinogen, and both proteins have elastin binding activity (Wann et al., 2000; Roche et al., 
2004). FnBPA and FnBPB are important virulence factors as they are crucial for eukaryotic 
cell invasion (Sinha et al., 1999). In terms of biofilm formation, these proteins have been 
implicated in the adherence of S. aureus to surfaces in EPS deficient mutants (O'Neill et al., 
2008). 
The S. aureus clumping factor proteins CIfA and CIfB belong to the serine-aspartate 
repeat (Sdr) family of proteins and have both been implicated in S. aureus heart valve 
colonisation during bacterial endocarditis (Josefsson et al., 1998; Rindi et al., 2006). In S. 
epidermidis, fibrinogen binding proteins have also been identified, such as SdrG, (also 
known as Fbe) (Hall et al., 2007). This protein also induces platelet activation and 
aggregation, and so may contribute to the virulence of S. epidermidis in infections such as 
endocarditis (Brennan et al., 2009). 
Staphylococci are also able to adhere to collagen via proteins such as SdrF in S. 
epidermidis and Cna in S. aureus (Zong et al., 2005; Arrecubieta et al., 2007). Such proteins 
contribute to the virulence of these organisms during infections such as osteomyelitis 
(Elasri et aL, 2002). 
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In S. aureus, the major autolysins of S. aureus (AtIA) and S. epidermidis (AtIE) are 
bifunctional proteins with amidase and glucosaminidase activity and are found associated 
with the septum during cell division (Yamada et al., 1996). In addition, both of these 
enzymes have been implicated in biofilm formation. Indeed, a S. epidermidis AtIE mutant 
generated by transposon insertion was unable to form biofilms on polystyrene surfaces, but 
retained biofilm forming- capacity on glass surfaces (Heilmann et al., 1996a). The at/E locus 
was subsequently found to encode a 148 kDa protein that is proteolytically modified to 
yield active 60 kDa amidase and 52 kDa glucosaminidase domains (Heilmann et al., 1997) 
Furthermore, AtIE possesses polystyrene and vitronectin binding capacity and. upon 
deletion of at1E, S. epidermidis displays reduced virulence in a rat central venous catheter 
model, indicating the importance of this protein in the virulence of S. epidermidis (Rupp et 
al., 2001). Similarly, an atlA deletion in S. aureus resulted in the formation of large cell 
clusters and loss of biofilm formation (Biswas et al., 2006). 
Teichoic acids are cell wall polymers that often contain alternating glycerol 
phosphate and ribitol phosphate groups (Baddiley et al., 1961; Baddiley et al., 1962) (Figure 
1.3). These polymers have a significant role in staphylococcal initial adherence during 
biofilm formation. Specifically, a S. oureus mutant, defective in D-alanine incorporation into 
teichoic acids, was unable to adhere to polystyrene or glass surfaces due to a stronger 
negative surface charge causing repulsive electrostatic forces. Biofilm-forming capacity was 
restored with the addition of divalent cations to counteract the negative charge (Gross et 
al., 2001). In S. epidermidis these polymers bind fibronectin, in combination with an 
unknown surface protein, suggesting a potential bridging function between the cells and 
fibronectin coated surfaces (Hussain et al., 2001b). 
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Figure 1.3 Structure of S. aureus cell wall teichoic acid. GIcNAc - N-acetylglucosamine, MurNAc - N- 
acetylmuramic acid, P- phosphate, ManNAc - N-acetylmannosamine, D-ala - D-alanine. Adapted 
from Xia et al (2010). 
1.2.1.2. Maturation 
Once attachment has occurred, the attached cells begin to divide and form microcolonies 
(Donlan, 2001a). Cell to cell adhesion then occurs, allowing maturation of the biofilm. One 
of the most typical features of a biofilm is the EPS component of the matrix, secreted by the 
adherent cells. In the case of staphylococci, this has gone by many names including slime- 
associated antigen, PS/A and PIA. For the purposes of this work, it will be referred to as PIA. 
This polymer, initially identified in S. epidermidis, is composed of poly-N-acetyl glucosamine 
(PNAG) and is also present in S. aureus (Mack et al., 1994; Mack et al., 1996; Cramton et al., 
1999). Synthesis of PIA has been attributed to the intercellular adhesion (ica) operon, which 
contains both a regulatory gene (icaR) and the biosynthetic genes icaADBC (Heilmann et al., 
1996b) (Figure 1.4). IcaA, C and D are membrane-associated proteins, whilst IcaB is mainly 
found in the extracellular fraction. IcaA possesses N-acetyl glucosaminetransferase activity, 
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utilising UDP-N-acetylglucosamine as a substrate, and only reaches optimal activity in the 
presence of IcaD (Gerke et al., 1998). The role of IcaC remains largely unknown; however it 
has been hypothesised that it may serve to translocate PIA to the cell surface. Furthermore, 
the presence of IcaAD alone can only yield oligomers of up to a maximum of 20 residues, 
and IcaC is required for the synthesis of longer chains (Gerke et aL, 1998). IcaB deacetylates 
PIA, a process necessary for attachment of PIA to the cell surface and for biofilm formation 
(Vuong et al., 2004). 
In addition to PIA, proteinaceous structures and teichoic acids, biofilms formed by 
staphylococci are also dependent on the production of extracellular DNA (eDNA) which 
forms part of the biofilm matrix. In S. aureus, the production of eDNA via cell lysis is 
controlled on the Cid/Lrg system. Specifically, the cidA gene encodes a murein hydrolase 
and functions to lyse a proportion of the population to release genomic DNA (Rice et al., 
2007). Conversely, the IrgAB genes encode a proposed antiholin and function to inhibit cell 
lysis (Mann et al., 2009). Furthermore, transcription from the cidABC and IrgAB operons is 
activated by CidR and the LytSR TCS, respectively (Yang et al., 2005; Sharma-Kuinkel et al., 
2009). Subsequent investigation has also demonstrated that S. aureus beta toxin binds to 
the eDNA and other proteins to form a nucleoprotein matrix (Huseby et al., 2010). 
Furthermore, although the production of PIA, by the expression of the ica operon, 
undoubtedly has an important role in biofilm formation in many staphylococcal strains, 
other studies have identified staphylococcal isolates lacking this operon that can still form 
biofilms (Ziebuhr et al., 1997; Fitzpatrick et al., 2002; Fitzpatrick et al., 2005). Indeed, 
deletion of the ica operon in the human clinical isolate UAMS-1 had no effect on biofilm 
formation (Beenken et al., 2004). 
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Figure 1.4 Production of PIA from the ica operon. IcaAD and IcaC are membrane-associated proteins 
that function to yield PNAG oligomers and translocate them across the membrane. IcaB then 
deacetylates the oligomers to associate them with the cell surface. Expression of IcaR results in 
down regulation of the icaADBCgenes. Adapted from O'Gara (2007). 
Several other genes have also been implicated in biofilm maturation. The 
accumulation associated protein (Aap), for example, was identified in a mutant strain of S. 
epidermidis derived from strain RP62A. This mutant, M7, lacks Aap and although capable of 
surface adhesion, is deficient in accumulation (Schumacher-Perdreau et al., 1994; Hussain 
et al., 1997). Interestingly, this strain was still able to produce PIA (Baldassarri et al., 1996). 
The biofilm-associated protein (Bap), which was first identified in a bovine mastitis isolate 
of S. aureus, also confers biofilm forming capacity (Cucarella et al., 2001). Mutations in the 
ica operon do not affect biofilm formation in this isolate (Cucarella et al., 2004). 
Furthermore, a homologue of Bap has been identified in S. epidermidis and other CNS 
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(Tormo et al., 2005). Sequence analysis demonstrates that Bap belongs to a family of over 
100 surface proteins from numerous bacterial species that may all have a role in biofilm 
formation (Lasa & Penades, 2006). However, so far this protein has only been identified in 
5% of bovine S. aureus isolates and has yet to be identified in any S. aureus clinical isolates 
(Cucarella et al., 2001). 
1.2.1.3. Biofilm regulation 
Regulation of biofilm formation in staphylococci may vary between strains, but the main 
regulators identified to date are IcaR, SigB, TcaR, the agr quorum sensing system, the SarA 
regulator and the ArIR-ArIS two component system (TCS). Regulation of expression from the 
ica locus is controlled by IcaR, from the tetR family of transcriptional regulators. This 
transcriptional repressor, located upstream of icaADBC, binds to the promoter region near 
the icaA start codon (Conlon et al., 2002a; Jefferson et al., 2004). Activation of icaADBC can 
occur through environmental stimuli in an IcaR-dependent manner. For example, addition 
of sodium chloride or ethanol can repress IcaR, therefore enhancing expression from 
icaADBC (Conlon et al., 2002b). 
The teicoplanin-associated locus regulator (TcaR), of the MarR family of 
transcriptional regulators, has also been shown to regulate expression from the ica operon 
negatively, but deletion of this gene alone is not sufficient to prevent PIA production 
(Jefferson et al., 2004). Further investigation revealed this regulation was due to the ability 
of TcaR to bind three 33 bp regions close to the IcaR binding region of the ica operon 
(Chang et al., 2010). Furthermore, the alternative sigma factor, SigB, and its positive 
regulator RsbU, have been shown to regulate biofilm formation in S. epidermidis and 
S. aureus (Rachid et al., 2000a; Knobloch et al., 2001). In S. epidermidis, SigB controls 
expression from the ica operon by repressing transcription of icaR (Knobloch et al., 2004). 
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In S. aureus, SigB induces biofilm formation under stress conditions, and SigB negative 
mutants are deficient in biohlm formation (Rachid et al., 2000a). It has also been shown to 
control expression from the agr system in S. aureus, for maintaining ica-independent 
biofilms which lack PIA (Lauderdale et al., 2009). 
The accessory gene regulator (agr) system is a staphylococcal quorum sensing 
system (Recsei et al., 1986; Otto et al., 1998). The TCS conducting signal transduction for 
the agr system is composed of AgrA, the response regulator, and AgrC, the histidine kinase 
sensor (Lina et al., 1998). Activation of the system occurs via an AgrD derivative, a 
thiolactone peptide pheromone, export of which is dependent on AgrB activation (ii et al., 
1995). Many S. aureus clinical isolates carry mutations in the agr system, which confers 
enhanced ability to form biofilms on polystyrene in vitro, suggesting that such strains may 
be more able to colonise implanted devices in vivo (Vuong et al., 2000). Furthmore, agr 
mutants have been shown to display reduced exotoxin production and increased surface 
protein production. Specifically, during colonisation expression of the agr system is minimal 
to allow surface adherence and biofilm formation. Expression is then increased, and via 
RNAIII, the main intracellular effector of the agr system, surface protein expression is 
reduced and exotoxin production is increased, potentially to aid nutrient acquisition in vivo 
(Recsei et al., 1986). In contrast with agr, mutation of sarA in S. aureus results in loss of 
biofilm forming capacity due to an increase in the production of extracellular proteases and 
nucleases (Beenken et al., 2010). Indeed, the addition of protease inhibitors and 
inactivation of nuclease, via a nuc mutation, in sarA mutants can restore biofilm formation 
(Tsang et al., 2008). The autolysis-related (arl) locus in S. aureus is another TCS which 
influences biofilm formation. This locus encodes the predicted ArIR-ArIS sensor kinase- 
response regulator system. An arlS transposon insertional mutant of S. aureus displayed 
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enhanced polystyrene adherence compared with the wild-type parent (Fournier & Hooper, 
2000). 
In addition to IcaR and TcaR, insertion of IS256, an insertion sequence element, into 
the ica genes, rsbU of the sigB operon and sarA locus has been shown to regulate PIA 
production negatively, resulting in a biofilm-positive to biofilm-negative phenotypic switch 
in S. epidermidis (Conlon et al., 2004). Similarly, insertion of IS256 into genes involved in 
biofilm formation in S. aureus is also associated with a switch to a biofilm-negative 
phenotype. In this case this process is negatively regulated by SigB, as the number of copies 
of this insertion sequence on the chromosome, and therefore the rate of phenotypic 
switching, was significantly increased in mutants lacking this transcription factor (Valle et 
a!., 2007). 
1.2.1.4. Environmental factors 
In addition to the cellular factors discussed so far, many environmental stimuli also 
modulate biofilm formation. Indeed, enhanced expression from the ica operon occurs 
during anaerobic conditions, compared with aerobic incubation, in both S. aureus and S. 
epidermidis (Cramton et al., 2001). 
The availability of sugars also influences biofilm formation. The addition of D- 
glucose, saccharose, lactose, D-galactose, maltose and fructose to growth media, induce 
expression of PIA in S. epidermidis (Mack et al., 1992). Similarly, the addition of 20.25% 
glucose (w/v) to brain-heart infusion broth enhances PIA production in S. aureus 
(McKenney et al., 2000). 
Metals such as iron, magnesium and calcium also affect biofilm production (Dunne 
& Burd, 1992; Deighton & Borland, 1993). S. epidermidis biofilm formation is increased in 
iron-limiting conditions (Deighton & Borland, 1993). In contrast, increasing concentrations 
16 
of magnesium or calcium increase biofilm formation in S. epidermidis, most likely through 
alteration of cell surface charge (Dunne & Burd, 1992). In a similar manner, the addition of 
alcohol results in increased PIA synthesis and biofilm formation. In particular, ethanol, 
isopropanol and n-propanol from skin disinfectants increase biofilm formation in S. 
epidermidis (Knobloch et al., 2002). 
Perhaps most worrying are reports implicating some antibiotics as biofilm inducers. 
For example, increased expression from the ica operon was observed in S. epidermidis in 
the presence of subinhibitory concentrations of tetracycline, quinupristin-dalfopristin and 
erythromycin (Rachid et al., 2000b). 
1.2.2. Staphylococcal biofilm infections 
1.2.2.1. Medical devices 
Modern medicine increasingly requires the use of indwelling medical devices to prolong 
and improve the quality of life for many individuals. These devices however, as with most 
medical interventions, are associated with side effects. One of the most common and 
serious of these is the potential for infection as these devices provide a platform for 
microbial colonisation and biofilm formation (Figure 1.5). Specifically, medical devices can 
become contaminated with bacteria which adhere and develop into biofilms thereby acting 
as a source of infection. Staphylococci, in particular, are able to adhere to numerous 
surface types and consequently a variety of indwelling devices. These include, but are not 
limited to, central nervous system shunts (Conen et al., 2008), contact lenses and other 
ocular implants (Green et al., 2008), endotracheal tubing (Estes & Meduri, 1995), 
intravascular devices (Sitges-Serra & Girvent, 1999), mechanical heart valves and cardiac 
pacemakers (Heimberger & Duma, 1989), urinary catheters (Weigel et al., 2007) and 
replacement joints (Khardori & Yassien, 1995). The severity of the resulting infections 
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following medical device colonisation varies, depending on both the nature and location of 
the device and the immunological status of the individual. 
Figure 1.5 Scanning electron micrographs of a cardiac pacemaker lead colonised with S. oureus 
isolated from a patient who had suffered three episodes of S. aureus bacteraemia. A The colonised 
pacemaker tip (bar = 500 µm). BA magnified view of the quadrangle indicated in A (Bar = 50 µm). 
CA magnified view of the quadrangle indicated in B (Bar =5 µm). DA magnified view of the same 
area as in C (Bar =5 . im) (Marrie et al., 1982). 
Furthermore, following colonisation by a single species, the resulting mature 
biofilms found on indwelling medical devices are often polymicrobial in nature. Urinary 
catheters, for instance, are primarily colonised by S. epidermidis, S. aureus, E. co/i, P. 
mirabilis or Enterococcus faecalis. During colonisation and development of the biofilm it 
remains a monoculture, but as the biofilm matures it can incorporate other species 
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including Klebsiella pneumoniae, P. aeruginosa, Providencia stuartii and P. mirabilis 
(Stickler, 1996). 
1.2.2.2. Cutaneous infections 
S. aureus is the causative organism of an array of cutaneous infections including pimples, 
impetigo, furuncles, carbuncles, cellulitis, abscesses and staphylococcal scalded skin 
syndrome (SSSS) (Tenover & Gorwitz, 2006). The role of biofilms in such infections remains 
poorly understood, although it has been established that S. aureus produces biofilms on 
damaged skin tissue and that this may be significant during the skin infection process 
(Akiyama et al., 2002; Akiyama et al., 2003). Furthermore, it has also been demonstrated in 
a mouse model, that biofilms of both S. aureus and S. epidermidis significantly inhibit re- 
epithelialisation, i. e. wound healing (Schierle et al., 2009). 
1.2.2.3. Native valve endocarditis (NVE) 
NVE is a condition that results from bacteria or fungi entering the bloodstream and 
subsequent colonisation of the vascular endothelium of the heart valves (Donlan, 2001b). In 
the absence of any indwelling medical device or prior cardiac surgery, NVE is frequently 
associated with intravenous drug abuse, where right-sided valvular endocarditis, in 
particular, often occurs due to the introduction of organisms into the bloodstream (Robbins 
et al., 1986). NVE typically develops on healthy heart valves, however damaged heart valves 
are also colonised as these abnormalities promote valvular thrombus formation (Weinstein 
& Schlesinger, 1974). A valvular thrombus is a mass of fibrin, platelets and erythrocytes that 
forms on the heart valve tissue (Riddle et al., 1989 672). This acts as a point of attachment 
for bacterial cells resulting in the formation of a vegetation (Scheid et al., 1978). Causative 
organisms of NVE form a diverse group ranging from viridans streptococci, enterococci, 
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pneumococci, staphylococci, including S. aureus, to Gram negative bacteria and fungi 
(Tunkel & Mandell, 1992). In the case of S. aureus, fibrinogen and fibronectin binding result 
in adherence to the thrombus and the subsequent vegetation formation (Que et al., 2005). 
It has been suggested that cell wall teichoic acids of S. aureus may also have a role in the 
adherence to endothelial cells (Weidenmaler et al., 2005). 
1.2.2.4. Osteomyelitis 
Osteomyelitis is the infection of bone or bone marrow as a result of the spread of 
microorganisms either haemotogenously or contiguously (Lew & Waldvogel, 1997). 
Haemotogenous osteomyelitis results in the seeding of the bone material with 
microorganisms from the bloodstream. Contiguous osteomyelitis, results from the 
introduction of microorganisms into the bone from surrounding tissues, such as penetrating 
tissue trauma, localised tissue infection or from a contaminated prosthetic joint (Lew & 
Waldvogel, 2004). Various species are capable of causing osteomyelitis in different age 
groups, but S. aureus remains the leading cause of osteomyelitis for all ages (Brady et a/., 
2008). 
1.2.2.5. Cystic fibrosis (CF) 
CF is one of the most commonly inherited diseases in humans (O'Sullivan & Freedman, 
2009). It is characterised by a decrease in electrolyte secretion plus an increase in the 
absorption of airway surface liquid by the lung epithelium, resulting in the formation of 
thick, dehydrated and sticky mucus (Reisin et al., 1994; Matsui et al., 1998). Increased 
mucus viscosity inhibits the normal mucociliary clearance mechanism by which cilia sweep 
mucus upwards to remove inhaled material from the lungs, thereby keeping them relatively 
sterile (Koch & Hoiby, 1993). The deficiencies associated with CF allow the persistence of 
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pathogens in the lungs permitting colonisation and infection. S. aureus is among the first 
organisms to colonise the CF lung but can be controlled by antibiotic therapy. Haemophilus 
influenzae is also capable of colonisation and can coexist with P. aeruginosa. However as 
antibiotic therapy increases P. aeruginosa tends to predominate due to innate and acquired 
resistance to many antibiotic classes (May et al., 1991). Other organisms reported as 
causing infection in the cystic fibrosis lung, particularly during the later stages of the 
disease, include non-tuberculous mycobacteria, members of the Burkholderia cepacia 
complex and Stenotrophomonas maltophilia (Isles et al., 1984; Karpati et al., 1994; Esther et 
al., 2010) 
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1.3. Antibiotic recalcitrance in biofilms 
Bacterial biofilms are highly refractory to inhibition and killing by most classes of 
antimicrobials including disinfectants and antibiotics (Figure 1.6). This phenomenon has 
been widely reported upon in the literature, and occurs in a broad spectrum of organisms. 
Currently, a general mechanism for this broad spectrum recalcitrance remains elusive. 
Several studies have demonstrated inhibition of antibiotic penetration by the biofilm matrix 
(Shigeta et al., 1997), whilst others have attributed resistance to slow growth for reasons 
such as oxygen limitation (Debeer et al., 1994). In addition, there are also reports of 
increased gene transfer and genetic mutation within biofilms that may promote the 
emergence of antibiotic resistant subpopulations (Cvitkovitch, 2004; Allegrucci & Sauer, 
2008). 
1.3.1. Limitation of antibiotic penetration 
Inhibition of antibiotic penetration into the core of biofilms has been demonstrated for 
several organisms. The aminoglycosides amikacin and gentamicin, for example, cannot 
penetrate P. aeruginosa biofilms (Shigeta et al., 1997). This may be due to the positively 
charged aminoglycosides binding to the negatively charged alginate (Gordon et al., 1988). 
Furthermore, the penetration of oxacillin, cefotaxime and vancomycin through S. aureus 
and S. epidermidis biofilms is limited (Singh et al., 2010b). However, the growth of S. aureus 
and S. epidermidis as a biofilm causes no inhibition of amikacin or ciprofloxacin penetration 
(Singh et al., 2010b). These findings suggest that although antibiotic penetration limitation 
may contribute to the refractory nature of biofilm cultures, it does not account for all 
antibiotic recalcitrance observed in biofilms. 
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Figure 1.6 The proposed mechanisms by which biofilms resist killing by antibiotics and other 
antimicrobial agents. A Penetration limitation of the antibiotic by the matrix. B Microenvironments 
reduce bacterial growth resulting in recalcitrance. C Survival of phenotypically or genetically resistant 
organisms due to persistence, genetic transfer or mutation. 
1.3.2. Microenvironments and slow growth 
Mature biofilms harbour populations of cells with slower growth rates than planktonic cells 
(Wentland et al., 1996). Cells with diminished growth rates are thought to exacerbate the 
recalcitrance of biofilms to antibiotics. P. aeruginosa biofilms, for example, show decreasing 
susceptibility to ciprofloxacin with decreasing growth rate (Evans et al., 1991). One factor 
responsible for decreasing the growth rate of bacteria in biofilms may be oxygen depletion 
(Debeer et al., 1994). This is demonstrated by P. aeruginosa biofilms where ciprofloxacin, 
carbenicillin, tobramycin, ceftazidime, chloramphenicol and tetracycline recalcitrance was 
observed as a result of the reduced growth rate of the bacterial cells following oxygen 
limitation (Borriello et al., 2004). 
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Furthermore, cells within biofilms may also undergo the general stress response 
(Liu et al., 2000; Mah & O'Toole, 2001). RT-PCR demonstrated the presence rpoS mRNA in 
CF sputum samples from patients who harbour severe P. aeruginosa biofllm infections 
(Foley et al., 1999). Consistent with this is the observation that E. coli mutants lacking rpoS 
were unable to form mature biofilms when compared with the equivalent wild-type strain 
(Ito et al., 2007). Furthermore, P. aeruginosa biofilms synthesise a sigma factor, AIgT, that is 
thought to act in conjunction with RpoS to regulate the stress response (Cochran et al., 
2000). Immature and mature biofilms of mutants lacking a/gT and rpoS were challenged 
with hydrogen peroxide and monochloramine. Immature biofilms of the mutant showed 
increased susceptibility to hydrogen peroxide, but retained recalcitrance to 
monochloramine when compared with the wild-type strain. In contrast, mature biofilms of 
both the mutant and wild-type were recalcitrant to both antimicrobial agents (Cochran et 
al., 2000). This demonstrates that the stress response only provides partial protection 
against antimicrobial agents, consequently implying the existence of alternative 
recalcitrance mechanisms within bacterial biofilms. 
1.3.3. Persistence 
Bacterial persistence, originally identified in S. aureus, is a phenomenon whereby a small 
proportion (.. 10-6) of a bacterial population is phenotypically tolerant to antibiotics (Bigger, 
1944). These persister cells differ from genetically antibiotic resistant mutants as their 
tolerance to antibiotics is non-inheritable (Jayaraman, 2008). The mechanisms surrounding 
bacterial persistence remain unclear. However, the isolation of a high persister (hip) mutant 
of E. coli identified the hip set of genes as significant in this phenomenon (Moyed & 
Bertrand, 1983). Subsequent isolation and transcriptional analysis of other hip mutant 
persisters, such as the hip A7 mutant of E. coli, identified increased expression of many 
genes, notably those encoding toxin-antitoxin (TA) modules (Keren et al., 2004). TA 
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modules generally consist of two genes, one encoding a stable protein, or 'toxin', that 
functions to inhibit a specific cellular process, and an unstable protein or antisense RNA, 
otherwise known as an 'antitoxin', functioning to inhibit the action of the 'toxin' and 
autoregulate the expression of the TA module (Gerdes et al., 2005). It has already been 
established that TA modules have an important role in plasmid maintenance (Faridani et al., 
2006), but their other roles in the bacterial cell are not completely understood. 
Nevertheless, there are reports of their involvement in programmed cell death (Aizenman 
et al., 1996) and, perhaps most intriguingly, there is evidence for their role as inhibitors of 
macromolecular synthesis, leading to bacteriostasis (Christensen et al., 2001). In this case, it 
has been postulated that inhibition of the synthesis of cellular macromolecules, such as 
DNA, RNA and protein, may lead to the "shielding" of antibiotic targets, resulting in 
insensitivity to said antibiotics. 
The presence of persister cells within biofilms has been suggested to significantly 
contribute to their antibiotic recalcitrance. The E. coli yafQ mutant (part of the dinJ-yafQ TA 
module), for example, can form biofilms comparable to the parental stain. However, 
exposure to cefazolin or tobramycin results in up to 2400-fold reduction in cell survival 
compared to wild-type biofilms (Harrison et al., 2009). 
1.3.4. Genetic transfer and mutation 
In addition to investigating phenotypic antibiotic recalcitrance, some studies have identified 
increased rates of genetic mutation and gene transfer, conferring antibiotic resistance 
(Cvitkovitch, 2004; Allegrucci & Sauer, 2008). In fact, it is thought that biofilms may 
represent an optimal environment for cell-to-cell processes to occur due to the close 
proximity of the cells to one another, resulting in increased diversity within the population. 
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1.3.4.1. Genetic transfer within biofilms 
Bacteria can acquire foreign DNA by transformation, conjugation and transduction. 
Transduction is the process of DNA transfer between bacteria via bacteriophages. This is 
regarded as the most prevalent form of horizontal gene transfer in S. aureus, where phages 
such as 411 and 80a transfer genes between strains (Cohen et aL, 1977; Christie et aL, 
2010; Lindsay, 2010). Tranformation is the process whereby bacteria bind, absorb and 
propagate foreign DNA from the surrounding environment. This occurs at increased rates 
amongst biofilm cultures compared with equivalent planktonic cultures (Maeda et al., 
2006; Blokesch & Schoolnik, 2008). For example, biofilms of V. cholerae grown on chitin 
absorb extracellular DNA at a higher rate than planktonic cultures. This was shown, in part, 
to result from repression of the extracellular nuclease, Dns, upon adherence to chitin 
surfaces (Blokesch & Schoolnik, 2008). Similarly, nonconjugative transfer of plasmid DNA 
occurs at high frequencies in biofilms of E. coli, whereas equivalent planktonic cultures 
showed little or no transformation (Maeda et al., 2006). Furthermore, DNA is an important 
structural component of the biofilm matrix (Tetz et al., 2009). In streptococci the 
competence-stimulation peptide (CSP) cell-to-cell signal is involved in competence for 
transformation, biofilm formation and autolysis. CSP controls genes involved in 
extracellular DNA binding and uptake. Mutations within one such gene, comGB, not only 
reduce DNA binding and uptake but also reduce biofilm formation. To complement these 
findings the presence of DNase during growth of the wild-type strain reduced biofilm 
formation to that of the comGB mutant, suggesting that DNA forms a necessary structural 
component of the biofilm matrix (Petersen et al., 2005). 
Conjugation in Gram negative bacteria has been the most extensively 
characterised, where active transfer of genetic material occurs through direct contact via a 
fertility (F) factor. In its simplest form, this fertility factor takes the form of the F pilus, 
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which is found only in F+ strains. The majority of genes necessary for the assembly of the 
pilus and the transfer of genetic material are found on the tra operon on the F factor. The F 
pilus initiates contact between the cells and then draws them closer via contraction. 
Transfer of the plasmid, via tra encoded type IV secretory system, from donor to recipient, 
renders the recipient F+. The transfer of chromosomal DNA may also occur as a result of 
chromosomal integration and excision by the plasmid (Cvitkovitch, 2004). In Gram positive 
bacteria, the process of conjugation is not as well characterised, but based on sequence 
analysis of conjugative plasmids, significant similarities have been found in the transfer (tra) 
region, but with an absence of pilus-encoding genes (Berg et al., 1998; Dougherty et al., 
1998; Grohmann et al., 2003). 
It is well established that the growth of bacteria on filters can significantly increase 
rates of conjugative transfer (Netherwood et al., 1999). Not only is the chance of cell-to-cell 
contact increased, but it is also thought that some genes involved in conjugation may be 
upregulated upon surface adherence. To assess these processes, numerous studies have 
been conducted to identify increased conjugative gene transfer in biofiims. E. faecalis, for 
example, was shown to transfer a conjugative plasmid containing a tetracycline resistance 
marker approximately 100 times greater than the rate observed in planktonic cultures 
(Cvitkovitch, 2004). 
Not only is it likely that conjugation occurs at higher frequencies in biofilm cultures, 
but some plasmids transferred via this mechanism actually enhance biofilm formation and 
allow the expansion of the population. For example, the conjugative plasmid pOLA52 
encodes the mrk operon which is responsible for type 3 fimbriae expression. Mutations 
within this operon on the plasmid reduce biofilm formation in E. coli up to 100-fold and 
significantly reduce transfer frequencies (Burmolle et al., 2008). Similarly, synergistic 
biofilm stimulation and formation was observed in a heterogeneous population of 
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uncharacterised E. coli strains in combination with the characterised E. coli K-12 strain. 
Although numerous mechanisms were likely to contribute to biofilm induction, the transfer 
of natural conjugative plasmids between strains occurred in the strains exhibiting the 
strongest biofilm stimulating effects (Reisner et al., 2006). 
1.3.4.2. Genetic mutation within biofilms 
In addition to the transfer of genetic material between organisms in biofilms, it has also 
been established that bacteria growing within a biofilm can exhibit increased rates of 
mutation. Streptococcus pneumoniae biofilms, for instance, were shown to have up to 55- 
fold higher mutation frequencies than planktonic cultures, which led to the emergence of 
variants that differed in capsule production, cell attachment and biofilm formation 
(Allegrucci & Sauer, 2008). Similarly, increased MFs and the occurrence of double stranded 
DNA breaks have also been observed in P. aeruginosa biofilms, as a consequence of 
endogenous oxidative stress within the biofilm culture (Boles & Singh, 2008; Driffield et aL, 
2008). 
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1.4. Primary objectives of this research programme 
Currently, there is little standardisation of model systems for biofilm development, and 
many of the biofilm models available are either high-throughput but yield immature 
biofilms, or low-throughput yielding mature biofilms (Ceri et al., 1999; Gander et al., 2005). 
Most of these systems place limitations on experimental design, such as limitations on 
incubation time and the flexibility to incorporate additional conditions into the system. 
Therefore, a novel high-throughput method for generating mature staphylococcal biofilms 
will be developed. Specifically, cellulose membrane disks, incubated with human plasma, 
will be used as a substratum for biofilm formation (Foster & Hook, 1998). Following 
development, the model will be validated using a number of methods, namely antibiotic 
susceptibility testing, D-amino acid induced biofilm degradation, transcriptional profiling 
and microscopy. Specifically, these techniques will be employed to assess the 
characteristics of cultures grown using this system, and compare these data to those of 
previously published staphylococcal biofilms. This system will then be employed for 
investigations of staphylococcal biofilm mutability. 
As previously described, biofilms of several bacterial genera have been shown to 
exhibit elevated mutability when compared with planktonic cultures (Allegrucci & Sauer, 
2008; Driffield et al., 2008). To assess whether this phenomenon is observed in 
staphylococcal biofilms, MFs of cultures grown using both static and flow biofilm models 
will be compared with planktonic cultures. 
The mechanisms driving any observed increases in MF will be elucidated. Previous 
studies have identified a reduction in the expression of antioxidant enzymes in biofilm 
culture. This may result in an increase in intracellular reactive oxygen species, and 
subsequently an increase in MF. With this in mind, antioxidants will be added to biofilm 
cultures and the resulting MFs determined. In addition, DNA microarray analysis will also be 
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performed to reveal any changes in gene expression that may account for increases in MF 
in biofilm culture. 
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CHAPTER 2 
2. Materials and Methods 
2.1. Bacterial strains 
Bacterial strains used throughout this study are described in Table 2.1. 
Table 2.1 Bacterial strains used in this study. 
Strain 
name 
Organism Comments Source or 
Reference 
Selection 
agent(s) 
SH1000 Staphylococcus (Horsburgh et al., None 
aureus 2002a) 
UAMS-1 Staphylococcus Proficient biofilm (Gillaspy et al., None 
aureus forming strain 1995) 
RP62A Staphylococcus Proficient biofilm ATCC35984 None 
epidermidis forming strain 
Newman Staphylococcus (Clauditz et al., None 
aureus 2006) 
Newman Staphylococcus Deletion of the (Clauditz et al., 5 vg/ml 
&crtM aureus staphyloxanthin 2006) chloramphenicol 
synthesis gene crtM 
MHKIIAM Staphylococcus sodA and sodM Gift from Prof SJ 
aureus defective mutant Foster 
KC043 Staphylococcus katA and ahpC Gift from Prof SJ 
aureus defective mutant Foster 
SHIM lux Staphylococcus 
aureus 
SH1000 W1 Staphylococcus 
aureus 
SH1000 W2 Staphylococcus 
aureus 
SH1000 LP1 Staphylococcus 
aureus 
SH1000 LP2 Staphylococcus 
aureus 
Carries luxABCDE Km (Holland et al., 
cassette on 2008) 
chromosome 
Isolated from SH1000 SH1000 
biofilm culture 
Isolated from SH1000 SH1000 
biofilm culture 
Isolated from SH1000 SH1000 
biofilm culture 
Isolated from SH1000 SH1000 
biofilm culture 
5 jig/ml 
tetracycline and 
erythromycin 
5 jig/ml 
tetracycline and 
erythromycin 
50 jig/ml 
ka na mycin 
None 
None 
None 
None 
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2.2. Bacterial growth media, chemicals and reagents 
All growth media were purchased from Oxoid (Basingstoke, Hampshire, UK). All chemicals 
and antibiotics were purchased from Sigma-Aldrich (Dorset, UK), with the following 
exceptions. Mupirocin was donated by GlaxoSmithKline (Brentford, Middlesex, UK) and 
taurine and vanillin were purchased from MP Biomedicals (Illkirch, France). Rifampicin was 
solubilised in 50% dimethyl sulphoxide and mupirocin was solubilised in 50% ethanol. 
2.3. Microbiological techniques 
2.3.1. Standard growth conditions 
Bacterial strains (Table 2.1) were grown at 37°C on Mueller-Hinton agar (MHA). Single 
colonies isolated on MHA plates were inoculated into Mueller Hinton broth (MHB) and 
incubated at 37°C with aeration to yield stationary phase cultures. 
2.3.2. Determination of bacterial susceptibility to antibiotics 
Minimum inhibitory concentrations (MICs) of antibiotics were determined by generating 2- 
fold serial dilution series of the antibiotics (BSAC, 1991). In the case of broth culture MICs, 
bacterial suspensions (106 cfu/ml) were combined with the antibiotic dilutions in 96-well 
microtitre plates (Nunc, Roskilde, Denmark) and incubated at 37°C for 18 hrs with shaking 
at 450 rpm (Titramax 1000, Heidolph, Essex, UK). When determining MICs using solid 
media, antibiotic dilutions were incorporated into MHA. Bacterial suspensions were then 
spotted onto these plates (106 cfu/spot), which were subsequently incubated at 37°C for 18 
hrs. The MIC was defined as the lowest concentration of the antibiotic at which no visible 
bacterial growth was observed. 
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2.3.3. Biofilm culture 
2.3.3.1. Cellulose disk biofilm model 
The disk biofilm model utilised mixed cellulose ester membrane filter disks (25 mm 
diameter, 0.22 µm pore size [Millipore, Billerica, MA, USA]) as a substratum for the 
propagation of staphylococcal biofilms. Sterile disks were preincubated in 4% (v/v) human 
plasma (Normal pooled human plasma with sodium citrate [Sera Laboratories International, 
Bolney, West Sussex, UK]), diluted in 0.05 M carbonate buffer (capsules [Sigma-Aldrich, 
Dorset, UK]), at 4°C overnight (Griffiths & O'Neill, 2009). The disks were then inoculated 
with a stationary phase culture of the test organism. Inoculated disks were subsequently 
placed on brain heart infusion agar (BHA) and incubated at 37°C for a minimum for 48 hrs, 
to allow adequate growth of at least 109 cfu/disk (Figure 2.1). To remove loosely-associated 
non-adherent cells, the disks were washed in sterile saline with gentle agitation. For S. 
aureus biofilms, adherent cells were then removed from the disks by incubation at 37°C for 
30 mins in buffered cellulase (1 mg/ml in 0.05 M citrate buffer [10x stock solution: 0.5 M 
sodium citrate and 0.5 M citric acid to pH 4.6]), which degrades the biofilm 
exopolysaccharide (Cescutti et al., 1998). In the case of S. epidermidis biofilms, cells were 
liberated from the disks by incubation in sodium metaperiodate (625 µM sodium 
metaperiodate and 3.125 mM sodium acetate, diluted in PBS) for 1 hr at 37°C, as this also 
degrades PIA (Kogan et al., 2006). Following incubation all samples were vigorously 
vortexed for 5 mins. In both cases, detached cells were subsequently washed in sterile 
saline and centrifuged for 10 mins at 5000 xg to pellet the cells, and then resuspended in 
sterile saline. These detachment procedures released all visible adherent material; 
however, the efficiency of release of the adherent cells was not determined due to 
resource limitation. 
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Figure 2.1 Image of S. aureus SH1000 96 hr biofilms grown on cellulose disks and incubated on BHA. 
2.3.3.2. Sorbarod biofilm model 
This system utilises small cylindrical filters composed of compacted cellulose fibres 
contained within a sheath, known as sorbarod filters, as a substratum for biofilm formation 
(Hodgson et al., 1995). The apparatus was assembled with Sorbarod filters (Ilacon, 
Tonbridge, UK) placed in the compartment at the top of the collection vessel (Figure 2.2). 
The apparatus was then autoclaved. To promote biofilm formation, 1 ml of 4% (v/v) human 
plasma was then added aseptically to the sorbarod filters, which were subsequently 
incubated at 4°C overnight. The apparatus was then incubated at 37°C to prewarm the 
MHB in the reservoirs prior to inoculation. Filters were inoculated with 1 ml of a stationary 
phase culture of the test organism (1x109 cfu). MHB was then pumped from the reservoirs 
across the inoculated sorbarod filters at a rate of 1 ml/min using a peristaltic pump (Watson 
Marlow 205U/CA, Falmouth, England). This not only initiated biofilm formation, but it also 
provided constant washing of the biofilms, to remove loosely-associated planktonic cells. 
Waste culture was extracted from the collection vessels every 24 hrs. Sorbarod filters were 
then harvested from the apparatus and placed in 10 ml saline. To detach the cells from the 
filter, the biofilms were vigorously vortexed and sonicated for 15 mins. Extended sonication 
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of up to 30 mins did not yield more cells from the biofilms than those sonicated for 15 mins 
(data not shown), suggesting that this process was not detrimental to the integrity of the 
liberated cells. 
Gas filter 
Media 
reservoir 
Peristaltic pump 
tubing 
Figure 2.2 Image of the Sorbarod biofilm apparatus. 
2.3.3.3. Adherent and planktonic population determination 
Location of 
Sorbarod filter 
Waste 
extraction valve 
Waste collection 
vessel 
To determine the proportion of planktonic and adherent cells in cellulose disk biofilms, they 
wer first grown using the method described above. Shed planktonic cells were 
enumerated by serially diluting the cells washed off during the saline wash step, followed 
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by plating on MHA agar. Adherent cells were enumerated by serially diluting the 
resuspended cell pellets after cell detachment, and then plating on MHA agar. The 
proportion of adherent or planktonic cells was then expressed as a percentage of the sum 
of both cell counts. 
2.3.3.4. Determining the proportion of phenotypic variants in planktonic and disk biofilm 
cultures 
Planktonic and disk biofilm cultures were prepared as described above. Planktonic cultures 
were diluted to 102 cfu/ml and enumerated following plating on MHA agar. In the case of 
disk biofilm cultures, the shed planktonic cells collected in the saline wash solution were 
combined with the shed planktonic cells remaining on the agar surrounding the disk 
biofilms. Adherent cells were detached in the manner previously described. Both shed 
planktonic and adherent cells were diluted to 102 cfu/ml, and enumerated by plating on 
MHA agar. The number of phenotypic variants in each culture type was enumerated and 
expressed as a proportion of the total number of colonies. 
2.3.3.5. Determining biofllm dissociation in the presence of amino acids 
Cellulose disk biofilms were allowed to grow for 48 hrs. These were then washed in sterile 
saline with agitation for 10 mins to remove loosely-associated planktonic cells. Biofilms 
were then incubated with either 100 µM L-tyrosine or D-tyrosine (dissolved in PBS), for 
30 mins at 37°C with shaking. All biofilms were then vortexed for 1 min, and then incubated 
with 1 mg cellulase/mI 0.05 M citrate buffer for a further 30 mins at 37°C with shaking. 
Viable counting was performed on both the amino acid (AA) and cellulase solutions. It was 
assumed that all cells were dissociated from the cellulose disk following cellulase 
treatment, as multiple cellulase treatments, or alternative treatments such as proteinase K 
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(data not shown), do not liberate significantly more organisms from the disks. Dissociation 
of cells in the presence of AA was then calculated as follows: 
cells dissociated = [AA cfu/ml / (AA cfu/ml + cellulase cfu/ml)] x 100 
Where AA cfu/ml and cellulase cfu/ml represent the viable counts yielded from the AA and 
cellulase treatments, respectively. 
2.3.4. Mutation frequencies 
MFs were determined in a similar manner to those described by O'Neill et al. (2001). 
Specifically, planktonic and resuspended biofilm cultures were serially diluted in PBS. 
Culture dilutions containing between 107 and 109 cfu/ml (depending on the strain and the 
antibiotic used for selection) were inoculated onto selection plates (MHA) containing 4x 
MIC of the selection antibiotic for isolation of spontaneous resistant mutants. Culture 
dilutions containing -102 cfu/ml were inoculated onto drug free plates (MHA) for 
enumeration of the total number of viable cells in the culture. Plates were incubated for 48- 
72 hrs at 37°C and MFs determined as the number of antibiotic-resistant mutants as a 
proportion of the total cell count. Antibiotic-resistant mutants were subcultured onto 
selective plates, also containing 4x MIC of the selective agent, to confirm the antibiotic 
resistant phenotype. 
2.3.5. Determining hydrogen peroxide susceptibility 
This method was adapted from Clauditz et al. (2006). Stationary phase bacteria were 
resuspended in PBS at a cell density of 106 cfu/ml, supplemented with various 
concentrations of hydrogen peroxide, and incubated at 4°C in the dark for 45 mins. To 
inactivate the hydrogen peroxide, catalase was added to the samples to a final 
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concentration of 2 U/ml. Samples were then serially diluted in PBS, plated on MHA and 
incubated at 37°C overnight. Colonies were then enumerated, and the susceptibility to 
hydrogen peroxide expressed as the percentage survival of the cells compared with the 
hydrogen peroxide-free control. 
2.3.6. Determination of bacterial doubling times 
To determine the doubling times of bacterial strains, their growth was monitored during 
exponential phase. Specifically, MHB media was inoculated with a 1: 200 dilution of a 
stationary phase culture of the test strain. The OD600 value of this culture was then followed 
until it reached 0.1. OD600 measurements were then recorded every 5 mins until the culture 
reached an OD600 value of 0.3. These values were then converted to loglo values and plotted 
against time (mins), and a line of best fit (LBF) calculated. Doubling times for the test strain 
was then determined using the following formula (Koch, 1994): 
Doubling time = Log102/Gradient of LBF 
2.3.7. Time-kill determination 
Time-kill curves in the presence of 32x MIC rifampicin were determined for S. aureus 
planktonic and biofilm cultures. Planktonic cultures were grown overnight and then diluted 
1: 100 into fresh BHB and incubated at 37°C with shaking, until an OD600 0.3 was reached. 
Planktonic cultures were then centrifuged at 5000 xg to pellet the cells. Cell pellets were 
resuspended in 1/10`h volume of BHB containing 32x MIC rifampicin. Conversely, biofilm 
cultures were grown using the cellulose disk model for 48 hrs at 37°C. Biofilms were then 
placed on BHA containing 32x MIC of rifampicin. For both culture types, drug-free control 
samples were also conducted. For biofilm cultures, individual biofilms were harvested 
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hourly and viable counts determined. However, for planktonic cultures, samples were taken 
from the cultures hourly, and the viable counts determined. 
2.4. Microscopy 
2.4.1. Confocal microscopy 
To visualise biofilms grown using the cellulose disk model, S. aureus biofilms were stained 
with FilmTracerTM FM® 1-43 biofilm stain (Invitrogen, Paisley, UK), and then visualised by 
confocal microscopy according to the manufacturers instructions. Images of S. aureus 
biofilm were captured on a Leica TCS SP2 Confocal Laser Scanning microscope under a 100x 
oil immersion objective using excitation/emission wavelengths of 472/580 nm. 
2.4.2. Atomic force microscopy 
S. aureus biofilms were also visualised by atomic force microscopy. Initially, S. aureus 
biofilms were placed on slides and air dried for 20 mins. Samples were then visualised using 
an Asylum MFP3D microscope (Asylum research, Santa Barbara, CA, USA) in tapping mode 
under ambient conditions using a silicone probe (nominal resonant frequency "300kHz 
[Olympus, Essex, UK]). 
2.5. Molecular biology techniques 
2.5.1. Genomic DNA purification 
Cultures were grown in BHB to achieve maximum cell densities. Chromosomal DNA was 
then extracted and purified using the PurElute Bacterial Genomic kit (EdgeBio, 
Gaithersburg, MD, USA). Cell lysis was achieved by supplementing the Spheroblast buffer 
with 150 pg/mI lysostaphin (Sigma, Dorset, UK) and 25% (w/v) sucrose and incubating for 1 
hr at 37°C. 
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2.5.2. Polymerase Chain Reaction (PCR) 
Genomic DNA was amplified using Thermo-start Taq DNA polymerase ReddyMix (ABgene, 
Epsom, UK). All reactions were carried out using 45 µI of ReddyMix, 1.5 µI of 
oligonucleotide primers (10 µM each), up to 3 VI of genomic DNA and DEPC 
(diethylpyrocarbonate) treated water to a final volume of 50 µl. DNA was amplified using 
the conditions detailed in Table 2.2. Oligonucleotide primers (Table 2.3) were synthesised 
by Eurofins MWG Operon (Ebersburg, Germany). Amplified products were visualised using 
agarose gel electrophoresis and subjected to DNA sequencing by Beckman Coulter 
Genomics (Essex, UK). 
Table 2.2 PCR cycling conditions used for the amplification of rsbU and sigB in S. aureus SH1000. 
Phase Temperature (°C) Time (mins) Cycles 
Initial denaturation 94 5 1 
Denaturation 94 1 
Annealing 50 1 30 
Extension 72 1.5 
Final extension 72 10 1 
Hold 4 - - 
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Table 2.3 Oligonucleotide primers used in the PCR amplification of rsbU and sigB in S. 
aureus SH1000. 
Primer Name Sequence (5'-3') 
Fwd_SigB 
_PCR 
TCGCGACATTTATGTGGATA 
Fwd_SigB 
_Int 
CGCGATCAGATAATATAGGT 
Rev_SigB_ Int CGTATTAAAGAAATTGGGCC 
Rev_SigB_ PCR TTTAACACTTTCTGGCGTTT 
rsbU Fwd AGCGCTGTATCCACCATATT 
rsbU Rev TGTTGCGGCAATAACTGGTA 
rsbU Int Fwd CTAGCTTCAGTCACACCATC 
rsbU Int Rev GCTTACAACAAACAATGCTT 
2.5.3. Agarose gel electrophoresis 
To visualise DNA fragments or genomic extracts, samples were subjected to agarose gel 
electrophoresis. Agarose was dissolved in Tris-acetate-EDTA (TAE) buffer (40 mM Tris 
acetate, 1 mM EDTA [Ethylenediaminetetraacetic acid]) to a final concentration of 1% 
(w/v). Molten 1% (w/v) agarose was combined with SYBRsafe DNA gel stain (Invitrogen, 
Paisley, UK) when pouring gels to allow visualisation of DNA. DNA markers, Hyperladder I or 
II (Bioline, London, UK), were used alongside DNA samples to allow determination of 
fragment sizes. A potential difference of 100 V was applied across the gel for 20-30 mins. 
DNA bands were then visualised by exposing the gel to blue light (450-495 nm). If 
necessary, bands were extracted and purified from the gel using the MinElute (elution in 10 
µl) or QlAquick (elution in 30 µI or more) Gel Extraction kit (Qiagen, Crawley, UK) according 
to the manufacturers instructions. 
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2.5.4. DNA quantification 
The concentration of DNA in samples was elucidated by determining their absorbance at 
260 nm. Specifically, a value of 1 represented a DNA concentration of 50 µg/ml (Sambrook 
et al., 1989). DNA purity was checked by determining the ratio of the absorbance values at 
260 nm: 280 nm and 260 nm: 230 nm. Here, ratios of around 1.8 were considered to indicate 
a sample free of contaminating protein and other organic compounds. 
2.5.5. Concentrating DNA by ethanol precipitation 
To increase the concentration of DNA in samples, ethanol precipitation was performed 
(Sambrook et al., 1989). Initially, sodium acetate (3 M pH 5.2) was added to DNA to a final 
concentration of 0.3 M. Two volumes of ice cold 100% ethanol were added to the DNA 
followed by incubation on ice for 15-30 mins. Samples were then centrifuged at 13000 xg 
for 15 mins, followed by careful removal of the supernatant. DNA pellets were washed with 
70% ethanol (v/v) and centrifuged again for 15 mins. The supernatant was removed and the 
DNA pellets air dried. DNA pellets were then resuspended in DEPC treated water or Tris- 
EDTA (TE) buffer (10 mM Tris-HCI, 1 mM EDTA pH 8.0) to the desired concentration. 
2.5.6. Total RNA extraction 
Total RNA was extracted from planktonic cultures and from biofilm cultures, grown using 
the cellulose disk biofilm model, of S. aureus SH1000. Planktonic cultures and resuspended 
biofilm cultures were centrifuged at 5000 xg to pellet cells, and then resuspended in 10 ml 
of RNAprotect bacterial reagent (Qiagen, Crawley, UK), to protect RNA integrity and 
prevent further gene expression changes, and then centrifuged again. The supernatant was 
removed and the pellets stored at -80°C. 
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Pellets were thawed at room temperature and washed in 10 ml of TE buffer to 
remove residual RNAprotect. Washed cells were then centrifuged at 5000 xg to pellet cells. 
Cells were resuspended in 1 ml TE buffer containing 200 Vg/ml RNase free lysostaphin 
(Sigma-Aldrich, Dorset, UK) and incubated at 37°C for 60-90 mins. Following this, proteinase 
K (Sigma-Aldrich, Dorset, UK) was added to the samples, to a final concentration of 
40 Vg/ml, and incubated for 10 mins at room temperature. Total RNA was then purified 
from these samples using the RNeasy Midi kit (Qiagen, Crawley, UK) following the 
manufacturers instructions, including an on-column DNase digestion using the RNase-free 
DNase kit (Qiagen, Crawley, UK). RNA samples were stored at -80°C for up to 1 year. 
The concentration of RNA was calculated by determining the absorbance value at 
260 nm. Specifically, an absorbance value of 1 at this wavelength corresponds to 40 µg/ml 
of RNA (QIAGEN, 2001). 
The purity of RNA in samples was determined by elucidating the ratio of 
absorbance values at 260 nm: 280 nm and 260 nm: 230 nm. Ratio of around 2 were 
considered to be free of protein, or other organic, contaminants (QIAGEN, 2001). 
2.5.7. Analysis of differential gene expression by microarray analysis 
Transcriptional profiling was performed using total RNA extracted from planktonic and 
cellulose disk grown biofilm cultures. cDNA synthesis, cDNA labelling, hybridisation and 
quantification of gene expression was performed by Roche Nimblegen (Madison, WI, USA) 
using 4x72K multiplex microarrays (4 samples at 72,000 probes per sample). Of the 2892 
predicted protein coding open reading frames (ORFs), 2887 were represented on the 
microarrays due to shared probes. Data were analysed using ArrayStarTM (DNASTAR). Here, 
genes were considered to be differentially regulated if they exhibited 2 or more fold up or 
downregulation (Beenken et aL, 2004; Sauer et al., 2004). 
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2.6. Internet resources 
S. aureus NCTC 8325 genome sequence (Last access: 04/08/2010): 
httg: //www. ncbi. nlm. nih. eov/sites/entrez? db=Genome&itool=toolbar 
Genome annotation for S. aureus NCTC 8325 (Last access: 06/09/2010): 
http: //cmr. icvi. orR/tier-scripts/CM R/CmrHomePa, Re. cgi 
S. aureus NCTC8325 gene ontology information (Last access: 06/09/2010): 
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S. aureus microarray meta-database (Last access): 13/09/2010): 
http: //www. bioinformatics. orp, /sammd/ 
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CHAPTER 3 
3. Development of a cellulose disk biofilm model 
3.1. Abstract 
The majority of bacterial biofilm models developed to date are complex and low 
throughput in nature. To address this, a higher throughput system was developed for the 
generation of staphylococcal biofilms that yielded high cell densities, as was required for 
subsequent biofilm mutability investigations. 
This system was initially optimised for use with S. aureus SH1000. Here, human 
plasma was incorporated to promote cellular adherence to cellulose membrane filter disks 
which were incubated on solid media. A minimum concentration of 4% (v/v) was sufficient 
to achieve maximum adherence of S. aureus SH1000 after 48 hrs of incubation, with 
approximately 95% of cells remaining adherent following a saline wash. Subsequently, it 
was established that addition of human plasma every 48 hrs of incubation was required to 
achieve similar levels of adherence when older disk cultures of up to 144 hrs were grown. 
This protocol was also optimised for use with S. aureus UAMS-1 and S. epidermidis RP62A. 
For detachment of S. aureus from the disks, buffered cellulase was effective. However, for 
S. epidermidis, sodium metaperiodate was used. 
Following method optimisation, the system was validated by confirming 
recalcitrance to killing by rifampicin, dissociation in the presence of D-tyrosine, and 
transcriptional profiling to compare gene expression with other S. aureus biofilm models. 
These validation procedures demonstrated this system to be an effective tool for the 
generation of staphylococcal biofilms. Microscopic visualisation using confocal and atomic 
45 
force microscopy revealed the biofilms to possess areas of undulation on their surface and 
a densely packed population of cells. 
In summary, a simple high-throughput biofilm model has been successfully 
developed for use with staphylococci. The high cell numbers achieved with this system 
make it useful for a broad range of applications. 
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3.2. Introduction 
As previously discussed, biofilms are found ubiquitously throughout the natural 
environment. The development, and subsequent investigation, of biofilms in vitro and in 
vivo has proven useful for the expansion of our understanding of these complex microbial 
communities. Indeed, the diverse range of available models has broadened our knowledge 
of both environmentally and medically relevant bacterial biofilms. 
3.2.1. Environmental biofilms 
Growth as a biofilm is common amongst organisms in the natural environment. Where the 
number of bacteria found colonising surfaces, such as riverbed rocks, significantly 
outnumbers those found as planktonic organisms (Zobell, 1943). These range from 
ubiquitous soil organisms to the bacteria colonising extreme ecological niches such as 
volcano vents. Numerous techniques have been developed to investigate biofilms from 
vastly differing environments. The models utilised to investigate biofilms formed by these 
organisms are also diverse, reflecting the differing environments from which they originate. 
One of the most straight forward techniques for studying environmental organisms in the 
field is the suspended slide method. Essentially, a microscope slide is suspended in soil or 
water, allowing the adherence of surrounding organisms (Marshall, 1985). This 
subsequently provides a platform for microscopic visualisation and analysis of these 
organisms directly from their natural habitat. Similarly, techniques utilising slides 
suspended in inoculated growth medium have also been used to investigate antibiofiim 
compounds for use against aquatic organisms such as P. aeruginosa (Borchardt et al., 
2001). Systems have also been developed to investigate other environmental niches. For 
example, rhizosphere biofilms have been studied using seed adherence and rumen biofilms 
via extracted rumenal fluid and particulate feed (Cheng et al., 1981; Espinosa-Urgel et al., 
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2000). Biofilms that colonise animals have also been investigated. Biofilms of Vibriofischeri 
colonising the Euprymna scolopes squid light organ, for example, have been investigated by 
incubating juvenile squid with seawater containing specific inocula and then monitoring 
colonisation and biofilm formation (Nyhoim et al., 2002). 
Techniques have also been developed for the investigation of biofilms found in 
extreme environments, such as those of hyperthermophiles. Indeed, biofilms of 
Archaeoglobus fulgidus were grown on the sides of culture vessels incubated anaerobically 
at 83°C, representing the natural environment of this hydrothermal vent and hot spring- 
dwelling archaeon (Lapaglia & Hartzell, 1997). Furthermore, the influence of microgravity 
on biofilm formation during spaceflight has also been elucidated. Specifically, biofilm 
growth on polycarbonate filters was investigated under microgravity conditions for P. 
aeruginosa (McLean et al., 2001). 
3.2.2. Medically relevant biofilms 
Biofilms are involved in the majority of bacterial infections including, but not limited to, CF, 
osteomyelitis, cutaneous infections, infective endocarditis, indwelling medical device- 
related infections and dental caries (Heimberger & Duma, 1989; May et al., 1991; Shani et 
al., 2000; Akiyama et al., 2003; Brady et al., 2008). Furthermore, the biofilm mode of 
growth is also prevalent amongst members of the human microflora (Macfarlane, 2008). To 
investigate the biofilms formed by such bacteria, as well as their antibiotic susceptibility 
profiles, a broad range of systems have been implemented. These can be categorised into 
in vivo and in vitro systems. 
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3.2.2.1. In vivo systems 
To represent biofilms during infection, on both medical devices and biological tissue, many 
in vivo systems have been employed (Table 3.1). 
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3.2.2.2. In vitro systems 
Many in vitro systems have also been developed to model biofllms formed by pathogens 
and members of the human microflora, some of which have also been used for antibiotic 
susceptibility testing in biofilms (Ceri et al., 1999) (Table 3.2). Compared to in vivo systems, 
the advantages of using such laboratory based techniques include ease of experimental 
control and reduced costs. However, care must be taken when developing in vitro models 
to ensure that they represent the infection, or condition, which they mimic. 
To date, many biofilm models have become available which allow development of 
biofilms from a range of bacterial species. These comprise flow cells, constant-depth film 
fermenters (CDFF), microtitre plate methods, including the Calgary biofilm device (CBD), 
and numerous variations of these (Kinniment et al., 1996; Ceri et al., 1999; Driffield et al., 
2008; Harmsen et al., 2010). These systems can be broadly categorised into continuous or 
batch culture methods, and flow or static culture methods. Flow cultures, such as flow cells, 
utilise a constant flow of liquid media to promote biofilm formation, often on the inside of 
tubing, coupons or Sorbarod filters (Driffield et al., 2008; Kroukamp et al., 2010). These 
systems can be advantageous over static systems (no flow) as they provide constant 
washing of the biofilms, and therefore removal of shed planktonic cells. Models that utilise 
batch cultures also have advantages over continuous cultures. These cultures are 
essentially the same as standard batch cultures, but with the addition of a surface for 
biofilm formation. Advantages include reduced risks of contamination, simple experimental 
design, high-throughput capacity and reduced costs (McLean et al., 2004). 
For the work described in this thesis, a simple high-throughput model was required 
that yielded staphylococcal biofilms of high cell densities for investigation of biofilm 
mutability, as described in future chapters. Accordingly, I developed a cellulose based 
system employing membrane disks on solid media. 
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3.3. Results and Discussion 
For the development of a new biofilm model, cellulose disks were chosen as a substratum 
as they provided a relatively porous material that could easily be manipulated for the 
purposes of biofilm development. 
3.3.1. Optimising adherence 
Initially, attempts were made to develop the cellulose disk model for studies with S. aureus 
SH1000. This strain was chosen due to its capacity to form biofilms, as a result of the repair 
of a mutation in rsbU, present in the parental strain S. aureus 8325-4 (Horsburgh et al., 
2002a). Specifically, this gene encodes a positive regulator of the alternative sigma factor, 
SigB, which has previously been shown to regulate production of adhesive molecules 
necessary for biofilm formation (Nicholas et al., 1999). Furthermore, human serum 
components, such as fibronectin and fibrinogen, promote the adherence of staphylococci 
to surfaces by interaction with these adhesins, such as CIfA, CIfB (clumping factors A and B), 
FnBPA and FnBPB (fibronectin binding proteins A and B) (O'Brien et al., 2002; Keane et al., 
2007). To exploit this, human plasma was added to the model to promote adhesion 
(Griffiths & O'Neill, 2009). Firstly, the minimum concentration of human plasma that 
promoted maximum adherent viable cell numbers was determined. To do this, disk cultures 
were first washed in saline to remove the non-adherent planktonic population of cells, and 
then incubated in buffered cellulase for 30 mins to induce detachment from the cellulose 
disks. Cellulase was used at it had previously been shown to cause inhibition and 
dissociation of biofilm cultures (Cescutti et al., 1998; Loiselle & Anderson, 2003). These data 
revealed that 4% (v/v) human plasma was sufficient to achieve a maximum adherent 
population of S. aureus SH1000, of around 2x 1010 cfu/disk, following 48 hrs of incubation 
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(Figure 3.1). Specifically, addition of human plasma to the system increased the proportion 
of adherent cells from 10%, in the absence of human plasma, to 93% (Figure 3.2). 
The method was then optimised for the development of older adherent cultures, to 
allow the formation of more mature biofilms. This was necessary as it became apparent 
that prolonged incubation of the cultures, at 144 hrs for example, resulted in a significant 
reduction in the amount of adherent cells, presumably due to degradation of plasma 
components (Figure 3.3). To address this issue, cultures were submerged in 4% (v/v) human 
plasma every 48 hrs and placed on a fresh BHA plate. This significantly improved the yield 
of adherent cells from 16% to 83% (Figure 3.3). 
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Figure 3.1 Optimisation of the cellulose disk biofilm model for use with S. aureus SH1000. Human 
plasma was diluted in 0.05 M carbonate bicarbonate buffer. The x-axis label 0 represents no human 
plasma or buffer, and 0(B) is buffer only. Data indicate the proportion of adherent cells, in 48 hr disk 
cultures, as a percentage of the maximum achieved at 10% (v/v) human plasma (red line). Data are 
based on three experimental replicates. Error bars indicate standard deviations. Maximum bound 
cells using 10% (v/v) human plasma was ^'1.8x1010 cfu/disk. 
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Figure 3.2 Determination of the proportion of adherent and planktonic cells present in S. aureus 
SH1000 cellulose disk cultures grown for 48 hrs, in the presence and absence of 4% (v/v) human 
plasma. Data are based on three experimental replicates. Error bars indicate standard deviations. 
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Figure 3.3 Optimisation of growth conditions for S. aureus SH1000 cellulose disk cultures grown for 
longer than 48 hrs. Graph illustrates the effect of human plasma addition every 48 hrs on biofilms 
grown for 144 hrs, compared with equivalent cultures only provided with human plasma before 
inoculation. Data are based on three experimental replicates. Error bars indicate standard 
deviations. 
55 
No human plasma 4% human plasma 
Preincubation with 4% human plasma 
4% human plasma added every 48 hrs 
0 
J 
0 
U 
U 
4J 
f0 
00 
0 
J 
1 
Figure 3.4 Adherent cell numbers of S. oureus UAMS-1 and S. epidermidis RP62A disk cultures 
compared with S. aureus SH1000. Data based on three experimental replicates. Error bars indicate 
standard deviations. 
The cellulose disk-human plasma protocol was also effective for use with S. aureus 
UAMS-1 and S. epidermidis RP62A. Compared with S. aureus SH1000, a small reduction, of 
0.8-0.9 log units, in adherent cells was observed for both UAMS-1 and RP62A (Figure 3.4). 
Buffered cellulase proved ineffective for liberating adherent S. epidermidis RP62A cells from 
the cellulose disks. As an alternative, a sodium metaperiodate/sodium acetate solution was 
used, as this has been reported to degrade the PIA matrix of S. epidermidis RP62A biofilms 
(Kogan et a/., 2006). Initially the MIC of sodium metaperiodate, in a 1: 5 ratio with sodium 
acetate (Kogan et al., 2006), was determined using broth microdilution. This was found to 
be 2.5 mM sodium metaperiodate and 12.5 mM sodium acetate. Accordingly, the mixture 
was then used at a subinhibitory concentration of'/4 x MIC for 30 min at 37°C, to promote 
biofilm dissociation. 
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3.3.2. Model validation 
As with any newly developed model system, validation that the organisms were growing as 
a biofilm was necessary. This was done by comparison with existing systems. One of the 
most broadly accepted and documented characteristics of biofilm cultures is their 
recalcitrance to antibiotics (Ito et al., 2009). Accordingly, to validate the cellulose disk 
model, time kill curves were determined for planktonic cultures and adherent bacteria 
grown using this system (Figure 3.5). Specifically, exponential phase planktonic cultures 
were concentrated and exposed to 32x MIC of the RNA polymerase inhibitor, rifampicin 
(MIC = 0.0078 µg/ml) (Campbell et al., 2001). In a similar manner, adherent cultures were 
grown for 48 hrs and then placed on agar plates containing 32x MIC rifampicin. Planktonic 
time kill data revealed that rifampicin reduced the number of viable cells by 2 logs after 5 
hrs. In contrast, adherent cultures demonstrated no significant reduction in viable cell 
number after 5 hrs of exposure. This demonstrates that the cellulose disk model is capable 
of growing adherent cells of S. aureus that are recalcitrant to antibiotics, i. e. with the same 
phenotypic characteristics as other established biofilm systems. 
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D-amino acids cause the breakdown of biofilms formed by staphylococci, and other 
bacterial species, a phenomenon not observed in the presence of L-enantiomers. This is 
due to incorporation of D-amino acid, such as D- tyrosine, into the peptide side chains of 
the cell wall instead of D-alanine (Kolodkin-Gal et al., 2010). Accordingly, the dissociation of 
adherent S. aureus SH1000 cultures in the presence of a D-amino acid was assessed (Figure 
3.6). In the presence of D- and L-tyrosine, 71.1% and 7.0% of the total population was 
dissociated, respectively. This again demonstrates that adherent organisms, generated 
using this system, behave in a similar manner to those generated in other established 
biofilm systems. However, due to the short incubation time with D-tyrosine, and the use of 
buffer, it is unlikely that bacterial cell division, and therefore peptidoglycan biosynthesis, 
would occur. Dissemination in the presence of D-amino acids in this case must therefore 
result from a secondary mechanism. 
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Figure 3.6 The dissociation of adherent cells of S. aureus SH1000 on cellulose disks in the presence of 
D-tyrosine and L-tyrosine. Data are based on three experimental replicates. Error bars indicate 
standard deviations. 
Several studies have generated transcriptional profiles of staphylococcal biofilm 
cultures, compared with planktonic cultures (Beenken et al., 2004; Resch et al., 2005). It 
was therefore appropriate to conduct DNA microarray analysis of adherent S. aureus 
SH1000 cultures, generated using the cellulose disk model, and compare these data with 
those of equivalent planktonic cultures to identify differentially regulated genes (an in 
depth discussion of the transcriptional profiles generated will be presented in Chapter 5). 
Differential gene expression profiles could then be compared with the previously published 
DNA microarray data. 
The transcriptional profiles of cultures generated using the cellulose disk model 
were compared to the available transcriptional profiles of other S. aureus biofilms 
(http: //www. bioinformatics. org/sammd/) to identify similarities in gene expression. 
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Initially, genes involved in biofilm formation were considered (Table 3.3). Statistical analysis 
of differentially regulated genes can be found in Appendix tables A. 1-A. 3. PIA synthesis 
genes (ica genes) were downregulated at 48 hrs of growth, most likely as a result of the 
upregulation of the negative regulator IcaR. Expression from the ica operon, and therefore 
PIA production, is thought to occur during the early stages of surface colonisation, and 
diminish as the biofilm ages (Vandecasteele et al., 2003; Beenken et al., 2004). Therefore, 
PIA synthesis genes may have been upregulated early in cellulose disk cultures, or 
alternatively, these adherent cells may not produce a PIA matrix. Indeed, many 
staphylococci are able to form biofilms without production of PIA, by generation of a 
proteinaceous matrix (Dice et al., 2009). Little differential regulation of genes involved in 
adhesin production was observed in cellulose disk cultures, such as those of clumping 
factors and fibronectin binding proteins, as observed in other biofilm systems (Resch et al., 
2005). In fact, both CIfA, which binds serum components such as fibrinogen (Keane et aL, 
2007), and SdrC, which promotes nasal epithelial cell colonisation (Corrigan et al., 2009), 
were downregulated in 144 hr and 48 hr cellulose disk cultures, respectively, when 
compared with planktonic cultures. However, a putative fibrinogen binding protein was 
upregulated in 48 hr disk cultures. 
Due to the protocol utilised for the collection of biofilm cells, where biofilms were 
washed in PBS and dispersed with buffered cellulase, significant gene expression changes 
may have occurred prior to the addition of RNAprotect. Therefore, although these data 
provide a valuable insight into the biofilm transcriptome, performing RT-PCR to corroborate 
these results would have been useful, had time permitted. 
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Table 3.3 Differential gene expression (fold change) of genes involved in biofilm formation and 
adherence in 48 hr disk (D48h) versus planktonic (P) cultures, 144 hr disk (D144h) versus planktonic 
cultures and 144 hr versus 48 hr disk cultures of S. aureus SH1000. Data are the mean of three 
experimental replicates. 
Locus tag Gene Function Fold change Fold change Fold change 
name P/D48h P/D144h D48h/D144 
h 
SAOUHSC_00620 sarA accessory regulator A 1.231 up 1.339 down 1.648 down 
SAOUHSC_03003 icaD poly-beta-1,6-N-acetyl-D- 2.236 down 1.356 down 1.648 up 
glucosamine synthesis 
protein IcaD 
SAOUHSC_03004 ica8 biofilm PIA synthesis 2.019 down 1.381 down 1.461 up 
deacetylase IcaB 
SAOUHSC_03002 icaA poly-beta-1,6-N-acetyl-D- 2.775 down 1.550 down 1.790 up 
glucosamine synthase 
SAOUHSC_03005 icaC biofilm PIA synthesis 1.479 down 1.166 down 1.268 up 
protein IcaC 
SAOUHSC_02798 sasG surface protein G 2.247 down 1.468 down 1.531 up 
SAOUHSC_00021 walK sensor protein YycG 1.121 down 1.422 down 1.268 down 
SAOUHSC_03001 icaR biofilm operon icaabcd hth- 5.525 up 2.089 up 2.644 down 
type negative 
transcriptional regulator 
IcaR 
SAOUHSC_00020 wa/R transcriptional regulatory 1.301 down 1.398 down 1.074 down 
protein WaIR 
SAOUHSC_01964 traP signal transduction protein 1.466 up 1.163 up 1.260 down 
TRAP 
SAOUHSC_00505 clpC ATP-dependent Clp 4.311 up 5.157 up 1.196 up 
protease, ATP binding 
subunit CIpC 
SAOUHSC_02862 clpL ATP-dependent Clp 6.058 down 5.460 down 1.109 up 
protease, ATP binding 
subunit CIpL 
SAOUHSC_01378 oppD2 peptide ABC transporter, 1.923 up 1.381 up 1.392 down 
ATP-binding protein 
SAOUHSC_01377 oppF2 peptide ABC transporter, 1.133 up 1.127 up 1.005 down 
ATP-binding protein 
SAOUHSC_02299 rsbW sigmaB negative effector 1.258 up 1.042 up 1.207 down 
RsbW 
SAOUHSC_01897 sigS RNA polymerase sigma 1.533 up 1.052 up 1.456 down 
factor, SigS 
SAOUHSC_00502 ctsR transcriptional regulator 8.875 up 10.829 up 1.220 up 
CtsR 
SAOUHSC_01380 oppB2 peptide ABC transporter, 1.496 up 1.301 up 1.150 down 
permease protein 
SAOUHSC_01379 oppC2 oligopeptide transporter 1.747 up 1.366 up 1.278 down 
membrane permease 
domain 
SAOUHSC_01586 srrA transcriptional regulatory 2.666 up 1.675 up 1.591 down 
protein SrrA 
SAOUHSC_01585 srrB sensor protein SrrB 1.160 up 1.126 up 1.029 down 
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Table 3.3 cont. 
SAOUHSC_00812 clfA clumping factor A 1.924 down 2.391 down 1.242 down 
SAOUHSC_02963 clf8 clumping factor B 1.248 down 1.050 down 1.188 up 
SAOUHSC_02803 fnbA fibronectin-binding protein 1.835 down 1.048 up 1.923 up 
A 
SAOUHSC_00544 sdrC serine-aspartate repeat- 2.322 down 1.330 down 1.746 up 
containing protein SdrC 
SAOUHSC_0054S sdrD serine-aspartate repeat- 1.735 down 1.249 down 1.389 up 
containing protein SdrD 
SAOUHSC_02690 zinc-binding lipoprotein 1.122 up 1.440 up 1.283 up 
AdcA 
SAOUHSC_02802 fibronectin binding protein 1.564 down 1.007 up 1.575 up 
B, putative 
SAOUHSC_01175 fibrinogen binding protein 2.250 up 1.763 up 1.276 dowr 
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Other S. aureus biofilm transcriptional profiles have identified urease (ure cluster) 
and arginine demaminase (arc cluster) activity as being upregulated, compared with 
planktonic cultures (Resch et al., 2005). Accordingly, expression from the ure and arc genes 
was investigated (Table 3.4). Similar to the findings of Resch et al., expression of the ure 
genes was significantly increased. The arc genes, however, were not significantly 
differentially regulated. Biofilm cultures have also previously been identified as 
downregulating the expression of toxins and proteases (Resch et al., 2005). In agreement 
with this, many genes encoding toxins and proteases were also found to be downregulated 
in the cellulose disk system (Tables 3.5 & 3.6). Furthermore, the majority of downregulated 
toxin or protease genes were identified in 48 hr disk cultures, not 144 hr cultures, 
suggesting that this phenomenon may primarily occur in immature adherent populations. 
Of these proteases, several Ssp and Spl type proteases were found to be downregulated. 
Both of these protease types are known to influence biofilm formation, where their 
overexpression, which can result from sigB deletion, inhibits ica-independent biofilm 
formation in S. aureus (Lauderdale et al., 2009; Marti et al., 2010). This suggests that the 
maintenance of extracellular protease levels, by SigB, is necessary for biofilm maturation. 
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Table 3.4 Differential gene expression (fold change) of genes involved in urease (ure) and arginine 
deaminase (arc) production in 48 hr disk (D48h) versus planktonic (P) cultures, 144 hr disk (D144h) 
versus planktonic cultures and 144 hr versus 48 hr disk cultures of S. aureus SH1000. Data are the 
mean of three experimental replicates. 
Locus tag Gene Function Fold change Fold change Fold change 
name P/D48h P/D144h D48h/D144 
h 
SAOUHSC_02561 ureC 
SAOUHSC_02558 ureA 
SAOUHSC_02559 urea 
SAOUHSC_0256S ureD 
SAOUHSC_02563 ureF 
SAOUHSC_02564 ureG 
SAOUHSC_02562 ureE 
SAOUHSC_02964 arcR 
SAOUHSC_02969 arcA 
SAOUHSC_02965 arcC2 
SAOUHSC 01129 arcCl 
urease, alpha subunit 
urease, gamma subunit 
urease, beta subunit 
urease accessory protein 
UreD 
urease accessory protein 
UreF 
urease accessory protein 
UreG 
urease accessory protein 
UreE 
cyclic nucleotide-binding 
domain protein 
arginine deiminase 
carbamate kinase 
carbamate kinase 
2.631 up 1.665 up 1.579 down 
2.285 up 1.565 up 1.460 down 
1.690 up 1.309 up 1.290 down 
4.712 up 1.781 up 2.645 down 
3.365 up 2.008 up 1.675 down 
2.478 up 1.733 up 1.430 down 
2.641 up 1.821 up 1.449 down 
1.694 down 1.290 down 1.312 up 
1.466 down 1.316 down 1.113 up 
1.884 down 1.361 down 1.383 up 
2.320 down 1.500 down 1.546 up 
Table 3.5 Differential gene expression (fold change) of genes involved in protease production in 48 
hr disk (D48h) versus planktonic (P) cultures, 144 hr disk (D144h) versus planktonic cultures and 144 
hr versus 48 hr disk cultures of S. aureus SH1000. Data are the mean of three experimental 
replicates. 
Locus tag Gene 
name 
SAOUHSC_01778 cIpX 
SAOUHSC_01716 
SAOUHSC_00958 
SAO UH SC_01717 
SAOUHSC_00987 ssp8 
SAOUHSC_00988 sspA 
SAOUHSC_01942 splA 
SAOUHSC_01941 sp/B 
SAOUHSC_01939 sp/C 
SAOUHSC_01938 sp/D 
Function 
ATP-dependent protease 
ATP-binding subunit CIpX 
peptidase U32 
serine protease HtrA-like 
peptidase U32 
staphopain B 
glutamyl endopeptidase 
serine protease SpIA 
serine protease SpIB 
serine protease SpIC 
serine protease SpID 
Fold change Fold change Fold change 
P/D48h P/D144h D48h/D144h 
2.952 up 2.650 up 1.114 down 
2.472 up 2.003 up 1.233 down 
1.514 down 1.288 down 1.175 up 
2.811 up 2.189 up 1.283 down 
2.682 down 2.483 down 1.079 up 
4.128 down 2.841 down 1.453 up 
2.111 down 1.405 down 1.502 up 
3.700 down 1.728 down 2.140 up 
2.592 down 1.529 down 1.695 up 
1.888 down 1.258 down 1.501 up 
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Table 3.6 Differential gene expression (fold change) of genes involved in toxin production in 48 hr 
disk (D48h) versus planktonic (P) cultures, 144 hr disk (D144h) versus planktonic cultures and 144 hr 
versus 48 hr disk cultures of S. aureus SH1000. Data are the mean of three experimental replicates. 
Locus tag Gene 
name 
Function Fold change 
P/D48h 
Fold change 
P/D144h 
Fold change 
D48h/D144h 
SAOUHSC_00354 staphylococcal enterotoxin, 1.382 down 1.147 down 1.205 up 
putative 
SAOUHSC_00383 exotoxin 6 1.576 down 1.234 down 1.277 up 
SAOUHSC_00384 exotoxin 7 1.153 down 1.126 down 1.024 up 
SAOUHSC_00386 exotoxin 2.473 down 1.389 down 1.780 up 
SAOUHSC_00389 exotoxin 2.819 down 1.410 down 1.998 up 
SAOUHSC_00390 exotoxin 10 2.314 down 1.457 down 1.587 up 
SAOUHSC_00391 exotoxin 1.982 down 1.327 down 1.493 up 
SAOUHSC_00392 staphylococcal exotoxin 5 1.430 down 1.238 down 1.155 up 
SAOUHSC_00393 exotoxin 1.231 down 1.162 down 1.059 up 
SAOUHSC_00394 staphylococcal exotoxin 3 1.735 down 1.494 down 1.161 up 
SAOUHSC_00395 staphylococcal exotoxin 2 1.384 down 1.257 down 1.100 up 
SAOUHSC_00399 staphylococcal exotoxin 1 1.669 down 1.239 down 1.347 up 
SAOUHSC_01124 exotoxin 1.653 down 1.261 down 1.310 up 
SAOUHSC_01125 exotoxin 1.537 down 1.270 down 1.209 up 
SAOUHSC_01127 exotoxin 1.510 down 1.177 down 1.283 up 
SAOUHSC_01133 exfoliative toxin A 1.186 down 1.155 down 1.026 up 
SAOUHSC_01705 enterotoxin P 1.054 down 1.092 down 1.035 down 
SAOUHSC_01954 leukocidin F subunit 2.301 down 1.497 down 1.536 up 
SAOUHSC_01955 leukotoxin LukE 2.479 down 1.422 down 1.742 up 
SAOUHSC_02241 bi-component toxin 1.474 down 1.302 down 1.132 up 
SAOUHSC_02709 gamma-hemolysin 1.293 down 1.102 up 1.425 up 
component C 
SAOUHSC_01121 alpha-hemolysin 1.152 down 1.049 up 1.208 up 
SAOUHSC_02260 hid delta-hemolysin 5.873 down 10.936 1.861 down 
down 
SAOUHSC_02243 aerolysin/Leukocidin family 1.734 down 1.361 down 1.273 up 
protein 
SAOUHSC_02163 h/b phospholipase C 1.281 down 1.491 down 1.163 down 
SAOUHSC_02240 phospholipase C 1.694 down 1.385 down 1.222 up 
SAOUHSC_02708 gamma-hemolysin h- 1.197 up 2.210 up 1.846 up 
gamma-II subunit, putative 
SAOUHSC_02710 leukocidin F subunit 1.930 down 1.378 down 1.399 up 
SAOUHSC_02709 gamma-hemolysin 1.293 down 1.102 up 1.425 up 
component C 
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3.3.3. Microscopic analysis 
Following optimisation of the cellulose disk model protocol, both confocal microscopy (CM) 
and atomic force microscopy (AFM) were used to visualise, and therefore further 
characterise, bacteria grown in this system. CM was performed using a cell membrane 
fluorescent stain (FilmTracerTM FM® 1-43). This generated images, showing a rough and 
undulating surface structure of the adherent cells (Figure 3.7). This type of surface is similar 
to previously published confocal images of staphylococcal biofilms (Rice et a/., 2007). 
However, these images (Figure 3.7) had poor cellular resolution, possibly due to poor 
staining as a result of interference by the biofilm extracellular matrix. This is a phenomenon 
that has previously been attributed to the slow penetration of chemicals into S. aureus 
biofilms (Jefferson et al., 2005). In response to this, disk cultures of S. aureus SH1000 grown 
for 48 and 144 hrs were subjected to AFM (Figure 3.8 and 3.9) (many thanks to Prof Simon 
Foster's group for assistance). This revealed similar surface structures to those observed 
using CM, whilst also providing significantly increased cellular resolution. No PIA was 
observed in these images. This may result from lack of PIA production by this strain in this 
system, or because this microscopic technique does not allow resolution of such structures, 
as no matrix is obviously apparent in any other published AFM images of biofilm cultures 
(Scher et al., 2007; Oh et al., 2009). However, taken into consideration with the 
transcriptional profiling data, demonstrating downregulation of PIA synthetic genes, it 
would appear that the organisms growing in this system may not be synthesising a 
polysaccharide matrix. 
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A B 
Figure 3.7 Confocal micrographs of cellulose disk biofilms of A S. aureus SH1000 and B S. aureus 
UAMS-1, incubated for 144 hrs. Cells were stained with FilmTracer'" FM® 1-43 
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Figure 3.8 Atomic force micrographs (left column) and 3D surface topography (right column) of 
adherent S. aureus SH1000 cultures grown for 48 hrs and generated using the cellulose disk model. 
Images show areas of A 10 µm2, B 20 µm2 and C 50 µm2. Work performed at the University of 
Sheffield in collaboration with Professor Simon Foster and Dr Robert Turner. 
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Figure 3.9 Atomic force micrographs (left column) and 3D surface topography (right column) of 
adherent S. aureus SH1000 cultures grown for 144 hrs and generated using the cellulose disk model. 
Images show areas of A 10 µm2, B 20 µm2 and C SO µm2. Work performed at the University of 
Sheffield in collaboration with Professor Simon Foster and Dr Robert Turner. 
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3.3.4. Concluding remarks 
Here I have generated a novel biofilm model for use with staphylococci that can develop 
mature biofilms in a high-throughput manner. This was necessary to overcome the 
inadequacies of other currently available systems. 
Cellulose disks were chosen as a substratum for biofilm formation on agar plates, as 
these were inexpensive and easy to manipulate. Human plasma was incorporated into the 
system to exploit the numerous surface proteins in staphylococci that promote biofilm 
formation (Patti et al., 1994). The method was optimised for developing both S. aureus and 
S. epidermidis biofilms for mutability investigations (presented in later chapters). To 
validate the system, kill curves in the presence of rifampicin, dissociation in the presence of 
D-tyrosine and transcriptional profiling were all performed. Bacteria grown using this 
system behaved in a similar manner to documented S. aureus biofilms, where recalcitrance 
to rifampicin, D-tyrosine-induced dissemination and commonalities with published 
transcriptional profiles were observed. Microscopy also allowed the visualisation of S. 
aureus disk cultures generated using this system. This demonstrated a densely packed 
population of cells with a rough and undulating surface. 
All the studies reported here suggest that the cellulose disk model supports the 
growth of staphylococci as biofilms. In addition, the simplicity of the system will enable it to 
be used for a range of applications. 
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CHAPTER 4 
4. Enhanced mutability of S. aureus biofilms and the effects 
of antioxidants 
Work presented in this chapter has also been presented as an oral presentation and as 
poster: 
Ryder, V. J., Miller, K., O'Neill, A. J. & Chopra, I. (2009) Enhanced mutability in 
staphylococcal biofilms. ARM, Birmingham, UK. 
Ryder, V. J., Miller, K., O'Neill, A. J. & Chopra, I. (2009) C1-1356 Enhanced mutability of 
Staphylococcus aureus in biofilms results from oxidative damage. ICAAC, San Francisco, 
USA. 
4.1. Abstract 
Growth as a biofilm renders bacteria recalcitrant to killing by most antibiotic classes. 
Physiological factors like slow growth and the prevention of antibiotic penetration by the 
biofilm matrix may contribute to this phenomenon. Also, the role of the biofilm growth 
phase as a mechanism to maximise gene transfer and genetic mutation is being recognised. 
This process could result in biofilm populations acting as a source of antibiotic resistant 
mutants. Previous studies have identified increased MFs in P. aeruginosa and S. 
pneumoniae biofilms. However, the contribution of genetic mutation in the emergence of 
antibiotic resistance in staphylococcal biofilms has not previously been studied. This work 
sought to investigate the mutability of staphylococcal biofilms, and elucidate mechanisms 
underlying any increased mutability. 
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MFs were determined, using rifampicin and mupirocin selection, for planktonic and 
biofilm cultures. For S. aureus SH1000, increases in MF of up to 4-fold and 14-fold were 
observed in biofilm cultures grown using the cellulose disk model and Sorbarod model, 
respectively. This increase in MF did not result from stationary phase dormancy, as 
stationary phase planktonic cultures demonstrated no increase in MF. S. aureus UAMS-1 
and S. epidermidis RP62A, prominent biofilm forming organisms, exhibited MF increases of 
up to 68-fold and 4-fold, respectively. 
Previous studies have suggested a role for oxidative stress in biofilm mutability. 
Accordingly, antioxidant compounds (taurine, vanillin and ascorbic acid) were incorporated 
into S. aureus biofilms grown using the cellulose disk model. All antioxidants tested reduced 
S. aureus SH1000 biofilm MFs to the level of planktonic cultures. For S. aureus UAMS-1, 
mupirocin selection identified taurine and vanillin as agents that reduced the biofllm MF. 
Rifampicin selection only identified vanillin as reducing the MF. 
Therefore, biofilms appear to represent a bacterial growth phase that is capable of 
accelerating the emergence of antibiotic resistant organisms. Furthermore, the increases in 
MF observed are likely to result from endogenous oxidative stress. 
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4.2. Introduction 
Growth as a biofilm is extensively reported to enable bacteria to resist killing by many 
antibiotic classes (Nickel et al., 1985; Ashby et al., 1994). As previously discussed, antibiotic 
recalcitrance may be phenotypic in nature and result from physiological features of the 
biofilm, such as the matrix, or slow growth as a result of starvation or oxygen limitation 
(Evans et al., 1991; Shigeta et al., 1997; Bordello et al., 2004). Alternatively, increased rates 
of genetic transfer by transduction or conjugation in biofilms, could also contribute to the 
spread of genetically inheritable antibiotic resistance (Cvitkovitch, 2004; Blokesch & 
Schoolnik, 2008). In a similar manner, chromosomal mutation may also have a role in the 
development of antibiotic resistance in the biofilm. Indeed, increased MFs have previously 
been identified in P. aeruginosa and S. pneumoniae biofilms (Allegrucci & Sauer, 2008; 
Driffield et al., 2008). Accordingly, this work sought to demonstrate whether increased MFs 
might be a phenomenon that occurs in staphylococcal biofilms. To do so, investigations 
were undertaken to examine the mutability of planktonic and biofilm cultures of S. aureus 
and S. epidermidis. 
4.2.1. Bacterial mutation 
Genetic mutation in bacteria is a tightly controlled process that directly affects the speed at 
which a population can adapt to the external environment (Brock et al., 1994). Indeed, the 
ability to survive in a changing environment, as a result of mutation, has been extensively 
reported in the characterisation of antibiotic resistant organisms arising in bacterial 
populations (Ovchinnikov Yu et al., 1981; Antonio et al., 2002). Such mutations are 
spontaneous in nature and result from the exposure of DNA to intra- or extracellular 
mutagens, such as reactive oxygen species (ROS) or radiation, or alternatively, the failure of 
DNA repair systems to correct replicative errors. Increased levels of intracellular ROS may 
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occur in biofilms (Beenken et al., 2004; Boles & Singh, 2008), and as such their role in 
mutation will be considered in more detail. 
4.2.1.1. Reactive oxygen species (ROS) 
ROS arise from normal cellular enzymatic reactions in aerobic conditions. Aerobic 
respiration, for example, utilises oxygen reduction to release energy, a by-product of which 
is the formation ROS (Fridovich, 1978). This has been suggested to make the major 
contribution to the production of ROS. However, subsequent reports have suggested that 
aerobic respiration contributes little to total ROS production, with the majority coming 
from other enzymatic reactions (Seaver & Imlay, 2004). These ROS, although important for 
cell signalling, can lead to the oxidation of vital cellular macromolecules such as DNA, 
proteins and lipids, if their levels are not maintained (Armel et al., 1977; Kono & Fridovich, 
1982). 
The reduction of molecular oxygen leads directly to the production of superoxide 
anion radicals (' 021 hydrogen peroxide (H202) and hydroxyl radicals (' OH"), by the removal 
of 1,2 or 3 electrons, respectively (Sies, 1997). These different ROS cause mutations in 
DNA, often through chemical alteration to the hydrogen bonds of the nucleotide moieties, 
resulting in modification of their coding specificity. However, mutation is also thought to 
occur due to conformational changes in the DNA or polymerase as a result of oxidative 
damage (Feig et al., 1994). Superoxide radicals can lead to C to T, G to T or G to C 
substitutions or CC to TT transitions (McBride et al., 1991; Tkeshelashvili et aL, 1991), and 
can also lead to strand breaks (Morgan et al., 1976). Hydrogen peroxide results in single 
stranded and double stranded breaks, although this is thought to be through a Fenton 
reaction with a variable valency metal ion bound to DNA, yielding hydroxyl radicals 
(Ananthaswamy & Eisenstark, 1977; Ward et al., 1987). 
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4.2.2. Antioxidants as antimutagens 
An antioxidant is defined as 'any substance that, when present at low concentrations 
compared with that of an oxidizable substrate, significantly delays or inhibits oxidation of 
that substrate' (Halliwell & Gutteridge, 1989). These agents may be enzymatic or non- 
enzymatic in nature. 
Bacteria utilise both enzymatic and non-enzymatic antioxidants to maintain the 
levels of ROS within the cell. These compounds eradicate various ROS types from the cell, 
and therefore prevent oxidation and subsequent damage to vital macromolecules such as 
DNA. 
4.2.2.1. Staphylococcal antioxidants 
Staphylococci possess numerous antioxidant enzymes that protect cellular macromolecules 
from ROS. Several major iron-dependent global regulators in S. aureus protect against 
oxidative stress. These are SarA, Fur, PerR, Zur and MntR (Horsburgh et al., 2001; Lindsay & 
Foster, 2001; Horsburgh et al., 2002b; Ballal & Manna, 2009). The antioxidant enzymes 
regulated by these proteins can be categorised into the superoxide dismutases (SODs), the 
catalases and the peroxidases (Harris, 1992). 
SODs catalyse the reduction of the superoxide anion into hydrogen peroxide and 
oxygen (McCord & Fridovich, 1968). These enzymes are classified according to the metal 
ion cofactor present in their active site; manganese-dependent, iron-dependent, 
copper/zinc-dependent or nickel-dependent (McCord & Fridovich, 1969; Keele et al., 1970; 
Lengfelder & Elstner, 1979; Kim et al., 1998). The best studied SOD in staphylococci, SodA, 
is a manganese-dependent SOD whose regulation is controlled by SarA (Ballal & Manna, 
2009). Another SOD gene, sodM, has subsequently been identified in S. aureus. SodM was 
shown to possess 75% homology to that of SodA, but is absent in CNS (Valderas & Hart, 
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2001; Valderas et al., 2002). These enzymes have a significant role in the virulence of S. 
aureus in the vertebrate host. Indeed, isogenic sodA, sodM and sodA/sodM deletion 
mutants were less virulent, in a mouse abscess model of infection, when compared to the 
parental strain (Karavolos et al., 2003). 
Catalases reduce hydrogen peroxide to water and oxygen. Only one catalase (KatA) 
has been identified in S. aureus. This enzyme is regulated by Fur and PerR, in an Fe(Il)- 
dependent manner (Horsburgh et al., 2001). Although the involvement of catalase in the 
virulence of staphylococci remains unclear, it may be important for the intracellular 
proliferation of S. aureus in a eukaryotic cell line (Martinez-Pulgarin et al., 2009). 
Similar to catalases, peroxidases function to reduce a range of peroxides, including 
hydrogen peroxide, but with the use of an external electron donor. The alkyl hydroperoxide 
reductase in S. aureus, AhpC, belonging to the family peroxiredoxins, is induced by 
hyperosmotic shock (Armstrong-Buisseret et al., 1995). This peroxidase has been shown to 
work in combination with KatA to protect against hydrogen peroxide. Specifically, 
mutations in either gene resulted in no loss of protection against hydrogen peroxide, due to 
compensatory expression of the other enzyme (Cosgrove et al., 2007). Furthermore, an 
atypical two-cysteine peroxidase (gene allocation SAOUHSC_01822) has recently been 
identified and crystallised from S. aureus NCTC8325, although the function of this remains 
unclear (Bhattacharyya et al., 2009). 
Non-enzymatic antioxidants in S. aureus include pigments, such as staphyloxanthin. 
Staphyloxanthin provides protection against hydrogen peroxide. Specifically, a 
staphyloxanthin-deficient mutant was less able to survive challenge with hydrogen 
peroxide than the parent strain (Clauditz et al., 2006). 
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4.2.3. Oxidative stress within biofilms 
Differential regulation of antioxidant enzyme gene expression has previously been reported 
for several organisms growing in biofilm culture. E. coli, for example, has been shown to 
display reduced expression of sodA (Schembri et al., 2003). Similarly, transcriptional 
analysis of P. aeruginosa biofilms has also revealed reduced expression of antioxidant 
enzymes, namely soda, ahpC and katA (Driffield et al., 2008). S. aureus, however, has been 
shown to up and downregulate sodA expression depending on the strain and biofilm model 
utilised (Resch et aL, 2005; Brady et al., 2006). It was therefore hypothesised that bacteria 
in biofilms may harbour increased levels of intracellular ROS. This may ultimately increase 
the MFs of these biofilm bacteria. Furthermore, the increased numbers of antibiotic 
resistant organisms emerging from P. aeruginosa biofilms, when compared with planktonic 
cultures, has been attributed to increased DNA strand breakage due to endogenous 
oxidative stress (Boles & Singh, 2008; Driffield et al., 2008). 
To assess the role of oxidative stress in the mutation of cells within bacterial 
biofilms, compounds previously demonstrated to possess antioxidant activity and 
antimutagenic activity in bacteria will be used to supplement cultures (Chopra et al., 2003). 
These compounds are vanillin, from the vanilla bean, taurine, which is found in most animal 
tissues, and ascorbic acid (vitamin C), which is found extensively in plants and animals 
(Figure 4.1) (Aruoma et aL, 1988; Kumar et al., 2000; Valpuesta & Botella, 2004). The 
antioxidant mode of action of ascorbic acid is well documented as being a peroxyl and 
oxygen radical scavenger (Jacob & Burri, 1996). Similarly, vanillin can reduce a variety of 
ROS (Lee et al., 2009). Taurine, however, has only been demonstrated to reducing 
hypochlorous acid, but it may function to prevent ROS generation (Schaffer et al., 2009). 
78 
ABC 
0 11 
HW'% Ö NH2 
HO 
H 
HO OO 
HO OH 
Figure 4.1 The chemical structures of antioxidants used in this work. A. Vanillin B. Taurine C. Ascorbic 
acid. 
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4.3. Results and Discussion 
4.3.1. Increased mutability of staphylococcal biofilm cultures 
MICs were first established for the antibiotics to be used in MF determinations (Table 4.1). 
Following this, planktonic and biofilm cultures were assessed for their respective MFs by 
selection of spontaneously arising resistant mutants using the RNA polymerase inhibitor, 
rifampicin, and the isoleucyl tRNA synthetase inhibitor, mupirocin (Hughes & Mellows, 
1980; Campbell et al., 2001). Spontaneous resistance to rifampicin and mupirocin occurs 
due to mutations in rpo8 and ileS, encoding the RNA polymerase ß-subunit and isoleucyl 
tRNA synthetase enzyme, respectively (Ovchinnikov et al., 1983; Yang et al., 2006). All 
stated P values were determined using an unpaired two-tailed Student's t-test. 
Table 4.1 Minimum inhibitory concentrations of the selections antibiotics for use in determining 
mutation frequencies of S. aureus SH1000, S. aureus UAMS-1 and S. epidermidis RP62A. 
MIC (mg/L) 
Strain Rifampicin Mupirocin 
S. aureus SH1000 0.0078 0.125 
S. aureus UAMS-1 0.0156 0.125 
S. epidermidis RP62A 0.0156 0.125 
4.3.1.1. Mutation frequencies in biofims of S. aureus SH1000 
Initially, MFs were determined for S. cure us SH1000 planktonic and biofiim cultures (grown 
using the cellulose disk model). From these data, significant increases in MF were observed 
between mature biofilm cultures and planktonic cultures (Figure 4.2). Specifically, 
statistically significant increases were observed between planktonic and 96 hr biofilm 
cultures, using rifampicin selection (>95% confidence, P=2.57x10-6), and between 
planktonic and both 72 hr and 96 hr biofilm culture, using mupirocin selection (>95% 
confidence, P=1.87x10' and 4.27x10"3, respectively). Biofilms incubated for 96 hrs had 
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increases in MF of 4.1-fold and 4.3-fold for rifampicin and mupirocin selection, respectively. 
Unexpectedly, a reduction in the MF of biofilms grown for 144 hrs, when compared with 
those at 96 hrs, was observed. It was postulated that these biofilms were yielding mutants 
with reduced growth rates, which would therefore not be visible on the selection plates for 
enumeration after 48 hrs of incubation. To investigate this, antibiotic selection plates were 
incubated for 72 hrs, instead of 48 hrs (Figure 4.3). This additional incubation time isolated 
significantly more mutants from the 144 hr biofilm cultures using mupirocin selection 
(>95% confidence, P=2.18x10) and rifampicin selection (>95% confidence, P=1.39x10-2) 
The number of spontaneous mutants yielded after 72 hrs of incubation of the selection 
plates was also assessed for 96 hr biofilm cultures. This did not yield more mutants than at 
48 hrs of incubation (data not shown), suggesting that the additional mutants generated for 
the 144 hr biofilms were indeed slow growing, and not just a result of prolonged 
incubation. 
To confirm that the observations made using the cellulose disk model were not 
specific to a static biofilm model, the experiments were repeated under shear flow using 
the Sorbarod model (Figure 4.4). Similar to the mature 144 hr biofilms grown using the 
cellulose disk model, mutants from this system were also slow growing. Therefore, 
selection plates were once again incubated for 72 hrs. This experiment also revealed 
significant increases in MF between planktonic and biofilm cultures of 13.8-fold and 6.7- 
fold using rifampicin (>95% confidence, P=2.71x10"2) and mupirocin (>95% confidence, P= 
6.67x10-3), respectively. Furthermore, to confirm that human plasma was not mutagenic 
and artificially increasing the MFs of the static biofilm cultures, 96 hr sorbarod biofilms 
were grown in the absence of human plasma (Figure 4.4). This confirmed that these 
cultures had equivalent MFs as those which incorporated human plasma, using both 
81 
rifampicin (<95% confidence, P=5.74x191) and mupirocin selection (<95% confidence, P= 
9.74x10-1). 
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Figure 4.3 Mutation frequencies of S. aureus SH1000 biofilm cultures grown for 144 hrs using the 
cellulose disk biofilm model. Spontaneous mutants were isolated from cultures using rifampicin and 
mupirocin selection. Biofilms were incubated for 144 hrs, and (48) or (72) indicate a 48 or 72 hr 
incubation of selection plates. Data are based on six experimental replicates. Error bars indicate 
standard deviations. 
In addition to exploring the possibility that human plasma was behaving as a 
mutagen, it was also considered that cells within biofilm cultures may be more mutable as a 
consequence of entering a stationary phase of growth. To analyse this, MFs were 
determined for planktonic stationary phase cultures of S. aureus SH1000. Initially, growth 
curves were determined for this strain to establish the onset of the stationary phase (Figure 
4.5). This revealed that S. aureus SH1000 entered stationary phase at approximately 24 hrs, 
and that this continued until at least 120 hrs. Accordingly, MFs were determined for 
stationary phase planktonic cultures incubated for 96 hrs (Figure 4.6), as this represented 
the time point at which the greatest increase in MF occurred in the cellulose disk biofilm 
cultures. This revealed no significant increase in MF compared with the planktonic cultures 
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grown for 18 hrs using either rifampicin (<95% confidence, P=7.72x10-') or mupirocin 
(<95% confidence, P=1.35x10-1) selection, suggesting that entry into the stationary phase 
alone does not influence mutability. 
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Figure 4.4 Mutation frequencies of planktonic and Sorbarod biofilm cultures of S. oureus SH1000. 
Spontaneous mutants arising from these cultures were isolated using rifampicin and mupirocin 
selection. P and B96h indicate planktonic and 96 hr biofilm cultures, respectively. Biofilm cultures 
were incubated in the presence (+HP) and absence (-HP) of 4% human plasma. Data are based on 
three experimental replicates. Error bars indicate standard deviations. 
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Figure 4.5 Growth curve of S. aureus SH1000 in BHB to identify the onset of stationary phase. Data 
are based on three experimental replicates. Error bars indicate standard deviations. 
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Figure 4.6 Mutation frequencies of planktonic (P) S. aureus SH1000 cultures, in BHB, grown for 18 
hrs and 96 hrs. Spontaneous mutants were isolated from cultures using the selection antibiotics 
rifampicin and mupirocin. Data are based on three experimental replicates. Error bars indicate 
standard deviations. 
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4.3.1.2. Mutation frequencies in biofilms of S. aureus UAMS-1 
To confirm that the data obtained with S. aureus SH1000 were not strain specific, MFs were 
also determined for S. aureus UAMS-1 biofilms, grown using the cellulose disk and Sorbarod 
biofilm models, in the same manner as S. aureus SH1000. Significant increases in MF were 
identified in the cellulose disk biofilms at all times points compared with planktonic 
cultures, using both rifampicin (>95% confidence, at 48 hrs P=5.35x10"3, at 72 hrs P= 
3.95x10"3, at 96 hrs P=1.56x10-2 and at 144 hrs P=1.81x10-2) and mupirocin (>95% 
confidence, at 48 hrs P=1.63x10-2, at 72 hrs P=4.90x10-3, at 96 hrs P=1.51x10-4 and at 
144 hrs P=1.79x10-3) selection (Figure 4.7). Here, the maximum MFs observed at 144 hrs 
were 67.8-fold and 9.3-fold higher than the planktonic cultures, for rifampicin and 
mupirocin selection, respectively. The differences in MF determined using rifampicin and 
mupirocin remains unexplained, although this does highlight the need for utilising at least 
two selective agents when investigating mutability. This proficient biofilm-forming strain 
did, however, display significantly larger increases in MF in biofilm culture than S. aureus 
SH1000, using the cellulose disk static system. In contrast, only relatively modest increases 
in MF were observed using the Sorbarod biofilm model (Figure 4.8). Here, rifampicin and 
mupirocin selection identified 2.8-fold and 3.1-fold increases compared with planktonic 
culture, respectively. However, this was only found to be statistically significant using 
mupirocin selection (>95% confidence, P=2.76x10-2) 
4.3.1.3. Mutation frequencies in biofllms of S. epidermidis RP62A 
To investigate whether the observed phenomena on MFs was specific to S. aureus, or 
whether it might be common amongst staphylococci, MFs were determined for S. 
epidermidis RP62A, also using the cellulose disk biofilm model (Figure 4.9). In this case, 
statistically significant differences were observed between planktonic cultures and biofilm 
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cultures at all times points using both rifampicin (>95% confidence, at 48 hrs P=3.35x10"2, 
at 72 hr P=7.01x10-3, at 96 hrs P=6.20x10-3 and at 144 hrs P=1.11x10-2) and mupirocin 
(>95% confidence, at 48 hrs P=7.27x10-3, at 72 hrs P=3.70x10-3, at 96 hrs P=5.98x10-3 and 
at 144 hrs P=1.03x10-2) selection. Maximum MFs were achieved at 72 hrs of incubation for 
biofilm culture, where 4.1-fold and 3.9-fold increases were observed, compared with the 
planktonic cultures, using rifampicin and mupirocin selection, respectively. This 
demonstrates that enhanced mutability in the biofilm mode of growth may therefore be a 
general occurrence amongst staphylococci. 
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Figure 4.7 Mutation frequencies of planktonic and cellulose disk-grown biofilm cultures of S. aureus 
UAMS-1. Spontaneous mutants were isolated from the cultures using A rifampicin and B mupirocin 
selection. P indicates planktonic cultures and 48h, 72h, 96h and 144h indicate biofilm (B) incubation 
time. Data are based on six experimental replicates. Error bars indicate standard deviations. 
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Figure 4.8 Mutation frequencies of planktonic and Sorbarod biofilm cultures of S. aureus UAMS-1. 
Spontaneous mutants arising from these cultures were isolated using rifampicin and mupirocin 
selection. P indicates planktonic and B144h indicates 144 hr biofilm (B) cultures, respectively. Data 
are based on three experimental replicates. Error bars indicate standard deviations. 
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4.3.2. S. aureus biofilm mutability and the effects of antioxidants 
4.3.2.1. Exogenous antioxidant agents 
There have been some reports suggesting that bacteria may suffer from endogenous 
oxidative stress when growing as a biofilm (Boles & Singh, 2008; Driffield et al., 2008). This 
suggested that increased levels of intracellular ROS in the biofilm may be responsible for 
the increase in MF observed for staphylococci in biofilms, as reported in earlier sections of 
this chapter. To test this hypothesis, three antioxidants were incorporated into the 
cellulose disk biofilm model in an attempt to reduce the level of ROS, and subsequently 
MFs, within the biofiims. 
S. aureus strains were assessed for their susceptibility to the test antioxidant 
compounds using broth microdilution (Table 4.2). Antioxidants were subsequently used at a 
concentration of 1%x MIC (in order to minimise any detrimental effects on growth), with the 
exception of taurine, which was used at 1mg/ml as it had no recordable MIC. 
Table 4.2 Minimum inhibitory concentrations of the antioxidant compounds used to supplement 
planktonic and biofilm cultures, as determined by broth microdilution. 
Antioxidant MIC (g/L) 
Strain Taurine Vanillin Ascorbic acid 
SH1000 >8 4 0.125 
UAMS-1 >8 4 0.125 
Following this, planktonic cultures of S. aureus SH1000 were supplemented with 
antioxidants, and the MFs determined (Figure 4.10). Addition of antioxidants revealed no 
reduction in the MF of the planktonic cultures, suggesting that bacteria within these 
cultures do not suffer a high degree of oxidative stress. However, the antioxidants did 
significantly increase MFs when rifampicin was used as the selective agent (>95% 
92 
confidence, with Taurine P=5.36x10-6, with vanillin P=2.72x104 and with ascorbic acid P= 
7.15x10-5) (Figure 4.10). The basis of this response is unknown. Subsequently, the same 
antioxidants were used to supplement S. aureus SH1000 biofilm cultures grown using the 
cellulose disk model for 96 hrs (Figure 4.11). Biofilms were incubated for 96 hrs, as cultures 
of this time point demonstrated the greatest increase in MF compared with planktonic 
cultures, in the absence of antioxidants. The antioxidants significantly reduced the MFs of 
the 96 hr biofilm cultures to the level of the planktonic cultures, using both rifampicin 
(>95% confidence, with taurine P=2.25x10-5, with vanillin P=1.64x10-5 and with ascorbic 
acid P=4.67x10-6) and mupirocin (>95% confidence, with taurine P=3.27x10-3, with vanillin 
P=3.66x10-3 and with ascorbic acid P=3.80x10-3) selection (Figure 4.11). These biofilms, 
therefore, may be suffering from endogenous oxidative stress. 
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To confirm these data, antioxidants were also added to S. aureus UAMS-1 
planktonic and biofilm cultures. Antioxidant compounds had no significant effect (<95% 
confidence) on the MF of UAMS-1 planktonic cultures, except vanillin that marginally, but 
significantly, increased the MF using rifampicin (>95% confidence, P=5.35x104) selection 
(Figure 4.12). Biofilms were grown, using the cellulose disk model, for 144 hrs, as biofilm 
cultures at this time point demonstrated the greatest increase in MF compared with 
planktonic cultures, in the absence of antioxidants. Here, the antioxidant compounds had 
differing effects on the MFs of the biofilm cultures (Figure 4.13). In the case of mupirocin 
selection, all antioxidants significantly reduced the MF of the biofilm cultures (>95% 
confidence, with taurine P=4.11x10-3, with vanillin p=5.59x10"3 and with ascorbic acid P= 
2.91x10"2). However, whilst using rifampicin selection, neither taurine (<95% confidence, P 
= 9.19x10-2) nor ascorbic acid (<95% confidence, P=1.95x10") significantly affected the 
biofilm MFs, and only vanillin reduced the MF (by 5-fold) (>95% confidence, P=2.99x10"3). 
The inability of some of these antioxidants to reduce the biofilm MFs of this strain is 
unexplained. 
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Figure 4.13 Mutation frequencies of S. aureus UAMS-1 planktonic and biofilm cultures supplemented 
with antioxidants. Spontaneous mutants were isolated from cultures using the selection antibiotics A 
rifampicin and B mupirocin. P indicates planktonic cultures in the absence of antioxidants, 144h 
indicates biofilms (B) incubated for 144 hrs and those supplemented with taurine (Tau), vanillin (Van) 
and ascorbic acid (Asc), respectively. Data are based on six experimental replicates. Error bars 
indicate standard deviations. 
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4.3.2.2. Endogenous antioxidant enzymes 
To assess the role of antioxidant enzymes in the mutability of S. aureus biofilms, strains of 
S. aureus SH1000 defective in either sodA/sodM (MHK11AM) or ahpC/katA (KC043) were 
investigated for their respective MFs. Initially, rifampicin MICs were determined for each of 
these strains. 
Table 4.3 Rifampicin minimum inhibitory concentrations of antioxidant enzyme defective mutants of 
S. aureus SH1000, as determined by broth microdilution. 
MIC (mg/L) 
Strain Rifampicin 
S. aureus MHK11AM 0.031 
S. aureus KC043 0.031 
Mupirocin selection had previously been found to be unsuitable for use in 
conjunction with additional selective agents for maintaining chromosomal mutations or 
plasmids (data not shown); therefore MFs were only determined using rifampicin selection 
for these strains. When compared with S. aureus SH1000, S. aureus MHK11AM had 
significant increases in planktonic MFs of 2.8-fold (>95% confidence, 1.78x10-2) (Figure 
4.14). Biofilm MFs increased 2.2-fold, when compared with S. aureus SH1000 but this was 
not found to be statistically significant (<95% confidence, P=5.30x10"2). This suggests that 
disrupting sodA and sodM expression does not significantly influence biofilm mutability, 
compared with planktonic culture. Following this, MFs were also determined for S. aureus 
KC043. Here, significant increases in planktonic MFs of 10.1-fold were observed (>95% 
confidence, P=4.69x10-6). Furthermore, biofilm MFs were increased 7.9-fold and were 
statistically significant (>95% confidence, P=2.76x10"5). Therefore, for both of these 
strains, the fold change in MF that occurs due to the absence of antioxidant enzymes is 
similar for planktonic and biofilm cultures. This demonstrates that although loss of 
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antioxidant enzymes causes an increase in mutability, this is not exacerbated by growth as 
a biofilm, and that loss of these enzymes is not therefore responsible for the increase in 
mutability observed in biofilms. 
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Figure 4.14 Mutation frequencies of S. aureus SH1000 and MHK11AM planktonic cultures (P) and 
biofilm cultures (B) incubated for 96 hrs generated using the cellulose disk biofilm model. 
Spontaneous mutants were isolated from cultures using rifampicin selection. Data are based on six 
experimental replicates. Error bars indicate standard deviations. 
6.0x10-' 
5.0x106 
4.0x10-6 
a 
3.0x10-6 
2.0x10-6 
1.0x106 
0 
Figure 4.15 Mutation frequencies of S. aureus SH1000 and KC043 planktonic cultures (P) and biofilm 
cultures (B) incubated for 96 hrs generated using the cellulose disk biofilm model. Spontaneous 
mutants were isolated from cultures using rifampicin selection. Data are based on six experimental 
replicates. Error bars indicate standard deviations. 
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4.3.3. Concluding remarks 
The data presented in this chapter have demonstrated that the growth of S. aureus and S. 
epidermidis as a biofilm confers an increase in mutability, when compared with planktonic 
cultures. This has been demonstrated for multiple strains in both static and flow biofilm 
models. To elucidate the role of oxidative stress in the mutability of biofilm cultures, 
antioxidant compounds were incorporated into biofilm cultures. Overall, the antioxidant 
agents were able to reduce the MFs of the biofilms significantly. This suggests that ROS play 
is significant role in Biofilm mutability. Furthermore, MFs of antioxidant enzyme defective 
mutants were also determined. However, although this revealed increases in MF for both 
planktonic and biofilm cultures compared to the wild-type, the fold increase in MF 
previously observed between planktonic and biofilm cultures was maintained in these 
mutants. This demonstrates that the mechanism driving biofilm mutability was distinct 
from the antioxidant enzymes being investigated. 
Increased mutability within biofilms, driven by endogenous oxidative damage, may 
therefore be a universal phenomenon amongst staphylococci that can accelerate the 
emergence of antibiotic resistance. 
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CHAPTER 5 
5. Investigating S. aureus biofilm development and enhanced 
mutability by transcriptional profiling 
5.1. Abstract 
DNA microarray analysis was performed to reveal the transcriptional profiles of S. aureus 
planktonic cultures and biofilms grown using the cellulose disk model. This analysis aimed 
to identify genes potentially involved in biofilm maturation and elucidate mechanisms 
underlying the increased mutational status of these biofilm cultures. 
When the transcriptional profiles of 48 hr and 144 hr biofiim cultures were 
compared, several functional groups were highly represented. At 144 hrs amino acid 
biosynthesis, cell envelope synthesis, regulatory functions, transport and binding groups all 
contained several differentially regulated genes. Specifically, at 144 hrs, many genes 
involved in histidine biosynthesis and encoding membrane proteins were found to be 
upregulated. Furthermore, at 144 hrs, transcriptional regulators that repress biofilm 
formation were found to be downregulated, whilst those that promote biofilm formation 
were upregulated. 
To investigate biofilm mutability, the expression levels of genes conferring 
antioxidant activity and encoding DNA repair activity were investigated. Antioxidant genes 
were found to be largely unaffected, with only sodA upregulated in the 48 hr biofilms. 
Staphyloxanthin expression, however, was significantly reduced. DNA repair genes were 
significantly upregulated in biofilm culture. The increased mutability previously observed 
during the biofilm mode of growth in S. aureus is therefore associated with an increase in 
DNA repair activity. 
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5.2. Introduction 
DNA microarray analysis has been used extensively to assess the transcriptional profiles of 
bacteria grown under different conditions. This technique is particularly useful as it can 
simultaneously provide information on the expression levels of all genes a given genome. In 
biofilm studies, this technique has been used to try to identify changes in gene expression 
between planktonic and biofilm cultures. Biofilm models utilised for such transcriptional 
profiling have included both static and flow culture systems, and have identified that gene 
expression in biofilms is distinct from that of both exponential and stationary phase 
planktonic growth (Beenken et al., 2004; Resch et al., 2005). However, data generated from 
microarray analysis can be affected by the biofilm model, growth media and strain used, as 
well as the microarray platform employed (Nagarajan et al., 2009). 
This work sought to utilise DNA microarray analysis to identify genes differentially 
expressed between 144 hr and 48 hr biofilms to investigate biofilm maturation and to 
elucidate a mechanism by which S. aureus becomes more mutable whilst growing as a 
biofilm. In addition, this was the first transcriptional profiling of S. aureus SH1000 biofilms, 
and will therefore provide a useful comparison with the biofilm transcriptional profiles 
already compiled on other S. aureus strains such as S. aureus UAMS-1 and 113 (Beenken et 
al., 2004; Resch et al., 2005). 
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5.3. Results and Discussion 
To assess the transcriptional status of planktonic and biofilm cultures, total RNA was 
extracted from planktonic cultures and 48 hr and 144 hr biofilm cultures, grown using the 
cellulose disk biofilm model, of S. aureus SH1000. The transcriptional profiles of these 
cultures were then determined by DNA microarray analysis, performed by Roche 
Nimblegen. The arrays contained probes for 2887, out of 2892, predicted coding sequences 
of the S. aureus NCTC 8325 genome due to shared probes. Microarray data were analysed 
using ArrayStarTM 4 software (DNASTAR), where genes exhibiting 22-fold difference in 
expression were regarded as being significantly differentially expressed (Beenken et al., 
2004). Statistical analysis of differentially regulated genes can be found in Appendix tables 
A. 1-A. 3, 
In 48 hr and 144 hr biofilms compared with planktonic cultures grown overnight, 
831 and 262 genes were differentially expressed, respectively (Figure 5.1 A and B). 
However, when biofilm cultures were compared, only 110 genes were differentially 
expressed (Figure 5.1C). From this it was concluded that the majority of differential gene 
expression in biofilms, when compared with planktonic cultures, occurs in the early stages 
of biofilm formation. For a comprehensive list of differentially expressed genes, please see 
Appendix tables A. 1-A. 3. 
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Genes were grouped according to the JCVI gene ontology classification 
(http: //cmr. icvi. org/cgi-bin/CMR/GenomePage. cgi? org=ntsa05). In both biofilm culture 
conditions, many cell envelope-associated genes were downregulated, when compared 
with planktonic culture (Figure 5.2 and 5.3A). This supports previous reports which 
identified little increase in viable cells following biofilm establishment, suggesting 
significantly reduced growth rates in the biofilm (Evans & Holmes, 1987; Prosser et al., 
1987). By comparison, differentially expressed genes involved in transport and binding 
were found to be mostly downregulated in 48 hr biofilms, but upregulated in 144 hr 
biofilms (Figure 5.2 and 5.3A). Furthermore, differentially expressed genes in the purine, 
pyrimidine, nucleotide and nucleoside groups, those involved in DNA metabolism and 
protein synthesis were mostly upregulated in both biofilm conditions (Figure 5.2 and 5.3A). 
Little difference was observed between the 48 hr and 144 hr biofilm cultures, 
where the majority of differentially expressed genes encoded hypothetical proteins. Of the 
genes assigned into ontological groups, differentially expressed genes were mostly 
transport and binding proteins, cell envelope-associated proteins or amino acid synthesis 
proteins, where the majority were upregulated. 
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Unclassified, Unknown function and Hypothetical proteins 
Transport and binding proteins 
Transcription 
Regulatory functions 
Purines pyrimidines nucleosides and nucleotides 
Protein synthesis 
Protein fate 
A Mobile and extrachromosomal element functions 
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Figure 5.3 Differentially expressed genes in A 144 hr biofilm cultures compared with planktonic 
cultures and B 144 hr biofilm cultures compared with 48 hr biofilm cultures of S. aureus SH1000. Red 
and green bars indicate downregulation and upregulation of genes, respectively, by 2 or more fold in 
the 144 hr biofilm cultures. Data are based on the mean of three experimental replicates. 
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5.3.1. Investigating biofim maturation 
To investigate the transition in gene expression from 48 hrs to 144 hrs of biofilm growth, 
differential gene expression between these biofilm cultures was assessed. A comprehensive 
list of all genes differentially regulated between biofilm cultures can be found in Appendix 
Table A. 3. 
Significantly fewer differentially expressed genes (110 genes) were observed 
between biofilm cultures, than were observed in biofilms compared with planktonic 
cultures (up to 831). Of these genes, 66 were found to encode hypothetical proteins or 
proteins of unknown function. The remaining 44 genes are listed in Table 5.1. Overall, a 
number of genes involved in amino acid biosynthesis, cell envelope functions, regulatory 
functions and transport and binding were upregulated. 
Among the amino acid biosynthesis genes found to be upregulated, genes involved 
in histidine biosynthesis (his operon) were highly represented. Many putative membrane 
proteins were upregulated in the cell envelope group. Furthermore, several transcriptional 
regulators were differentially regulated in 144 hr biofilms compared with 48 hr biofilms. Of 
these regulators, MgrA expression was reduced and SarT expression was increased. MgrA is 
a regulator of autolysis, virulence and efflux pump expression (Ingavale et al., 2005). This 
regulator represses biofilm formation in an ica-independent manner, by control of surface 
protein expression and downregulation of RNAIII from agr (Trotonda et al., 2008). 
Conversely, SarT controls expression of alpha haemolysin, and inactivation of this regulator 
causes an increase in RNAIII from agr (Schmidt et al., 2001). The agr TCS and production of 
the regulatory RNAIII, influence the production of biofilms in an ica-independent manner, 
through control of genes such as extracellular proteases (Boles & Horswill, 2008; 
Lauderdale et a!., 2009). Although no significant difference in gene expression was 
observed for agr, significant downregulation of delta haemolysin, encoded by RNAIII 
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(Janzon et al., 1989), was observed in both 48 hr and 144 hr biofilms (Table 3.6). The 
differential gene expression observed in these biofilms may therefore be promoting biofilm 
formation in an ica-independent manner (Lauderdale et al., 2009). This type of 
staphylococcal biofilm has been identified in a number of clinical isolates that do not 
synthesize PIA, and instead synthesize a proteinaceous matrix (Kogan et al., 2006; Chaignon 
et al., 2007). Such a matrix could also, therefore, be present in S. aureus SH1000 biofilms 
generated in this system. 
111 
Table 5.1 Characterised differentially expressed genes in 144 hr biofilms (B144h) compared with 48 
hr biofilms (B48h) of S. aureus SH1000. Data are the mean of three experimental replicates. 
ORF Gene 
name 
Function Fold change 
B48h/B144h 
Functional group 
SAOUHSC_00341 cystathionine gamma-synthase 2.096 up Amino acid biosynthesis 
(CGS) (O- 
succinylhomoserine(thiol)-lyase) 
SAOUHSC_01366 anthranilate synthase 2.062 up Amino acid biosynthesis 
component I 
SAOUHSC_01367 anthranilate synthase 2.249 up Amino acid biosynthesis 
component II 
SAOUHSC_02281 i1vD dihydroxy-acid dehydratase 2.233 up Amino acid biosynthesis 
SAOUHSC_03009 hisA phosphoribosylformimino-5- 2.468 up Amino acid biosynthesis 
aminoimidazole carboxamide 
ribotide isomerase 
SAOUHSC_03010 hisH imidazole glycerol phosphate 2.304 up Amino acid biosynthesis 
synthase, glutamine 
amidotransferase subunit 
SAOUHSC_03013 histidinol dehydrogenase 2.099 up Amino acid biosynthesis 
SAOUHSC_03014 hisG ATP phosphoribosyltransferase 2.009 up Amino acid biosynthesis 
catalytic subunit 
SAOUHSC_03015 hisZ ATP phosphoribosyltransferase 2.328 up Amino acid biosynthesis 
regulatory subunit 
SAOUHSC_02715 adenosylmethionine-8-amino-7- 2.024 up Biosynthesis of 
oxononanoate cofactors, prosthetic 
aminotransferase groups, and carriers 
SAOUHSC_00089 sugar transferase 2.277 up Cell envelope 
SAOUHSC_00182 membrane protein, putative 2.112 up Cell envelope 
SAOUHSC_00254 membrane protein, putative 2.677 up Cell envelope 
SAOUHSC_00298 nonE N-acetylmannosamine-6-P 2.136 up Cell envelope 
epimerase 
SAOUHSC_00718 membrane protein, putative 2.211 down Cell envelope 
SAOUHSC_00871 dItC D-alanine--poly(phosphoribitol) 2.090 down Cell envelope 
ligase subunit 2 
SAOUHSC_02576 secretory antigen precursor 2.076 up Cell envelope 
SsaA, putative 
SAOUHSC_02888 membrane protein, putative 2.268 up Cell envelope 
SAOUHSC_02932 betA choline dehydrogenase 2.084 up Cellular processes 
SAOUHSC_02565 ureD urease accessory protein UreD 2.645 down Central intermediary 
metabolism 
SAOUHSC_02924 4-aminobutyrate 2.252 up Central intermediary 
aminotransferase metabolism 
SAOUHSC_03012 histidinol-phosphate 2.011 up Central intermediary 
aminotransferase, putative metabolism 
SAOUHSC_02645 LytTr DNA-binding region 2.208 up DNA metabolism 
SAOUHSC_00076 ornithine cyclodeaminase, 2.081 up Energy metabolism 
putative 
SAOUHSC_01452 aldi alanine dehydrogenase 1 2.093 up Energy metabolism 
SAOUHSC_02830 D-lactate dehydrogenase 2.077 down Energy metabolism 
SAOUHSC_00051 1-phosphatidylinositol 2.106 up Fatty acid and 
phosphodiesterase precursor, phospholipid 
putative metabolism 
112 
Table 5.1 cont. 
SAOUHSC_01941 splB serine protease SpIB 2.140 up Protein fate 
SAOUHSC_00017 rpll ribosomal protein L9 2.040 down Protein synthesis 
SAOUHSC_00694 mgrA HTH-type transcriptional 2.391 down Regulatory functions 
regulator MgrA 
SAOUHSC_01285 regulatory protein, MerR 2.194 down Regulatory functions 
SAOUHSC_02461 transcriptional regulator, MerR 2.443 down Regulatory functions 
family 
SAOUHSC_02726 transcription activator, effector 2.239 up Regulatory functions 
binding 
SAOUHSC_02799 sarT HTH-type transcriptional 2.205 up Regulatory functions 
regulator SarT 
SAOUHSC_02908 aminoglycoside 2.073 up Regulatory functions 
phosphotransferase: Fructosami 
ne kinase 
SAOUHSC_03001 icaR biofilm operon icaabcd hth-type 2.644 down Regulatory functions 
negative transcriptional 
regulator IcaR 
SAOUHSC_00078 general substrate 2.003 up Transport and binding 
transporter: Major facilitator proteins 
superfamily MFS_1 
SAOUHSC_00136 nitrate transport ATP-binding 2.103 up Transport and binding 
protein NrtD proteins 
SAOUHSC_00138 ABC transporter, permease 2.288 up Transport and binding 
protein proteins 
SAOUHSC_00209 PTS system, glucose-specific 2.319 up Transport and binding 
IIBC component, putative proteins 
SAOUHSC_02662 PTS system, sucrose-specific 2.020 up Transport and binding 
IIBC component proteins 
SAOUHSC_02754 ABC transporter, ATP-binding 2.045 up Transport and binding 
protein proteins 
SAOUHSC_02806 gluconate permease, putative 2.150 up Transport and binding 
proteins 
5.3.2. 
5.3.3. Investigating biofilm mutability 
5.3.3.1. Genes with antioxidant capacity 
To deduce the nature of the increased mutability observed for staphylococcal biofilm 
cultures, the transcriptional profiling data were analysed for differential regulation of genes 
that may contribute to genetic mutation. Accordingly, genes encoding proteins with 
antioxidant activity were investigated for their respective expression levels, as were genes 
involved in DNA repair. 
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Previous studies have identified differential regulation of genes encoding 
antioxidant enzymes in biofilm culture, compared with planktonic culture. In P. aeruginosa 
and E. coli, these enzymes have been identified as downregulated (Schembri et al., 2003; 
Driffield et al., 2008). These results suggest that downregulation of antioxidant enzymes in 
biofilm cultures may render the cells more sensitive to oxidative stress, and therefore 
mutation due to ROS. However, in S. aureus biofilms, enzymes such as sodA, are both 
upregulated and downregulated in biofilm culture, depending on the biofilm model and 
strain utilised (Resch et al., 2005; Brady et al., 2006). 
Of all the antioxidant enzymes investigated here, only sodA was found to be 
upregulated in 48 hr biofilm culture, compared with planktonic culture (Table 5.2). This 
supports other transcriptional profiling data for S. aureus, identifying sodA as being 
upregulated in static biofilms (Resch et al., 2005). This manganese-dependent SOD is 
regulated by SarA and provides protection against superoxide radicals (Ballal & Manna, 
2009). Upregulation of this enzyme in the biofilm state suggests that cells within these 
cultures are suffering increased endogenous oxidative stress. No other significant 
differences in antioxidant enzyme expression were found between the biofilm and 
planktonic conditions. Furthermore, expression of this enzyme is not upregulated in 144 hr 
biofilms, which, unlike 48 hr biofilms, display increased MFs compared with planktonic 
cultures. Therefore, the impact of oxidative stress on the older biofilm cultures may be 
greater, since sodA expression does not increase. 
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Table 5.2 Differential gene expression (fold change) of antioxidant genes in 48 hr biofilms (B48h) 
compared with planktonic cultures (P), 144 hr biofilms (B144h) compared with planktonic cultures 
and 144 hr biofilms compared with 48 hr biofilms of S. aureus SH1000. Data are the mean of three 
experimental replicates. 
ORF Gene 
name 
Function Fold change 
P/B48h 
Fold change 
P/B144h 
Fold change 
B48h/B144h 
SAOUHSC_00365 ahpC alkyl hydroperoxide 1.364 up 1.124 up 1.212 down 
reductase subunit C 
SAOUHSC 01327 katA catalase 1.247 down 1.533 down 1.229 down 
SAOUHSC_01653 sodA superoxide dismutase [Mn] 2.256 up 1.577 up 1.430 down 
SAOUHSC_00093 sodM superoxide dismutase [Mn] 1.361 down 1.260 down 1.080 up 
SAOUHSC_00785 trxB thioredoxin-disulfide 1.263 up none 1.263 down 
reductase 
SAOUHSC_01999 alkyl hydroperoxide 1.220 up 1.022 down 1.247 down 
reductase/ Thiol specific 
antioxidant/ Mal allergen 
SAOUHSC_02949 glutathione peroxidase 1.233 down 1.173 down 1.051 up 
SAOUHSC_01282 glutathione peroxidase 1.439 up 1.163 up 1.236 down 
SAOUHSC_01822 tpx alkyl hydroperoxide 1.971 up 1.468 up 1.342 down 
reductase/ Thiol specific 
antioxidant/ Mal allergen 
The expression of genes involved in the synthesis of carotenoid pigment was also 
investigated, as such pigments, like staphyloxanthin, are known to possess antioxidant 
activity (Clauditz et al., 2006) (Table 5.3). These genes were for the most part 
downregulated. Staphyloxanthin production, from the crt operon, was found to be 
significantly affected, as all the biosynthetic genes in this pathway were downregulated in 
one or both of the biofilm cultures. However, although loss of this pigment causes an 
increase in susceptibility to killing by hydrogen peroxide, it does not cause in an increase in 
mutability (please see Chapter 6 section 6.3.1 for details). 
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Table 5.3 Differential gene expression (fold change) of genes involved in pigment biosynthesis in 48 
hr biofilms (B48h) compared with planktonic cultures (P), 144 hr biofilms (B144h) compared with 
planktonic cultures and 144 hr biofilms compared with 48 hr biofilms of S. aureus SH1000. Data are 
the mean of three experimental replicates. 
ORF Gene 
name 
Function Fold change 
P/B48h 
Fold change 
P/B144h 
Fold change 
B48h/B144h 
SAOUHSC_02879 crtM dehydrosqualene synthase 3.233 down 2.717 down 1.190 up 
SAOUHSC_02877 crtN dehydrosqualene 3.989 down 2.654 down 1.502 up 
desaturase 
SAOUHSC_02882 crtO glycosyl-4,4'- 2.569 down 1.539 down 1.669 up 
diaponeurosporenoate 
acyltransferase 
SAOUHSC_02881 crtP 4,4'-diaponeurosporene 3.883 down 2.022 down 1.919 up 
oxidase 
SAOUHSC_02880 crtQ 4,4'-diaponeurosporenoate 4.095 down 2.409 down 1.699 up 
glycosyltransferase 
5.3.3.2. Genes involved in DNA repair 
Of the 47 genes identified as being involved in DNA repair, 14 and 9 were found to be 
differentially regulated in 48 hr and 144 hr biofilms, respectively, when compared with 
planktonic cultures (Table 5.4). No differential expression of this group of genes was 
observed between biofilm conditions. Furthermore, in 48 hr biofilm cultures, 12 of the 14 
differentially expressed genes were upregulated, 8 of which were also upregulated in 144 
hr biofilm cultures. 
In both biofilm conditions the expression of mutS2 was significantly increased. This 
gene product is part of the family of proteins that form the methyl-directed mismatch 
repair (MMR) system. However, unlike the homologue MutS1, which is involved in DNA 
mismatch recognition, MutS2 is primarily involved in preventing homologous and 
homeologous recombination (Pinto et al., 2005). 
Proteins involved in homologous recombination, such as RecF, RuvA and RecU, 
were also upregulated in the biofilm state (He et al., 2006; Carrasco et al., 2009). RecF and 
RuvA, have been implicated in the repair of double-stranded DNA breaks, whilst also 
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promoting mutation, a phenomenon that is thought to allow the bacterial population to 
adapt to overcome environmental stress (He et al., 2006). 
Expression of the LexA repressor was also upregulated in biofilm cultures. The 
expression from this ORF was upregulated in 48 hr biofilm cultures, but not 144 hr biofilm 
cultures, when compared with planktonic cultures. This protein is involved in the bacterial 
SOS response, where it negatively regulates itself and the production of genes involved in 
this response (Brent & Ptashne, 1980). Specifically, RecA binds DNA lesions, resulting from 
stress conditions, resulting in the cleavage of LexA and the production of SOS response 
genes (Brent & Ptashne, 1980; Horii et al., 1981). This response occurs in populations of 
bacteria undergoing stress, such as starvation (Taddei et al., 1995). Upregulation of LexA in 
this case, however, suggests a downregulation of the SOS response due to its negative 
regulation of SOS response genes. 
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Table 5.4 Differential gene expression (fold change) of genes involved in DNA repair, in 48 hr biofilms 
(B48h) compared with planktonic cultures (P), 144 hr biofilms (B144h) compared with planktonic 
cultures and 144 hr biofilms compared with 48 hr biofilms of S. aureus SH1000. Data are the mean of 
three experimental replicates. 
ORF Gene Function Fold change Fold change Fold change 
name P/B48h P/B144h B48h/B144h 
SAOUHSC_02621 3-methyladenine DNA 2.230 down 1.520 down 1.467 up 
glycosylase 
SAOUHSC_00905 addA recombination helicase 1.671 up 1.475 up 1.132 down 
AddA 
SAOUHSC_00904 addB ATP-dependent nuclease 1.644 up 1.388 up 1.184 down 
subunit B 
SAOUHSC_00505 c/pC ATP-dependent Clp 4.311 up 5.157 up 1.196 up 
protease ATP-binding 
subunit clpC 
SAOUHSC_02862 clpL ATP-dependent Clp 6.058 down 5.460 down 1.109 up 
protease, ATP-binding 
subunit CIpL 
SAOUHSC_01472 DnaQ family 1.709 up 1.078 up 1.585 down 
exonuclease/DinG family 
helicase, putative 
SAOUHSC_02122 ligA DNA ligase, NAD- 1.648 up 1.236 up 1.332 down 
dependent 
SAOUHSC_01658 endonuclease IV 1.313 up 1.341 up 1.021 up 
SAOUHSC_01333 lexA LexA repressor 2.421 up 1.804 up 1.341 down 
SAOUHSC_00477 mfd transcription-repair 1.063 up 1.017 down 1.081 down 
coupling factor 
SAOUHSC_01273 mutL DNA mismatch repair 1.555 down 1.365 down 1.139 up 
protein MutL 
SAOUHSC_01099 mutS2 MutS2 protein 3.049 up 2.440 up 1.249 down 
SAOUHSC_01272 mutS DNA mismatch repair 1.224 down 1.195 down 1.023 up 
protein MutS 
SAOUHSC_02123 pcrA ATP-dependent DNA 1.322 up 1.111 up 1.189 down 
helicase PcrA 
SAOUHSC_00004 recF DNA replication and repair 2.683 up 2.233 up 1.201 down 
protein RecF 
SAOUHSC_01194 recG ATP-dependent DNA 1.972 up 1.287 up 1.531 down 
helicase RecG 
SAOUHSC_00445 recR recombination protein RecR 1.700 up 1.248 up 1.361 down 
SAOUHSC_01751 ruvA Holliday junction DNA 2.970 up 2.016 up 1.472 down 
helicase RuvA 
SAOUHSC_01750 ruv8 Holliday junction DNA 1.365 up 1.367 up 1.001 up 
helicase RuvB 
SAOUHSC_01720 putative Holliday junction 2.125 up 1.369 up 1.552 down 
resolvase 
SAOUHSC_01342 exonuclease SbcC 1.786 up 1.112 up 1.606 down 
SAOUHSC_01341 exonuclease SbcD 1.042 down 1.058 down 1.015 down 
SAOUHSC_00564 ung uracil-DNA glycosylase 1.451 down 1.208 down 1.200 up 
SAOUHSC_01102 uvrC excinuclease ABC, C subunit 2.030 up 1.579 up 1.284 down 
SAOUHSC_00458 excinuclease ABC, C 1.002 up 1.006 down 1.009 down 
subunit, N-terminal 
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Table 5.4 cont. 
SAOUHSC_01796 mutts formamidopyrimidine-DNA 1.856 up 1.439 up 1.289 down 
glycosylase 
SAOUHSC_02276 DNA mismatch repair 1.312 down 1.307 down 1.003 up 
protein MutS, C-terminal 
SAOUHSC_01615 recN DNA repair protein RecN 1.948 up 1.725 up 1.128 down 
SAOUHSC_00507 radA DNA repair protein RadA 1.611 up 1.382 up 1.165 down 
SAOUHSC_00730 recQ ATP-dependent DNA 1.962 up 1.437 up 1.365 down 
helicase RecQ 
SAOUHSC_01262 recA protein RecA 1.834 up 1.687 up 1.086 down 
SAOUHSC_01098 DNA-dependent DNA 5.763 up 4.058 up 1.420 down 
polymerase beta chain 
SAOUHSC_01744 recJ single-stranded-DNA- 1.119 up 1.031 down 1.154 down 
specific exonuclease Red 
SAOUHSC_01693 competence protein ComEA 1.197 down 1.072 down 1.116 up 
helix-hairpin-helix region 
SAOUHSC_02005 mutt A/G-specific adenine 1.591 down 1.337 down 1.190 up 
glycosylase 
SAOUHSC_00780 uvrA excinuclease ABC, A subunit 1.030 down 1.102 down 1.070 down 
SAOUHSC_01768 DNA-3-methyladenine 1.459 up 1.115 up 1.308 down 
glycosylase 1 
SAOUHSC_00503 UvrB/UvrC motif-containing 2.876 up 2.982 up 1.036 up 
protein 
SAOUHSC_00612 HhH-GPD 1.019 down 1.171 down 1.148 down 
SAOUHSC_01466 recU recombination protein U 5.242 up 4.832 up 1.084 down 
SAOUHSC_01469 endonuclease III, putative 2.979 up 2.235 up 1.332 down 
SAOUHSC_01667 recO DNA repair protein RecO 1.512 up 1.164 up 1.299 down 
SAOUHSC_01363 ImpB/MucB/SamB family 1.587 up 1.653 up 1.041 up 
protein 
SAOUHSC_02111 DNA polymerase IV 1.381 up 1.402 up 1.015 up 
SAOUHSC_02861 ogt methylated-DNA--protein- 1.034 up 1.043 up 1.008 up 
cysteine methyltransferase 
SAOUHSC_00699 DNA photolyase, FAD- 1.346 down 1.342 down 1.002 up 
binding 
SAOUHSC 00779 UvrABC system protein B 1.619 up 1.217 up 1.330 down 
5.3.4. Concluding remarks 
Initially, the DNA microarray data obtained from transcriptional profiling were used to 
highlight genes potentially involved in biofilm maturation, by comparing 48 hr and 144 hr S. 
aureus biofilm transcriptional profiles. The amino acid biosynthesis, cell envelope, transport 
and binding and regulatory function groups were particularly represented in the group of 
genes found to be differentially regulated between the two cultures. Histidine biosynthetic 
genes and genes encoding cell membrane proteins were significantly upregulated. 
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Furthermore, genes encoding transcriptional regulators of virulence and biofilm formation 
were also found to be differentially expressed. 
These data were also used to elucidate the mechanism of increased mutability 
observed within staphylococcal biofilms, when compared with planktonic cultures. It was 
hypothesised that differential regulation of genes conferring antioxidant capacity may 
promote mutation in biofilm cultures. However, little differential regulation of genes 
encoding antioxidant enzymes was observed in biofilm cultures, with only sodA being 
upregulated in 48 hr biofilms. However, expression of genes involved in carotenoid pigment 
biosynthesis, which possesses antioxidant activity, was significantly downregulated. 
Additionally, increased expression of numerous genes involved in DNA repair was observed 
in the biofilm cultures, some of which promote mutation. However, a definitive mechanism 
for increased mutability in biofilms remains elusive. 
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CHAPTER 6 
6. Emergence of new S. aureus phenotypes from biofilm 
cultures 
Work presented in this chapter has also been presented as a poster: 
Ryder, V. J., O'Neill, A. J& Chopra, I. (2010). "Phenotypic variants arising in Staphylococcus 
aureus biofilms may promote dissemination during infection". Biofilms4, Southampton, UK. 
6.1. Abstract 
The biofilm mode of growth promotes the emergence of phenotypic variants, such as small 
colony variants which have reduced antibiotic sensitivity and increased biofilm forming 
capacity. Here, I have observed and characterised two other phenotypic variant types 
emerging from S. aureus SH1000 biofilms. These were either white variants (WVs) or large 
pale variants (LPVs). 
The variant types were present in both the adherent population of the biofilm, and 
the shed population of cells, in both static and flow biofilm systems. In the static system, 
WVs comprised up to 2.0% and 26.5% of the adherent and shed phases, respectively. LPVs, 
by comparison, formed up to 14.9% and 51.6% of the adherent and shed phases, 
respectively. WVs had lost biofilm forming capacity, as adherence to cellulose disks was 
significantly diminished when compared to the parental strain, S. aureus SH1000. LPVs, 
however, retained biofilm forming capacity. In terms of mutability, WVs displayed up to a 2- 
fold increase in MF compared with SH1000. LPV MFs remained the same as S. aureus 
SH1000. Additionally, WVs had reduced resistance to hydrogen peroxide, but this did not 
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result in increased MF in the presence of sublethal concentrations of hydrogen peroxide. 
Subsequently, mutations in the alternative sigma factor, SigB, were identified in WVs. 
Due to their high proportion in the shed planktonic population of cells, and the 
inability of WVs to form biofilms, these phenotypic variants isolated from S. aureus biofilm 
cultures may represent a novel mechanism by which cells can disseminate from biofilm 
culture. 
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6.2. Introduction 
Recent studies suggest that biofilms comprise heterogeneous populations of bacteria. The 
results discussed so far in this thesis have supported this idea, since antibiotic resistant 
subpopulations exist in the biofilms. Several papers have reported the emergence of 
phenotypic variants, with altered colony morphology, from biofilm culture. One example is 
the small colony variant (SCV). Several bacterial species enrich their population with SCVs 
upon growth as a biofilm. P. aeruginosa biofilms generate large numbers of SCVs, the 
properties of which include autoaggregation in liquid culture and increased expression of 
genes involved in surface adherence, specifically the psl and pel loci (Kirisits et al., 2005). 
Similarly, some S. aureus strains also produce SCVs in biofilm culture. Much like the 
SCVs isolated from P. aeruginosa, S. aureus SCVs exhibit enhanced biofilm forming capacity. 
These SCVs autoaggregate and produce higher amounts of PIA than the wild-type (Singh et 
al., 2010a). S. aureus SCVs have also been isolated from various infections, suggesting that 
these phenotypic variants may have a role in pathogenicity (Agarwal et al., 2007; Schneider 
et al., 2008). Such S. aureus SCV isolates display an enhanced ability to persist 
intracellularly, and their transcriptional profiles indicate an upregulation of the 
fermentation pathway (Moisan et al., 2006). Moreover, these variants display reduced 
sensitivity to a variety of antimicrobials, such as triclosan, cephalosporins, linezolid, 
vancomycin and the fluoroquinolones (von Eiff et al., 2005; Bayston et al., 2007; Tsuji et al., 
2008). 
Colonies exhibiting morphological variation also emerge from S. pneumoniae 
biofilms. These variants include both SCVs and larger mucoid variants. S. pneumoniae SCVs 
autoaggregate in liquid culture and form well-structured biofilms. However, the large 
mucoid variants form unstructured biofilms and do not aggregate in liquid culture 
(Allegrucci & Sauer, 2007). 
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This chapter will discuss the identification, emergence and characterisation of WVs 
and LPVs from S. aureus SH1000 biofilms. 
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6.3. Results and Discussion 
During mutability studies with S. aureus SH1000, as described in previous chapters, it 
became apparent that two distinct colony variants emerged from cellulose disk biofilms. 
These were WVs and LPVs (Figure 6.1). Steps were taken to confirm that these variants 
were not merely contaminants of the cultures. To demonstrate this, biofilms of S. aureus 
SH1000 lux (carries lux ABCDE Km cassette on chromosome) were grown. Two WVs (W1 
and W2) and LPVs (LP1 and LP2) were isolated from 144 hr cellulose disk biofilms of S. 
aureus SH1000 and SH1000 lux and then assessed for luminescence (Figure 6.2). This 
demonstrated that all colony types isolated from S. aureus SH1000 lux biofilms were 
luminescent, and were therefore not contaminants. Interestingly, the WVs were 
significantly more luminescent than the wild-type and LPV phenotypes. However, the 
reasons for this remain unclear. 
The emergence of both of these variants from S. aureus SH1000 cellulose disk 
biofilms was also quantified by determining the proportion of each variant in the adherent 
and the shed planktonic populations (Figure 6.3). 
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Figure 6.2 Luminescence of S. aureus SH1000 and SH1000 lux phenotypic variants isolated from 144 
hr cellulose disk biofilms. WT and Lux denote wild type S. aureus SH1000 and SH1000 lux, 
respectively. Data are based on three experimental replicates. Error bars indicate standard 
deviations. 
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Table 6.1 The emergence of white variants and large pale variants from additional planktonic and 
biofilm culture conditions (bold text) than those shown in Figure 6.1. Cultures were incubated 
aerobically, except from where anaerobic incubation is indicated. Data are based on three 
experimental replicates. Standard deviations are shown. 
Condition White Standard Large pale Standard 
variants (%) deviation variants (%) deviation 
(%) (%) 
Planktonic cultures 
18 hr 0 0 0 0 
144 hr 0 0 1.09 0.82 
144 hr anaerobic 0 0 1.55 1.22 
Biofilm cultures 
96 hr cellulose disk biofilms 0.16 0.20 1.62 0.59 
96 hr sorbarod biofilms 0.16 0.24 2.35 2.68 
This revealed that the shed planktonic population of cells harboured a higher 
proportion of phenotypic variants, than the adherent population of the biofilm cultures at 
144 hrs. These variants were absent from planktonic cultures of S. aureus SH1000 grown for 
18 hrs. Specifically, biofilms grown for 48 hrs harboured 0.1% and 0.2% WVs in the 
adherent and shed planktonic populations, respectively. At 144 hrs of biofilm growth, 
however, 2.0% and 26.5% of the adherent and shed planktonic populations were WVs.. 
Similarly, at 48 hrs of biofilm growth 0.1% of the adherent and shed planktonic populations 
were LPVs. However, when biofilms were incubated for 144 hrs, 14.9% and 51.6% of the 
adherent and shed planktonic populations of the biofilm cultures were LPVs, respectively. 
To confirm that the emergence of these variants was not specific to this biofilm system, the 
number of variants emerging from the sorbarod biofilm model was also deduced (Table 
6.1). Here, comparable numbers of WVs were found emerging from the adherent 
population of 96 hr sorbarod biofilms as from 96 hr cellulose disk biofilms, where 0.16% of 
the viable cells were found to be WVs. Similarly, 1.62% and 2.35% of the adherent 
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population of 96 hr cellulose disk and sorbarod biofilms, respectively, were found to be 
LPVs. 
To elucidate further the mechanism driving the emergence of these variants, 
planktonic cultures were incubated for 144 hrs in both aerobic and anaerobic conditions. 
This aimed to determine whether older cultures harboured more WVs and LPVs, and 
whether anaerobic growth may also promote the emergence of these variants. Under all 
planktonic conditions tested, no WVs were observed, indicating that these variants only 
emerge during the biofilm mode of growth. LPVs, however, emerged from 144 hr cultures. 
Under aerobic and anaerobic conditions, 1.09% and 1.55% were found, respectively. 
However, these values are significantly lower than the values determined for cellulose disk 
biofilm cultures. Therefore, these data suggest that the biofilm mode of growth 
exacerbates the production of both of these variant types. Furthermore, as anaerobic 
conditions did not affect the respective levels of WVs and LPVs in planktonic cultures, this 
environment does not promote variant emergence. 
After quantifying the total proportions of WVs and LPVs in S. aureus SH1000 
biofilms, the two representative isolates (W1-2 and LP1-2) for each phenotype, from two 
distinct biofilms, were characterised further. Initially, growth rates, during exponential 
phase, were determined for W1, W2, LP1 and LP2 and compared with S. aureus SH1000 
(Table 6.2). There were no significant changes in the growth rates of these phenotypic 
variants, suggesting that the genetic basis of their variation does not influence doubling 
time. 
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Table 6.2 Growth rates of S. aureus SH1000, WI, W2, LP1 and LP2. 
S. aureus strain Doubling time (mins) Standard deviation 
SH 1000 32.30 1.95 
wi 32.76 1.26 
W2 31.36 2.45 
LP1 31.75 1.58 
LP2 30.78 2.07 
6.3.1. Characterising white variants 
Attempts were made to characterise the WVs Wi and W2. Biofilm forming capacity was 
initially assessed using the cellulose disk biofilm model (Figure 6.4). In this case, biofilms 
were grown for 48 hrs and then washed to remove loosely associated planktonic cells. 
Adherent cells were then removed by incubation with cellulase. The viable counts of both 
the wash solution and cellulase-detached adherent population were then calculated. 
Compared to the parental strain, the WVs were significantly impaired in biofilm formation, 
with the vast majority of the cells being washed off the cellulose disks. Specifically, only 
6.5% and 3.6% of the total population of cells were adherent in biofilms of W1 and W2, 
respectively. Following this, the WVs were assessed for their MF (Figure 6.5) using MIC data 
of the selection antibiotics (Table 6.3). This revealed that WVs exhibited marginal increases 
in MF of up to 2-fold compared with the parental strain, S. aureus SH1000. However, 
differences in MF between the wild-type and the WVs were not found to be statistically 
significant, except for W2 using rifampicin selection (>95% confidence, P=1.54x10-4). 
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Figure 6.4 The proportion of adherent and non-adherent cells on cellulose disk biofilms of S. aureus 
SH1000, W1 and W2. Data shown represent three experimental replicates. Errors bars indicate 
standard deviations. 
Table 6.3 Minimum inhibitory concentrations of rifampicin and mupirocin for various strains of S. 
aureus, determined by agar dilution. 
MIC (mg/L) 
SH1000 Wi W2 Newman Newman 
AcrtM 
Rifampicin 0.0078 0.0078 0.0078 0.0078 0.0078 
Mupirocin 0.125 0.0625 0.0625 0.125 0.0625 
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Figure 6.5 Mutation frequencies of S. aureus SH1000 and white variants W1 and W2. Spontaneous 
mutants were isolated from the cultures using the selection antibiotics rifampicin and mupirocin. 
Data are based on three experimental replicates. Error bars indicate standard deviations. 
A previous study demonstrated increased susceptibility to hydrogen peroxide in a 
staphyloxanthin deficient mutant (Clauditz et al., 2006). Accordingly, the susceptibility of 
W1 and W2 to hydrogen peroxide was also determined (Figure 6.6). In this case, 
susceptibility was calculated as the percentage survival following exposure to a range of 
hydrogen peroxide concentrations. Strains W1 and W2 demonstrated increased 
susceptibility to hydrogen peroxide, since concentrations as low as 1 mM were sufficient to 
reduce the population of the variant strains by up to 51%, with no effect on wild-type cells 
(Figure 6.6). These observations are consistent with loss of staphyloxanthin synthesis in W1 
and W2, also explaining their white phenotypes. 
Due to the observed increased susceptibility to hydrogen peroxide, and their 
moderate increase in MF, it was hypothesised that when exposed to subinhibitory 
concentrations of hydrogen peroxide, the W1 and W2 variants may be more mutable than 
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wild-type SH1000. This may contribute to the increased mutability previously observed in S. 
aureus biofilm cultures. To test this hypothesis, planktonic cultures of the variants and wild- 
type strain, were grown in the presence of 10 µM hydrogen peroxide, and the MF of each 
culture determined (Figure 6.7). This revealed no significant increase in MF, compared with 
the parental strain, for the variant strains, using either rifampicin (<95% confidence, for W1 
P=4.87x10-1 and for W2 P=4.10x10-1) or mupirocin (<95% confidence, for W1 P=1.36x101 
and for W2 P=8.20x10-2) selection. Therefore, although staphyloxanthin provides 
protection against hydrogen peroxide, by acting as an antioxidant, loss of this pigment does 
not translate into increased mutability in the presence of sub-lethal concentrations of 
hydrogen peroxide. To explore further that loss of staphyloxanthin production does not 
cause increased mutability, MFs were also determined for S. aureus Newman and a 
staphyloxanthin defective mutant (tcrtM) (MIC data of selection antibiotics shown in Table 
6.3). Whilst determining MFs using mupirocin selection, for S. aureus Newman AcrtM, it 
was apparent that chloramphenicol selection, to maintain the crtM mutation, was 
interfering with the experiment, causing the MFs to appear artificially high (data not 
shown). To overcome this, planktonic cultures of this strain were initially grown in the 
presence of chloramphenicol, which was then omitted from the mupirocin selection plates 
during MF determination. To confirm mupirocin resistant mutants had retained the crtM 
mutation, colonies were subcultured onto chloramphenicol selection plates. The MF data 
revealed that loss of staphyloxanthin caused no statistically significant increase in 
mutability compared to the wild-type using rifampicin (<95% confidence, P=6.08x10"2) or 
mupirocin (<95% confidence, P=7.06x10-1) selection. 
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Figure 6.7 Mutation frequencies of S. aureus SH1000 and white variants W1 and W2 cultures 
exposed to 10 µM hydrogen peroxide. Spontaneous mutants were isolated from the cultures using 
the selection antibiotics rifampicin and mupirocin. Data are based on three experimental replicates. 
Error bars indicate standard deviations. 
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Figure 6.8 Mutation frequencies of S. aureus Newman and Newman &crtM planktonic cultures. 
Spontaneous mutants were isolated from the cultures using the selection antibiotics rifampicin and 
mupirocin. Data are based on three experimental replicates. Error bars indicate standard deviations. 
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Considering both the biofilm-forming deficiency and the non-pigmented 
appearance of these variants, it was postulated that they may be carrying mutations in the 
alternative sigma factor, sigB, or its regulatory genes, such as rsbU. This was based on the 
identification of SigB as a global regulator of many genes, including but not limited to, 
biofilm formation and pigment production in S. aureus (Bischoff et al., 2004). Accordingly, 
PCR amplification and nucleotide sequence determination of sig8 and rsbU was carried out 
for both isolated strains and compared to that of S. aureus SH1000. Although neither had 
mutations in rsbU, both possessed mutations in sigB at DNA binding residues of the sigma 
factor, presumably preventing interaction with gene promoter regions. W1 had a 163 base 
pair deletion in the chromosome from bases 2131888-2132050, resulting in the truncation 
of the protein from Cys217. W2 had an A to G substitution at chromosome base 2131975, 
altering the amino acid sequence at Leu242Pro. 
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6.3.2. Characterising large pale variants 
In a similar manner to the WVs, the two LPVs isolated from S. aureus SH1000 cellulose disk 
biofilms were initially assessed for biofilm forming capacity (Figure 6.9). Unlike the WVs, the 
LPVs formed biofilms comparable to those of the parent strain. Indeed, of the total cells, 
biofilms of SH1000, LP1 and LP2 were comprised of 93.4%, 84.6% and 83.0% adherent cells, 
respectively. 
Following this, MFs were determined for LP1 and LP2 (Figure 6.10). MIC data 
revealed that these mutants were slightly less susceptible to rifampicin and mupirocin 
compared to SH1000 (Table 6.4). Specifically, the MICs were consistently 4-fold higher for 
rifampicin and 2-fold higher for mupirocin, compared with SH1000. Marginal but significant 
increases in MF were observed for the LPVs compared with SH1000 (>95% confidence, LP2 
using rifampicin selection P=2.20x10-2, LP1 using mupirocin selection P=4.00x10"2 and LP2 
using mupirocin selection P=3.98x10"2) except LP1 using rifampicin selection which was not 
statistically significant (<95% confidence, P=1.02x10-'). 
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Figure 6.9 The proportion of adherent and non-adherent cells in cellulose disk biofilms of S. aureus 
SH1000, LP1 and LP2. Data represent three experimental replicates. Errors bars indicate standard 
deviations. 
Table 6.4 Minimum inhibitory concentrations of rifampicin and mupirocin for S. aureus SH1000, LP1 
and LP2, determined by agar dilution. 
MIC (mg/L) 
SH1000 LP1 LP2 
Rifampicin 0.0078 0.0313 0.0313 
Mupirocin 0.1250 0.2500 0.2500 
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Figure 6.10 Mutation frequencies of S. aureus SH1000 and large pale variants, LP1 and LP2. 
Spontaneous mutants were isolated from the cultures using the selection antibiotics rifampicin and 
mupirocin. Data are based on three experimental replicates. Error bars indicate standard deviations. 
The inability of WVs to form biofilms in the cellulose disk model, and the 
preferential appearance of WVs and LPVs in biofilm cultures, compared with planktonic 
culture, where they are found mostly in the shed phase, suggests that they may have a role 
in dissemination from the biofilm. This process is regarded to be the last step in biofilm 
formation and is though to enable bacteria to disperse and colonise new ecological niches 
(Sauer et al., 2002). Although detachment can occur by an increase in shear forces, many 
organisms have developed active dissemination mechanisms. P. aeruginosa and S. mutans, 
for example, synthesise enzymes that degrade the biofilm exopolysaccharide matrix and 
surface proteins, respectively, liberating the attached cells (Boyd & Chakrabarty, 1994; Lee 
et al., 1996). S. aureus SH1000 may therefore enrich the biofilm population with phenotypic 
variants that promote dissemination. The sigB mutations carried by the WVs, although 
allowing the release of S. aureus from biofilm culture, may also result in virulence 
attenuation, as this sigma factor controls the production of a variety of virulence factors 
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(Bischoff et al., 2004). However, the parent strain of S. aureus SH1000,8325-4, also carries 
a small deletion in the sigB positive regulator, rsbU, suggesting that inactivation of sigB in 
this strain lineage might be a natural process (Horsburgh et al., 2002a). 
6.3.3. Concluding remarks 
Colonies exhibiting morphological variation were identified emerging from static biofilms of 
S. aureus SH1000. WVs and LPVs were observed in both the adherent and shed planktonic 
populations of cellulose disk biofilm cultures. However, a significantly larger number were 
observed in the shed planktonic populations of the biofilms. Variants were also identified in 
biofilms grown using a flow system (Sorbarod biofilm model), suggesting that their 
production is not model specific. 
WVs had lost biofiim formation, and possessed minor increases in MF compared to 
the wild-type. However, this was not observed in a staphyloxanthin defective mutant, 
suggesting that pigment loss does not equate to an increase in mutability. WVs also had 
increased susceptibility to killing by hydrogen peroxide. However, this did not translate to 
an increase in mutability in the presence of sublethal concentrations of hydrogen peroxide, 
compared with S. aureus SH1000. Molecular analysis revealed that WVs harbour mutations 
in the alternative sigma factor, SigB, a global regulator of both biofilm formation and 
staphyloxanthin production. 
LPVs had similar biofilm forming capacity as the wild-type. No increase in MF was 
observed for these variants compared to the parental strain. The molecular basis of their 
variation remains undefined. 
Due to preferential emergence of both variant types in biofilm cultures, compared 
with planktonic culture, their larger numbers in the population of planktonic cells shed 
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from biofilms and the loss of biofilm formation exhibited by WVs, it appears that these 
phenotypic variants may promote dissemination of S. aureus SH1000 from biofilms. 
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7. General conclusions and future studies 
Growth of bacteria as a biofilm confers broad antibiotic recalcitrance through mechanisms 
that remain largely undefined. Some studies have demonstrated reduced antibiotic 
penetration, high levels of persisters and slow growth in biofilms, as mechanisms to 
promote antibiotic recalcitrance (Ito et al., 2009; Singh et al., 2009; Singh et al., 2010b). In 
addition, there is limited evidence for increased genetic transfer and mutation in biofilm 
cultures, when compared with planktonic cultures, to confer genotypic antibiotic resistance 
(Cvitkovitch, 2004; Allegrucci & Sauer, 2008). However, the role for genetic mutability as a 
mechanism that may contribute to the emergence antibiotic resistance in biofilms, 
particularly in Gram positive bacteria, has not been investigated in detail. This work sought 
to investigate this issue. 
Initially, a novel biofilm model was generated to allow high-throughput screening of 
biofilms for an array of applications. This was necessary as the currently available biofilm 
models are often low-throughput in nature, or if high-throughput, only yield simplistic 
biofilms (Ceri et al., 1999; Driffield et al., 2008). Cellulose disks were chosen as a 
substratum, with the incorporation of human plasma to exploit staphylococcal surface 
proteins that bind human serum components resulting in surface adherence (MSCRAMMs) 
(Bozzini et al., 1992; Nicholas et al., 1999; O'Brien et al., 2002). Validation of the model was 
performed by demonstrating antibiotic recalcitrance and dissemination in the presence of 
D-amino acids, as both of these phenomena had been previously reported for 
staphylococcal biofilms (Zheng & Stewart, 2002; Kolodkin-Gal et al., 2010). Transcriptional 
profiling also demonstrated upregulation of genes encoding urease activity, and 
downregulation of toxin and protease genes, differential expression of which has previously 
been demonstrated for S. aureus in biofilms (Resch et al., 2005). Visualisation of the 
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cultures grown on the disks by confocal and atomic force microscopy, revealed a compact 
population of cells harbouring a rough surface, also consistent with biofilm growth. 
This new model is therefore an efficient means of generating staphylococcal 
biofilms. Furthermore, the simplicity of the system could enable it to be developed for use 
with other bacterial species, in addition to S. aureus and S. epidermidis, by exploitation of 
factors that promote adherence, such as the human plasma that was used in this case. 
Mutability studies were then conducted utilising the novel biofilm system 
generated. S. aureus and S. epidermidis biofiims were shown to harbour bacteria with 
increased MFs compared with planktonic cultures, both in this new static biofilm model and 
also an established flow system. Limited studies with other organisms, such as S. 
pneumoniae and P. aeruginosa, have shown increased mutability when these species grow 
as a biofilm (Allegrucci & Sauer, 2008; Driffield et al., 2008). Biofilms of E. co/i and P. 
aeruginosa downregulate expression of antioxidant enzymes, whilst S. aureus can up and 
downregulate expression of such enzymes depending on the biofilm model and strain 
utilised (Schembri et al., 2003; Resch et al., 2005; Brady et al., 2006; Driffield et al., 2008). It 
was therefore hypothesised, that increased mutability in cellulose disk biofilm cultures of S. 
aureus may be a consequence of endogenous oxidative stress, potentially due to 
downregulation of antioxidant enzyme gene expression. Accordingly, antioxidant agents 
were incorporated into S. aureus biofilms. This revealed that antioxidant agents 
significantly reduced biofilm MFs, confirming an involvement for ROS in biofilm mutability. 
Transcriptional profiling revealed little differential expression of antioxidant enzymes, 
where only sodA was upregulated in the biofilm cultures. However, significant 
downregulation of genes involved in carotenoid pigment biosynthesis, which provide 
protection against oxidative stress (Clauditz et al., 2006), was observed. To further validate 
the observation of downregulation of staphyloxanthin biosynthesis in these biofilms, the 
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respective levels of this pigment could be directly assayed (Resch et al., 2005). It was 
hypothesised that reduced pigmentation of cells within biofilm cultures may render them 
more susceptible to endogenous oxidative damage by ROS. However, non-pigmented 
mutants (as discussed in Chapter 6), although less able to survive hydrogen peroxide 
treatment, were not more mutable in the presence of sublethal concentrations of hydrogen 
peroxide. The DNA microarray analysis data also demonstrated upregulation of numerous 
genes involved in DNA repair in biofilm cultures, consistent with the observations of 
increased mutability of S. aureus in biofilm culture. 
As well as further investigating the nature of increased mutability in biofilms, it may 
also be useful to assess the levels of recombination. Specifically, recombination frequencies 
could be deduced and compared with planktonic cultures, to see if these events also 
contribute to increased mutability. Furthermore, as previously stated, there are limited 
reports of increased rates of conjugative transfer in biofilms, assumed to result from 
increased cell-to-cell contact due to the high cell densities in biofilms (Cvitkovitch, 2004). 
AFM of cellulose disk biofilms revealed that they form a tightly compact population of cells. 
Therefore, this may be an appropriate system to investigate the impact of conjugative 
transfer on the emergence of antibiotic resistance in biofilms, in the case of strains with 
conjugative plasmids encoding an antibiotic resistance marker. 
In addition, as several genes responsible for the regulation of agr and RNAIII were 
differentially regulated in the biofilm, further investigation of the effect of expression of 
these genes on biofilm architecture is required. Specifically, reduced expression of agr and 
RNAIII genes is necessary to maintain the integrity of ica-independent biofiims possessing a 
proteinaceous matrix (Boles & Horswill, 2008; Lauderdale et al., 2009). The data generated 
here suggest that RNAIII or ogr expression would be downregulated. No differential 
regulation of agr was observed, however, significant downregulation of the delta 
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haemolysin was observed in biofilms, which is encoded by RNAIII (Janzon et al., 1989). 
Furthermore, preliminary experiments showing complete degradation of S. aureus biofilms 
subjected to proteinase K treatment (data not shown) suggest that these cultures rely 
heavily on proteinaceous components for adherence to the disks. 
Biofilms are known to harbour phenotypic variants, such as SCVs. Whilst generating 
staphylococcal biofilms using the cellulose disk model, two new and distinct colony types 
displaying morphological variation were identified in the biofilm cultures. These colonies 
were WVs and LPVs. WVs were shown to have lost biofilm forming capacity in the cellulose 
disk system, harbour a modestly increased MF and have an increased susceptibility to 
hydrogen peroxide. This is likely due to the observed mutations in the alternative sigma 
factor, SigB, which controls the expression of numerous genes involved in staphyloxanthin 
production and biofilm formation. LPVs, however, maintained biofilm forming capacity and 
had no significant increase in MF, compared with the parental strain. Both of these variants 
were mostly found in the population of planktonic cells which is shed from the biofilm, 
suggesting a role for them in the dissemination of S. aureus from biofilms. If the 
information gathered using DNA microarray analysis is taken into consideration with the 
observation of mutations in SigB in the WVs, this is highly indicative of ica-independent 
mechanisms of biofilm formation in the disk model. SigB controls expression of the agr 
quorum sensing system which is involved in dissemination of S. aureus from biofilms (Boles 
& Horswill, 2008). Specifically, mutants defective in sigB show higher levels of agr and 
RNAIII expression, which results in higher levels of extracellular proteases, presumably 
resulting in the breakdown of proteinaceous structures providing adherence (Lauderdale et 
al., 2009). Therefore, if biofilms formed by S. aureus SH1000 have a proteinaceous matrix, 
biofilm-forming capacity of the WVs should be restored in the presence of extracellular 
protease inhibitors (Lauderdale et al., 2009). 
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Due to time constraints, the genetic basis of the LPV phenotype was not elucidated. 
However, whole genome nucleotide sequence determinations of these variants would be 
useful in determining the nature of their morphological variation. Furthermore, assessing 
both WVs and LPVs in a model of infection would provide information as to whether they 
are attenuated in virulence. WVs in particular could be attenuated due to their mutations in 
SigB (Bischoff et a!., 2004). In addition, it will be important to assess other S. oureus strains 
for such variants, to confirm whether this phenomenon is specific to this strain. 
In summary, I have demonstrated that staphylococcal biofilms are significantly 
more mutable than their planktonic counterparts, and that this phenomenon may promote 
heterogeneity in the biofilm, in the form of both antibiotic resistant mutants and 
morphological variants. 
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Appendix 
Table A. 1 Differentially expressed genes in 48 hr biofilm cultures versus planktonic cultures, of S. 
aureus SH1000. Data are the average of three experimental replicates. P values were determined 
using a Student's t-test in ArrayStar'"" (DNASTAR). 
Locus tag Gene name Product name/Function Fold change P value 
Upregulated genes 
SAOUHSC_00001 dnaA chromosomal replication initiator 3.237 up 3.18x10-27 
protein DnaA 
SAOUHSC_00003 hypothetical protein 3.673 up 4.52x1027 
SAOUHSC_00004 recF DNA replication and repair protein 2.683 up 4.29x1024 
RecF 
SAOUHSC_00005 DNA gyrase, B subunit 2.072 up 2.32x1019 
SAOUHSC_00014 membrane protein, putative 2.160 up 2.46X10-22 
SAOUHSC_00017 rpll ribosomal protein L9 3.055 up 2.64x1023 
SAOUHSC_00028 hypothetical protein 2.399 up 5.14x10 9 
SAOUHSC_00029 hypothetical protein 3.193 up 1.58x10 9 
SAOUHSC_00032 hypothetical protein 3.880 up 2.23x1023 
SAOUHSC_00035 pyridine nucleotide-disulphide 3.002 up 1.05X10-21 
oxidoreductase family protein 
SAOUHSC_00036 meta Ilo-beta-lactamase family protein 2.560 up 8.29x1023 
SAOUHSC_00037 sulfide: quinone oxidoreductase 3.927 up 9.56x10 22 
SAOUHSC_00141 hypothetical protein 2.777 up 6.98x1022 
SAOUHSC 00173 azoR azoreductase 2.639 up 6.36x1028 
SAOUHSC_00245 truncated transposase 2.067 up 8.32x101s 
SAOUHSC_00345 hypothetical protein 2.246 up 7.57x10" 
SAOUHSC_00348 rpsF ribosomal protein S6 4.889 up 8.31x10-23 
SAOUHSC_00349 single-stranded DNA-binding protein 2.894 up 4.45x1019 
SAOUHSC_00440 hypothetical protein 3.249 up 6.98x10-20 
SAOUHSC_00441 acetyltransferase family protein 3.389 up 1.18X10-29 
SAOUHSC_00442 DNA polymerase III gamma/tau 3.386 up 3.35x1031 
subunit 
SAOUHSC_00444 hypothetical protein 2.378 up 2.41x1023 
SAOUHSC_00453 hypothetical protein 2.092 up 2.65x107 
SAOUHSC_00465 protein veg 3.055 up 7.53x1016 
SAOUHSC_00472 prs ribose-phosphate pyrophosphokinase 2.846 up 6.93x10 22 
SAOUHSC_00473 hypothetical protein 3.435 up 3.22x1020 
SAOUHSC_00474 rplY ribosomal protein L25, Ctc-form 2.581 up 2.96x10'12 
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Locus tag Gene name Product name/Function Fold change P value 
SAOUHSC_00491 2-amino-4-hydroxy-6- 2.654 up 3.59x10,24 
hydroxymethyldihydropteridine 
pyrophosphokinase 
SAOUHSC_00492 hypothetical protein 5.062 up 2.00x10'21 
SAOUHSC_00493 lys5 lysyl-tRNA synthetase 2.261 up 6.68x10-26 
SAOUHSC_00502 ctsR transcriptional regulator CtsR 8.875 up 9.23x10 29 
SAOUHSC_00503 UvrB/UvrC motif-containing protein 2.876 up 2.54x10-22 
SAOUHSC_00504 ATP: guanido phosphotransferase 4.200 up 2.29x1022 
SAOUHSC_00505 clpC ATP-dependent Clp protease ATP 4.311 up 6.80x1027 
binding subunit CIpC 
SAOUHSC_00508 PIN domain protein 2.022 up 1.39x1013 
SAOUHSC_00516 secE preprotein translocase, SecE subunit 2.062 up 6.52x10'11 
SAOUHSC_00519 rplA ribosomal protein Li 2.096 up 1.13x10-21 
SAOUHSC_00550 GIcNAc-PI de-N-acetylase family 3.452 up 8.42x10-29 
protein 
SAOUHSC_00551 hypothetical protein 2.285 up 6.11x1024 
SAOUHSC_00555 HAD-superfamily hydrolase, subfamily 3.236 up 1.14x10-16 
IA, variant 1 
SAOUHSC_00556 proline/betaine transporter, putative 4.042 up 1.29x10,31 
SAOUHSC_00560 hypothetical protein 2.362 up 1.10x10-21 
SAOUHSC_00561 hypothetical protein 4.170 up 4.76x1014 
SAOUHSC_00574 eutD phosphotransacetylase 3.600 up 2.06x10-29 
SAOUHSC_00575 lipoate-protein ligase A family protein 4.252 up 2.88x10 27 
SAOUHSC_00604 hypothetical protein 2.648 up 7.76x10-23 
SAOUHSC_00605 acetyltransferase, gnat family 2.031 up 9.69x10-13 
SAOUHSC_00617 hypothetical protein 2.012 up 3.70x101s 
SAOUHSC_00618 hypothetical protein 2.861 up 1.71x1015 
SAOUHSC_00634 manganese ABC transporter substrate- 2.671 up 5.62x1012 
binding lipoprotein 
SAOUHSC_00636 ABC-3 2.068 up 5.24x10,7 
SAOUHSC_00638 iron dependent repressor: FeoA 2.909 up 9.41x10-21 
SAOUHSC_00641 tagH teichoic acids export protein ATP- 2.618 up 1.07x1024 
binding subunit 
SAOUHSC_00651 YitT family protein 2.374 up 1.42x1018 
SAOUHSC_00652 ferrichrome transport ATP-binding 2.952 up 2.88x1024 
protein FhuC 
SAOUHSC_00659 hypothetical protein 2.876 up 1.09X10-23 
SAOUHSC_00663 acetyltransferase, gnat family 3.409 up 1.66x10-12 
SAOUHSC_00668 ABC transporter, permease protein 2.268 up 5.17x10-19 
SAOUHSC_00669 YkaA 2.713 up 9.80x10'15 
SAOUHSC_00676 hypothetical protein 2.104 up 1.73x1016 
SAOUHSC_00678 hypothetical protein 3.235 up 5.49x10,14 
SAOUHSC_00680 hypothetical protein 4.355 up 4.22x1013 
SAOUHSC_00694 mgrA HTH-type transcriptional regulator 5.235 up 2.38x1024 
MgrA 
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SAOUHSC_00711 CBS domain protein 2.488 up 1.24x10-20 
SAOUHSC_00714 saeS sensor histidine kinase SaeS 2.328 up 1.01x10-17 
SAOUHSC_00718 membrane protein, putative 3.091 up 2.12x10"13 
SAOUHSC_00728 ItaS glycerol phosphate lipoteichoic acid 4.056 up 3.09x10 27 
synthase 
SAOUHSC_00729 ABC transporter, ATP-binding protein 2.642 up 2.01x10-21 
SAOUHSC_00735 hypothetical protein 3.013 up 5.63x10,15 
SAOUHSC_00741 nrdl ribonucleotide reductase stimulatory 6.012 up 1.54x1031 
protein 
SAOUHSC_00742 ribonucleoside-diphosphate reductase 3.281 up 1.60x10 25 
subunit alpha 
SAOUHSC_00743 nrdF ribonucleoside-diphosphate reductase, 2.030 up 1.03x10-21 
beta subunit 
SAOUHSC_00790 clpP ATP-dependent Cip protease, 2.617 up 7.13x102' 
proteolytic subunit CIpP 
SAOUHSC_00800 hypothetical protein 2.477 up 1.87x1016 
SAOUHSC_00801 secG preprotein translocase, SecG subunit 2.019 up 2.27x10-16 
SAOUHSC_00819 hypothetical protein 3.352 up 5.16x10-24 
SAOUHSC_00833 nitroreductase 3.897 up 1.18x10-33 
SAOUHSC_00835 arsenate reductase 2.535 up 3.23x1012 
SAOUHSC_00861 lipA lipoic acid synthetase 2.807 up 2.60x1021 
SAOUHSC_00867 hypothetical protein 8.863 up 1.93x10-22 
SAOUHSC_00868 hypothetical protein 7.379 up 0 
SAOUHSC_00869 dltA D-alanine-activating enzyme 2.966 up 7.47x1025 
SAOUHSC_00870 DItB protein, putative 4.964 up 6.72x1032 
SAOUHSC_00871 d1tC D-alanine--poly(phosphoribitol) ligase 5.021 up 4.97x10,30 
subunit 2 
SAOUHSC_00872 DltD, C-terminal: DltD, N-terminal: DltD, 2.201 up 2.12X10-23 
central region 
SAOUHSC_00880 Na+/H+ antiporter family protein 2.024 up 3.52x1013 
SAOUHSC_00892 RNA binding S1 2.505 up 7.76x10'19 
SAOUHSC_00900 pgi glucose-6-phosphate isomerase 2.906 up 1.09x1028 
SAOUHSC_00909 Cof protein: HAD-superfamily 2.004 up 3.80x10-20 
hydrolase subfamily IIB 
SAOUHSC_00910 N-6 Adenine-specific DNA methylase 2.379 up 2.16x1013 
YitW 
SAOUHSC_00912 ATP-dependent Cip protease, ATP- 3.924 up 1.91x10-28 
binding subunit CIpB 
SAOUHSC_00934 spxA transcriptional regulator Spx 2.947 up 1.1410-31 
SAOUHSC_00935 mecA adapter protein 4.675 up 1.85x10.2$ 
SAOUHSC_00938 hypothetical protein 2.445 up 2.15x1013 
SAOUHSC_00939 protozoan/cyanobacterial globin 2.271 up 2.45x10'15 
family protein 
SAOUHSC_00941 hypothetical protein 2.879 up 5.20x1019 
SAOUHSC_00942 GTP pyrophosphokinase 2.525 up 1.77x10-27 
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SAOUHSC_00943 ppnK probable inorganic 2.128 up 5.19x10-24 
polyphosphate/ATP-NAD kinase 
(Poly(P)/ATP NAD kinase) 
SAOUHSC_00944 ribosomal large subunit pseudouridine 2.303 up 1.74x1018 
synthase, RIuD subfamily 
SAOUHSC_00947 enoyl-[acyl-carrier-protein] reductase 2.375 up 3.63x10 21 
[NADH] 
SAOUHSC_00982 isochorismate synthase family protein 2.233 up 3.17x1022 
SAOUHSC_00991 acyltransferase 3 3.084 up 9.34x10-14 
SAOUHSC_00996 hypothetical protein 2.518 up 2.95x1020 
SAOUHSC_00997 transcriptional regulator, putative 2.701 up 1.71x1026 
SAOUHSC_00998 fmtA Protein FmtA 3.338 up 3.36x1018 
SAOUHSC_01005 hypothetical protein 7.220 up 3.54x10,37 
SAOUHSC_01007 folD FolD bifunctional protein 2.203 up 1.76x1013 
SAOUHSC_01008 phosphoribosylaminoimidazole 2.911 up 2.88x10,20 
carboxylase, catalytic subunit 
SAOUHSC_01009 phosphoribosylaminoimidazole 2.412 up 1.28x10,22 
carboxylase, ATPase subunit 
SAOUHSC_01010 purC phosphoribosylaminoimidazole- 2.977 up 2.17x1018 
succinocarboxamide synthase 
SAOUHSC_01011 phosphoribosylformylglycinamidine 2.053 up 1.15x10-22 
synthase, PurS protein 
SAOUHSC_01025 membrane protein, putative 4.998 up 4.25x1021 
SAOUHSC_01036 hypothetical protein 2.881 up 1.40x1013 
SAOUHSC_01037 hypothetical protein 4.314 up 1.74x1014 
SAOUHSC_01055 inositol monophosphatase family 2.104 up 1.32x10-21 
protein, putative 
SAOUHSC_01060 hypothetical protein 2.251 up 1.21x10.7 
SAOUHSC_01069 allergen V5/Tpx-1 related 2.254 up 1.02x10-16 
SAOUHSC_01073 hypothetical protein 2.075 up 3.95x10*17 
SAOUHSC_01074 hypothetical protein 2.427 up 1.04x10-17 
SAOUHSC_01077 hypothetical protein 5.903 up 6.63x10-32 
SAOUHSC_01078 rpmF ribosomal protein L32 3.241 up 4.03x1023 
SAOUHSC_01096 hypothetical protein 2.200 up 3.87x10'11 
SAOUHSC_01097 CvpA family protein 2.506 up 1.26x1012 
SAOUHSC_01098 DNA-dependent DNA polymerase beta 5.763 up 7.56x1031 
chain 
SAOUHSC_01099 mutS2 MutS2 protein 3.049 up 9.65x1026 
SAOUHSC_01100 trxA thioredoxin 3.157 up 7.73x10-23 
SAOUHSC_01101 hypothetical protein 3.368 up 8.86x1015 
SAOUHSC_01102 uvrC excinuclease ABC, C subunit 2.030 up 1.10x1020 
SAOUHSC_01108 hypothetical protein 2.078 up 2.30x1025 
SAOUHSC_01120 hypothetical protein 2.065 up 5.27x107 
SAOUHSC_01139 hypothetical protein 4.591 up 1.73X10-29 
SAOUHSC_01140 hypothetical protein 5.289 up 9.15x1030 
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SAOUHSC_01141 hypothetical protein 4.130 up 1.04x10-27 
SAOUHSC_01152 hypothetical protein 2.253 up 3.73x1023 
SAOUHSC_01153 hypothetical protein 2.179 up 1.08x1024 
SAOUHSC_01154 sepF cell division protein, SepF 2.471 up 1.19x1022 
SAOUHSC_01155 hypothetical protein 3.562 up 7.72x1017 
SAOUHSC_01158 hypothetical protein 5.127 up 4.68x1030 
SAOUHSC_01164 pyrR PyrR bifunctional protein 3.935 up 1.31x1018 
SAOUHSC_01165 uracil permease 2.827 up 3.87x1024 
SAOUHSC_01166 pyrB aspartate carbamoyltransferase 5.777 up 1.27x1031 
catalytic subunit 
SAOUHSC_01168 pyrC dihydroorotase 2.830 up 2.02x1024 
SAOUHSC_01169 carbamoyl phosphate synthase small 3.834 up 7.57x1030 
subunit 
SAOUHSC_01170 car8 carbamoyl phosphate synthase large 2.049 up 7.65x10,26 
subunit 
SAOUHSC_01172 pyrE orotate phosphoribosyltransferase 2.272 up 8.07x1019 
SAOUHSC_01173 hypothetical protein 2.948 up 4.09x10,12 
SAOUHSC_01175 fibrinogen binding protein 2.250 up 1.42x1018 
SAOUHSC_01176 gmk guanylate kinase 2.745 up 5.16x1027 
SAOUHSC_01178 phosphopantothenoylcysteine 2.168 up 3.34x1015 
decarboxylase/phosphopantothenate- 
-cysteine ligase 
SAOUHSC_01182 polypeptide deformylase 2.325 up 1.25x10'" 
SAOUHSC_01185 rlmN Ribosomal RNA large subunit 2.109 up 4.07x1020 
methyltransferase N 
SAOUHSC_01188 rsgA ribosome small subunit-dependent 2.419 up 2.88x1021 
GTPase A 
SAOUHSC_01191 rpmB ribosomal protein L28 2.213 up 7.85x1012 
SAOUHSC_01192 hypothetical protein 3.726 up 2.11x10 22 
SAOUHSC_01201 acpP acyl carrier protein 2.969 up 5.13x10,14 
SAOUHSC_01211 rpIS ribosomal protein L19 2.174 up 1.92x1010 
SAOUHSC_01216 sucC succinyl-CoA synthetase subunit beta 2.575 up 1.85x1011 
SAOUHSC_01232 rps8 ribosomal protein S2 2.839 up 2.35x10-18 
SAOUHSC_01233 hypothetical protein 4.368 up 1.68x1018 
SAOUHSC_01234 tsf translation elongation factor Is 2.292 up 2.51x1018 
SAOUHSC_01242 rime ribosome maturation factor RimP 3.885 up 5.78x10 24 
SAOUHSC_01250 rpsO ribosomal protein S15 2.484 up 3.94x1015 
SAOUHSC_01261 competence/damage-inducible protein 2.284 up 9.62x10,22 
CinA N-terminal domain, putative 
SAOUHSC_01283 GTP-binding protein 2.242 up 1.16x10-19 
SAOUHSC_01285 regulatory protein, MerR 2.991 up 4.84x10-11 
SAOUHSC_01309 hypothetical protein 3.602 up 1.81x1012 
SAOUHSC_01313 sensor kinase protein 2.140 up 1.34x1012 
SAOUHSC_01317 hypothetical protein 2.790 up 4.83x10 21 
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SAOUHSC_01330 guaC guanosine 5'-monophosphate 2.507 up 5.06x10,27 
oxidoreductase 
SAOUHSC_01331 hypothetical protein 5.471 up 5.13x10-26 
SAOUHSC_01332 hypothetical protein 2.848 up 2.80x1017 
SAOUHSC_01333 lexA LexA repressor 2.421 up 4.84x1020 
SAOUHSC_01336 protein Stu0508 3.395 up 1.34x1015 
SAOUHSC_01337 transketolase 2.566 up 4.58x1018 
SAOUHSC_01347 aconitate hydratase 1 2.577 up 1.90x1017 
SAOUHSC_01349 hypothetical protein 2.167 up 6.66x1013 
SAOUHSC_01359 mprF phosphatidylglycerol lysyltransferase 2.549 up 1.84x10,20 
SAOUHSC_01360 msrAl methionine-S-sulfoxide reductase 2.171 up 1.14x10,22 
SAOUHSC_01361 msrR regulatory protein MsrR 2.334 up 7.66x1012 
SAOUHSC_01362 hypothetical protein 2.182 up 1.22x10 9 
SAOUHSC_01373 femA aminoacyltransferase FemA 2.639 up 5.22x1014 
SAOUHSC_01392 ABC transporter, ATP-binding protein, 2.411 up 1.18x1015 
putative 
SAOUHSC_01402 msa protein Msa 2.004 up 8.76x1011 
SAOUHSC_01403 cspA cold shock protein CspA 4.560 up 8.35x10,22 
SAOUHSC_01404 hypothetical protein 6.375 up 8.63x10,13 
SAOUHSC_01405 hypothetical protein 3.603 up 4.94x1019 
SAOUHSC_01406 acyP acylphosphatase 2.995 up 6.57x1012 
SAOUHSC_01407 5-bromo-4-chloroindolyl phosphate 3.011 up 4.55x1010 
hydrolysis protein XpaC 
SAOUHSC_01408 hypothetical protein 3.091 up 4.47x101° 
SAOUHSC_01430 glucose-specific phosphotransferase 2.303 up 1.47x1016 
enzyme IIA component 
SAOUHSC_01431 msrB methionine-R-sulfoxide reductase 2.273 up 6.88x1017 
SAOUHSC_01432 msrA2 methionine-S-sulfoxide reductase 2.107 up 2.28x1012 
SAOUHSC_01436 YphP 2.018 up 3.05x1016 
SAOUHSC_01437 cvfC conserved virulence factor C 2.084 up 1.03x1019 
SAOUHSC_01439 hypothetical protein 2.461 up 3.45X10-26 
SAOUHSC_01462 gpsB cell cycle protein GpsB 3.483 up 9.45x10-12 
SAOUHSC_01463 hypothetical protein 2.974 up 1.45x1012 
SAOUHSC_01464 hypothetical protein 5.377 up 1.01x10-18 
SAOUHSC_01466 recU recombination protein U 5.242 up 1.73x1019 
SAOUHSC_01467 penicillin-binding protein 2 3.889 up 3.86x10'23 
SAOUHSC_01468 hypothetical protein 3.990 up 2.46x1016 
SAOUHSC_01469 endonuclease III, putative 2.979 up 4.82x10-22 
SAOUHSC_01470 DnaD and phage-associated region 2.508 up 7.06x10-20 
SAOUHSC_01476 MazG nucleotide 2.594 up 2.43x1015 
pyrophosphohydrolase domain 
superfamily 
SAOUHSC_01477 Zn-dependent protease 3.506 up 1.55x10101' 
SAOUHSC_01478 YpjA 2.243 up 9.25x1026 
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SAOUHSC_01479 hypothetical protein 2.156 up 2.46x10-20 
SAOUHSC_01480 TPR repeat 2.622 up 2.89x1018 
SAOUHSC_01490 DNA-binding protein HU 1 2.520 up 1.54x10 7 
SAOUHSC_01504 ferredoxin 6.732 up 3.78x10 29 
SAOUHSC_01505 riboflavin transporter 4.083 up 2.16x10,24 
SAOUHSC_01586 srrA transcriptional regulatory protein SrrA 2.666 up 1.72x10-14 
SAOUHSC_01588 scp8 segregation and condensation protein 2.036 up 1.06x10-16 
B 
SAOUHSC_01589 scpA segregation and condensation protein 2.694 up 2.73x10-14 
A 
SAOUHSC_01599 glucose-6-phosphate 1-dehydrogenase 4.299 up 3.80x10-32 
SAOUHSC_01605 6-phosphogluconate dehydrogenase, 2.014 up 1.95x1013 
decarboxylating 
SAOUHSC_01607 hypothetical protein 2.601 up 1.58x1011 
SAOUHSC_01608 hypothetical protein 2.413 up 9.58x10' 
SAOUHSC_01610 YgiW 2.224 up 5.97x10-22 
SAOUHSC_01621 nusB transcription antitermination factor 2.658 up 2.25x10-13 
NusB 
SAOUHSC_01622 YqhY 2.237 up 7.58x10'16 
SAOUHSC_01627 lipoprotein, putative 2.055 up 2.98x10 6 
SAOUHSC_01647 hypothetical protein 2.507 up 3.09x10 8 
SAOUHSC_01648 tetratricopeptide repeat domain 2.823 up 2.59x10 9 
protein 
SAOUHSC_01653 sodA superoxide dismutase [Mn] 2.256 up 2.11x10-5 
SAOUHSC_01655 fur ferric uptake regulation protein 2.140 up 6.88x10-12 
SAOUHSC_01656 hydrophobic membrane protein ZurM 2.319 up 4.31x1022 
SAOUHSC_01657 ABC transporter, putative 2.680 up 3.16x10-22 
SAOUHSC_01662 rpoD RNA polymerase sigma factor RpoD 2.837 up 7.20x10-24 
SAOUHSC_01663 DNA primase 4.080 up 1.39x1026 
SAOUHSC_01665 CBS domain protein 2.345 up 2.86x10-1° 
SAOUHSC_01673 PhoH family protein 2.037 up 7.43x1019 
SAOUHSC_01678 rpsU ribosomal protein S21 2.722 up 6.38x1017 
SAOUHSC_01679 hypothetical protein 2.230 up 3.52x1017 
SAOUHSC_01681 prmA ribosomal protein L11 3.312 up 9.45x10,35 
methyltransferase 
SAOUHSC_01682 dnaJ DnaJ protein 2.396 up 1.35x102' 
SAOUHSC_01683 dnaK molecular chaperone DnaK 3.575 up 5.92x1025 
SAOUHSC_01684 grpE co-chaperone GrpE 13.738 up 6.67x10-28 
SAOUHSC_01685 hrcA heat-inducible transcription repressor 18.090 up 3.94x10,3° 
HrcA 
SAOUHSC_01689 rpsT ribosomal protein S20 2.764 up 6.85x1015 
SAOUHSC_01698 hypothetical protein 2.216 up 4.19x10-13 
SAOUHSC_01701 had superfamily (subfamily iiia) 2.231 up 1.40x1021 
phosphatase 
SAOUHSC_01702 mtnN MTA/SAH nucleosidase 2.383 up 5.71x1018 
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SAOUHSC_01715 udk uridine kinase 2.453 up 6.40x10-26 
SAOUHSC_01716 peptidase U32 2.472 up 6.55X10-27 
5AOUHSC_01717 peptidase U32 2.811 up 3.47x1027 
SAOUHSC_01718 0-methyltransferase, family 3 2.462 up 3.72x1010 
SAOUHSC_01720 putative Holliday junction resolvase 2.125 up 1.29x1025 
SAOUHSC_01721 protein Stu1959 2.216 up 4.24x1023 
SAOUHSC_01725 mnmA tRNA-specific 2-thiouridylase MnmA 3.004 up 9.27x10-29 
SAOUHSC_01726 mnmA tRNA-specific 2-thiouridylase MnmA 2.806 up 2.89x1023 
SAOUHSC_01727 aminotransferase, class V 2.650 up 1.28x1024 
SAOUHSC_01736 hypothetical protein 3.554 up 5.98x1013 
SAOUHSC_01741 dtd D-tyrosyl-tRNA(Tyr) deacylase 2.586 up 3.70x10-28 
SAOUHSC_01751 ruvA Holliday junction DNA helicase RuvA 2.970 up 2.09x1018 
SAOUHSC_01752 ACT domain protein PheB 3.036 up 1.76x10-23 
SAOUHSC_01753 obgE SpoOB-associated GTP-binding protein 2.120 up 1.86x10-23 
SAOUHSC_01755 rpmA ribosomal protein L27 3.096 up 1.84x1027 
SAOUHSC_01756 hypothetical protein 11.287 up 1.17x10 32 
SAOUHSC_01757 rplU ribosomal protein L21 8.655 up 5.20x1037 
SAOUHSC_01758 rod shape-determining protein MreD 3.599 up 1.01x10-24 
SAOUHSC_01759 rod shape-determining protein MreC 3.964 up 6.97x10 20 
SAOUHSC_01760 hypothetical protein 4.448 up 4.02x1028 
SAOUHSC_01761 hypothetical protein 5.602 up 1.10x10-34 
SAOUHSC_01762 hypothetical protein 2.662 up 3.60x10,22 
SAOUHSC_01778 clpX ATP-dependent protease ATP-binding 2.952 up 1.17x1018 
subunit ClpX 
SAOUHSC_01779 tig trigger factor 4.831 up 6.02x10-33 
SAOUHSC_01780 hypothetical protein 3.626 up 1.18x1012 
SAOUHSC_01784 rpIT ribosomal protein L20 2.204 up 1.58x1012 
SAOUHSC_01785 rpm/ ribosomal protein L35 3.393 up 3.25x1025 
SAOUHSC_01786 infC translation initiation factor IF-3 4.049 up 9.74x1025 
SAOUHSC_01789 hypothetical protein 3.157 up 4.82x1022 
SAOUHSC_01792 replication initiation and membrane 2.512 up 4.22x1021 
attachment protein 
SAOUHSC_01793 nrdR transcriptional regulator NrdR 3.033 up 2.53x10.21 
SAOUHSC_01797 DNA polymerase 1 2.297 up 2.73x10'14 
SAOUHSC_01801 isocitrate dehydrogenase 3.216 up 2.13x1015 
SAOUHSC_01802 citrate synthase 2 2.412 up 2.28x10-19 
SAOUHSC_01829 rpsD ribosomal protein S4 2.026 up 4.25x10-14 
SAOUHSC_01850 catabolite control protein A 3.620 up 5.01x10-20 
SAOUHSC_01851 hypothetical protein 2.301 up 2.18x10,6 
SAOUHSC_01865 trm8 tRNA (guanine-N(7)-)- 3,914 up 2.18x10-24 
methyltransferase 
SAOUHSC_01866 aminoglycoside phosphotransferase 2.269 up 1.39x1023 
SAOUHSC_01870 RNA pseudouridine synthase family 2.219 up 1.85x1017 
protein 
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SAOUHSC_01896 hypothetical protein 2.678 up 4.08x1012 
SAOUHSC_01927 transposase, IS3 family, truncation- 2.539 up 4.09x10-13 
related protein, putative 
SAOUHSC_01928 transposase 2.662 up 1.27x10,12 
SAOUHSC_01957 hypothetical protein 5.337 up 2.44x10-19 
SAOUHSC_01962 hernE uroporphyrinogen decarboxylase 2.169 up 2.36x1017 
SAOUHSC_01963 hypothetical protein 2.090 up 4.84x101' 
SAOUHSC_01972 prsA foldase protein PrsA 4.742 up 6.66x10-25 
SAOUHSC_01997 perR peroxide-responsive repressor Peril 5.120 up 1.3410-24 
SAOUHSC_02001 hypothetical protein 3.042 up 1.35x10-23 
SAOUHSC_02012 mgt monofunctional glycosyltransferase 4.316 up 5.01x10-32 
SAOUHSC_02098 DNA-binding response regulator VraR, 3.807 up 8.23x1029 
putative 
SAOUHSC_02099 sensor protein VraS 5.584 up 6.29x10-25 
SAOUHSC_02100 hypothetical protein 10.020 up 1.24x1026 
SAOUHSC_02101 hypothetical protein 7.618 up 1.16x1026 
SAOUHSC_02107 Mur ligase family protein 2.429 up 7.97x10-21 
SAOUHSC_02108 ftnA ferritin 4.046 up 1.97x10-24 
SAOUHSC_02109 hypothetical protein 5.468 up 5.70x10,16 
SAOUHSC_02110 exonuclease 3.475 up 9.40x10-23 
SAOUHSC_02112 hypothetical protein 3.179 up 4.97x10 24 
SAOUHSC_02124 pcrB protein PcrB 2.390 up 3.94x1017 
SAOUHSC_02150 : Thiol-disulfide isomerase and 2.732 up 5.24x1018 
thioredoxins 
SAOUHSC_02151 ABC-2 type transport system permease 2.134 up 2.62x10-6 
protein 
SAOUHSC_02153 membrane protein, putative 2.117 up 4.26x108 
SAOUHSC_02175 hypothetical phage protein 2.701 up 6.04x10,13 
SAOUHSC_02176 hypothetical protein 2.910 up 5.39x10,21 
SAOUHSC_02254 groEL chaperonin GroEL 3.080 up 1.82x1023 
SAOUHSC_02255 groES co-chaperonin GroES 8.246 up 8.90x1032 
SAOUHSC_02258 nitroreductase 3.747 up 2.62x10-18 
SAOUHSC_02280 hypothetical protein 2.183 up 2.45x1013 
SAOUHSC_02294 hypothetical protein 10.127 up 6.27x10-19 
SAOUHSC_02301 phosphoserine phosphatase RsbU 2.363 up 7.77x1019 
SAOUHSC_02302 sigmaB regulation protein RsbU, 3.465 up 7.75x1019 
putative 
SAOUHSC_02303 mazF Toxin MazF 2.966 up 1.46x1017 
SAOUHSC_02316 DEAD-box ATP dependent DNA 3.897 up 1.55x1027 
helicase 
SAOUHSC_02318 ddl D-alanine--D-alanine ligase 2.095 up 4.41x1018 
SAOUHSC_02343 ATP synthase F1, gamma subunit 2.072 up 2.07x10 9 
SAOUHSC_02346 atpH ATP synthase F1, delta subunit 2.659 up 8.46x1012 
SAOUHSC_02350 atpB ATP synthase FO, A subunit 2.889 up 5.47x1011 
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SAOUHSC_02351 hypothetical protein 3.197 up 4.77x10-13 
SAOUHSC_02364 hypothetical protein 3.507 up 1.37x1027 
SAOUHSC_02365 UDP-N-acetylglucosamine 1- 3.545 up 3.59x1025 
carboxyvinyltransferase 
SAOUHSC_02381 general stress protein 20U 3.594 up 1.69x1011 
SAOUHSC_02391 hypothetical protein 2.481 up 8.10x1017 
SAOUHSC_02406 hypothetical protein 2.546 up 8.34x1015 
SAOUHSC_02409 arginase 2.007 up 1.91x10-17 
SAOUHSC_02416 hypothetical protein 7.246 up 3.49x10,16 
SAOUHSC_02423 UTP-glucose-l-phosphate 2.056 up 1.45x1023 
uridylyltransferase family protein 
SAOUHSC_02430 ABC transporter periplasmic binding 2.936 up 1.44x1016 
protein, putative 
SAOUHSC_02448 cell surface hydrolase 2.599 up 2.67x10 27 
SAOUHSC_02460 aldo/keto reductase 2.078 up 2.51x1025 
SAOUHSC_02461 transcriptional regulator, MerR family 3.685 up 1.41x10-23 
SAOUHSC_02471 hypothetical protein 2.678 up 2.74x10 8 
SAOUHSC_02473 hypothetical protein 2.262 up 3.73x10-12 
SAOUHSC_02478 rpIM ribosomal protein L13 2.704 up 4.03x1029 
SAOUHSC_02486 rpsK ribosomal protein Sil 2.135 up 1.28x10-12 
SAOUHSC_02488 rpmJ ribosomal protein L36 2.181 up 1.13x1016 
SAOUHSC_02503 rpsQ ribosomal protein S17 2.321 up 2.48x1015 
SAOUHSC_02515 hypothetical protein 2.643 up 2.51x10'5 
SAOUHSC_02516 permease family protein 2.085 up 3.86x1017 
SAOUHSC_02536 moaA molybdenum cofactor biosynthesis 2.061 up 2.92x1023 
protein A 
SAOUHSC_02538 molybdopterin converting factor, 2.264 up 1.09X10-21, 
subunit 1 
SAOUHSC_02540 molybdopterin converting factor, 2.320 up 2.81x10-22 
subunit 2 
SAOUHSC_02558 ureA urease, gamma subunit 2.285 up 1.16x10,22 
SAOUHSC_02561 ureC urease, alpha subunit 2.631 up 9.55x1031 
SAOUHSC_02562 ureE urease accessory protein UreE 2.641 up 4.99x10-30 
SAOUHSC_02563 ureF urease accessory protein UreF 3.365 up 1.36x1027 
SAOUHSC_02564 ureG urease accessory protein UreG 2.478 up 1.36x10 28 
SAOUHSC_02565 ureD urease accessory protein UreD 4.712 up 3.00x10-22 
SAOUHSC_02566 sarR accessory regulator 2.510 up 3.01x10'9 
SAOUHSC_02583 transcriptional regulator, putative 3.278 up 2.36x10"22 
SAOUHSC_02589 phosphosugar-binding transcriptional 3.503 up 4.95x1028 
regulator, RpiR family 
SAOUHSC_02645 LytTr DNA-binding region 2.223 up 6.55X10-27 
SAOUHSC_02646 hypothetical protein 2.177 up 6.07x1024 
SAOUHSC_02659 regulatory protein, TetR 4.229 up 4.81X10-24 
SAOUHSC_02660 cationic transporter 2.685 up 4.97x10,22 
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SAOUHSC_02691 addiction module toxin, Txe/YoeB 2.976 up 1.80x1023 
family 
SAOUHSC_02692 prevent-host-death protein 2.695 up 5.30x10-29 
SAOUHSC_02694 lipoprotein, putative 2.769 up 7.87x1012 
SAOUHSC_02695 lipoprotein, putative 3.356 up 3.14x1012 
SAOUHSC_02698 probable amino-acid ABC transporter 2.239 up 2.45x10'15 
permease protein YckJ 
SAOUHSC_02724 hypothetical protein 2.926 up 6.85x1023 
SAOUHSC_02747 hypothetical protein 2.889 up 1.04x1025 
SAOUHSC_02756 addiction module toxin, Txe/YoeB 2.189 up 2.62x10.9 
family 
SAOUHSC_02757 prevent-host-death protein 3.747 up 5.68x1012 
SAOUHSC_02830 D-lactate dehydrogenase 2.123 up 5.69x10'15 
SAOUHSC_02839 L-serine dehydratase, iron-sulfur- 2.419 up 4.26x1023 
dependent, alpha subunit 
SAOUHSC_02840 L-serine dehydratase, iron-sulfur- 2.320 up 2.05x10-18 
dependent, beta subunit 
SAOUHSC_02841 regulatory protein PfoR 3.152 up 1.11x1019 
SAOUHSC_02845 thioredoxin 2.801 up 4.32x1033 
SAOUHSC_02846 hypothetical protein 3.151 up 1.97x10 26 
SAOUHSC_02848 glcB pts system, glucose-specific iibc 2.343 up 6.36x10-17 
component 
SAOUHSC_02872 hypothetical protein 3.604 up 3.50x1025 
SAOUHSC_03001 icoR biofilm operon icaabcd hth-type 5.525 up 3.22x10 20 
negative transcriptional regulator IcaR 
SAOUHSC_03055 rpmH ribosomal protein L34 2.931 up 9.22x1017 
SAOUHSC_AO0332 hypothetical protein 2.604 up 1.02x10.21 
SAOUHSC_AO1041 hypothetical protein 7.603 up 1.38x1031 
SAOUHSC_AO1081 hypothetical protein 2.138 up 1.32x101° 
SAOUHSC_AO1910 hypothetical protein 2.344 up 7.87x10,16 
SAOUHSC_AO1912 hypothetical protein 4.034 up 1.99x10-26 
SAOUHSC_AO2189 hypothetical protein 4.253 up 2.42x1016 
Downregulated genes 
SAOUHSC_00009 serS seryl-tRNA synthetase 2.311 down 3.97x10-12 
SAOUHSC_00010 AzIC family protein 2.702 down 3.22x10-'° 
SAOUHSC_00012 branched-chain amino acid transport 2.232 down 8.12x109 
protein (AzID) 
SAOUHSC_00025 Ser/Thr protein phosphatase family 3.637 down 9.80x101° 
protein 
SAOUHSC_00049 hypothetical protein 2.670 down 9.11x1012 
SAOUHSC_00051 1-phosphatidylinositol 3.120 down 4.77x109 
phosphodiesterase precursor, putative 
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SAOUHSC_00057 aminoacylase 2.054 down 0 
SAOUHSC_00058 major facilitator superfamily MFS_1 2.730 down 4.96x10-12 
SAOUHSC_00060 Na/Pi cotransporter family protein 2.295 down 0 
SAOUHSC_00062 integral membrane domain protein 2.285 down 1.11x10'9 
SAOUHSC_00064 norG HTH-type transcriptional regulator 2.318 down 5.19x10-7 
NorG 
SAOUHSC_00071 iron compound ABC transporter, 2.462 down 1.75x10-1° 
permease protein SirC 
SAOUHSC_00072 iron compound ABC transporter, 2.745 down 1.54x10-13 
permease protein SirB 
SAOUHSC_00074 lipoprotein 2.472 down 2.90x10-11 
SAOUHSC_00075 sbnA Probable siderophore biosynthesis 2.324 down 1.59x10 9 
protein SbnA 
SAOUHSC_00076 ornithine cyclodeaminase, putative 3.087 down 8.40x10'1° 
SAOUHSC_00077 IucA/IucC 3.113 down 6.17x101° 
SAOUHSC_00078 general substrate transporter: Major 3.066 down 2.03x101° 
facilitator superfamily MFS_1 
SAOUHSC_00079 IucA/lucC 2.466 down 1.23x101° 
SAOUHSC_00080 IucA/lucC 2.118 down 1.73x1011 
SAOUHSC_00081 hpch/hpai aldolase family protein 2.353 down 2.48x10-12 
SAOUHSC_00082 pyridoxal-dependent decarboxylase 2.634 down 1.31x10-12 
SAOUHSC_00083 hypothetical protein 2.540 down 3.48x10'1° 
SAOUHSC_00084 hypothetical protein 2.278 down 4.96x108 
SAOUHSC_00087 hypothetical protein 2.034 down 1.05x102 
SAOUHSC_00088 NAD-dependent 2.515 down 5.45x10'9 
epimerase/dehydratase family protein 
SAOUHSC_00089 sugar transferase 3.632 down 5.57x101° 
SAOUHSC_00090 glycosyl transferase, group 1 family 2.450 down 5.81x10-1° 
protein 
SAOUHSC_00091 0-antigen polymerase 2.419 down 9.42x10'8 
SAOUHSC_00092 polysaccharide extrusion protein 2.267 down 2.46x1011 
SAOUHSC_00103 phosphonate ABC transporter, 2.454 down 2.67x10.12 
permease protein 
SAOUHSC_00104 phnC phosphonate ABC transporter, ATP- 2.488 down 1.09x10-12 
binding protein 
SAOUHSC_00106 : PPE-repeat proteins 3.139 down 6.53x10-12 
SAOUHSC_00108 hypothetical protein 2.269 down 2.31x10-3 
SAOUHSC_00113 alcohol dehydrogenase, iron- 2.098 down 6.98x10-13 
containing 
SAOUHSC_00114 capsular polysaccharide biosynthesis 5.352 down 0 
protein, putative 
SAOUHSC_00115 capsular polysaccharide synthesis 7.641 down 1.33x1015 
enzyme Cap5B 
SAOUHSC_00116 capsular polysaccharide synthesis 5.626 down 0 
enzyme Cap8C 
159 
Locus tag Gene name Product name/Function Fold change P value 
SAOUHSC_00117 capsular polysaccharide biosynthesis 7.224 down 2.51x10-15 
protein Cap5D, putative 
SAOUHSC_00118 capsular polysaccharide biosynthesis 5.721 down 0 
protein Cap5E, putative 
SAOUHSC_00119 capsular polysaccharide synthesis 5.759 down 0 
enzyme Cap8F 
SAOUHSC_00120 UDP-N-acetylglucosamine 2-epimerase 4.880 down 0 
SAOUHSC_00121 capsular polysaccharide synthesis 3.955 down 7.03x1011 
enzyme 0-acetyl transferase Cap5H, 
putative 
SAOUHSC_00122 capsular polysaccharide biosynthesis 3.538 down 8.40x1011 
protein Cap5l, putative 
SAOUHSC_00123 capsular polysaccharide biosynthesis 2.448 down 5.42X10-6 
protein CapSJ, putative 
SAOUHSC_00124 capsular polysaccharide biosynthesis 2.398 down 8.91x10,6 
protein Cap5K, putative 
SAOUHSC_00125 Cap5L protein/glycosyltransferase, 4.082 down 2.83x1012 
putative 
SAOUHSC_00126 capsular polysaccharide biosynthesis 4.296 down 3.52x1015 
protein Cap8M 
SAOUHSC_00127 Cap5N protein/UDP-glucose 4- 3.903 down 2.54x1015 
epimerase, putative 
SAOUHSC_00128 CapSO protein/UDP-N-acetyl-D- 4.606 down 0 
mannosaminuronic acid 
dehydrogenase 
SAOUHSC_00129 UDP-N-acetylglucosamine 2-epimerase 2.152 down 0 
SAOUHSC_00134 hypothetical protein 2.172 down 4.59x1015 
SAOUHSC_00135 pANL51 2.576 down 0 
SAOUHSC_00136 nitrate transport ATP-binding protein 3.274 down 5.18x10'2 
NrtD 
SAOUHSC_00137 lipoprotein, putative 2.611 down 2.53x1015 
SAOUHSC_00138 ABC transporter, permease protein 3.849 down 1.94x1011 
SAOUHSC_00139 hypothetical protein 2.771 down 2.81x10.12 
SAOUHSC_00144 surfactin synthetase subunit 2 2.404 down 8.02x1011 
SAOUHSC_00147 argB acetylglutamate kinase 2.148 down 1.32x10-11 
SAOUHSC_00148 argJ arginine biosynthesis bifunctional 2.484 down 8.53x10-14 
protein ArgJ 
SAOUHSC_00150 ornithine--oxo-acid transaminase 2.471 down 7.47x1013 
SAOUHSC_00154 hypothetical protein 2.439 down 7.20x10'8 
SAOUHSC_00162 type I restriction-modifi cation system, 2.030 down 2.76x10-11 
R subunit 
SAOUHSC_00167 peptide ABC transporter, ATP-binding 2.280 down 1.32x10-15 
protein 
SAOUHSC_00169 peptide ABC transporter, permease 3.073 down 1.47x10-9 
protein 
SAOUHSC_00170 RGD-containing lipoprotein 2.750 down 2.32x10'11 
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SAOUHSC_00175 multiple sugar-binding transport ATP- 2.855 down 2.85x101° 
binding protein 
SAOUHSC_00176 extracellular solute-binding protein, 2.524 down 7.04x1013 
family 1 
SAOUHSC_00177 binding-protein-dependent transport 2.347 down 6.06x1011 
systems inner membrane 
component: TM2 
SAOUHSC_00179 oxidoreductase, Gfo/ldh/MocA family 2.631 down 1.86x1012 
SAOUHSC_00180 oxidoreductase, N- 2.201 down 1.35x10-11 
terminal: Oxidoreductase, C-terminal 
SAOUHSC_00181 sugar phosphate isomerase/epimerase 2.129 down 1.36x10-12 
SAOUHSC_00182 membrane protein, putative 2.796 down 2.99x107 
SAOUHSC_00183 uhpT major facilitator superfamily MFS_1 2.130 down 7.80x1011 
SAOUHSC_00185 sensor histidine kinase family protein 2.689 down 3.08x10.13 
SAOUHSC_00186 periplasmic iron binding protein 2.315 down 8.64x1013 
SAOUHSC_00188 pflA pyruvate formate-lyase 1-activating 2.661 down 2.77x10-13 
enzyme 
SAOUHSC_00189 hypothetical protein 2.288 down 7.86x10 9 
SAOUHSC_00190 glycerophosphoryl diester 2.003 down 1.46x101° 
phosphodiesterase 
SAOUHSC_00200 membrane protein, putative 2.922 down 6.66x10" 
SAOUHSC_00205 hypothetical protein 2.245 down 1.76x10'5 
SAOUHSC_00208 hypothetical protein 2.036 down 7.09x10 8 
SAOUHSC_00209 PTS system, glucose-specific IIBC 3.873 down 1.03x101° 
component, putative 
SAOUHSC_00211 pyrimidine-specific ribonucleoside 2.346 down 4.67x1013 
hydrolase RihA 
SAOUHSC_00213 phosphoenolpyruvate-dependent 2.012 down 6.20x1011 
sugar phosphotransferase system, eiia 
2: prd 
SAOUHSC_00214 phosphoenolpyruvate-dependent 2.253 down 1.49x10-12 
sugar phosphotransferase system, eiia 
2 
SAOUHSC_00216 PTS system, sorbitol-specific IIC 3.021 down 1.26x10-12 
component 
SAOUHSC_00217 arabitol-phosphate dehydrogenase 2.448 down 7.86x10-12 
SAOUHSC_00219 hexitol dehydrogenase 2.645 down 1.77x10-13 
SAOUHSC_00221 alcohol dehydrogenase, zinc- 2.199 down 1.99x10,11 
dependent 
SAOUHSC_00233 IrgB Antiholin-like protein IrgB 2.692 down 2.65x1012 
SAOUHSC_00242 regulatory protein, Lacl: Periplasmic 2.470 down 1.35x10-15 
binding protein/Lacl transcriptional 
regulator 
SAOUHSC_00251 membrane protein, putative 2.220 down 5.23x101° 
SAOUHSC_00254 membrane protein, putative 3.522 down 4.68x105 
SAOUHSC_00256 chap 3.095 down 6.25x10'11 
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SAOUHSC 00257 virulence factor EsxA 2.358 down 1.48x1014 
SAOUHSC_00264 protein EsaC 2.607 down 3.34x10-11 
SAOUHSC 00265 virulence factor EsxB 2.604 down 3.43x10-13 
SAOUHSC_00267 hypothetical protein 3.086 down 2.46x1045 
SAOUHSC_00284 5-nucleotidase, lipoprotein e(P4) 2.633 down 1.67x10-9 
family 
SAOUHSC_00285 ABC transporter, permease protein 2.885 down 0 
SAOUHSC_00287 ABC transporter, ATP-binding protein, 2.410 down 2.43x1015 
putative 
SAOUHSC_00289 hypothetical protein 3.586 down 4.38x10' 
SAOUHSC_00290 regulatory protein PfoR 2.857 down 1.78x10-12 
SAOUHSC_00294 sodium: solute symporter family 2.578 down 2.40x1011 
protein 
SAOUHSC_00295 nanA sialic acid lyase 3.014 down 9.82x10'5 
SAOUHSC_00296 ROK family protein 2.871 down 8.46x1012 
SAOUHSC_00298 nanE N-acetylmannosamine-6-phosphate 2- 3.308 down 8.81x1012 
epimerase 
SAOUHSC_00299 nucleoside recognition 3.107 down 4.00x1011 
SAOUHSC_00300 lipase precursor 5.127 down 0 
SAOUHSC_00302 NADH-dependent flavin 2.743 down 0 
oxidoreductase, oye family 
SAOUHSC_00310 ulaA ascorbate-specific PTS system enzyme 2.630 down 8.99x1012 
IIC 
SAOUHSC_00311 phosphotransferase system, 2.638 down 5.27x10-13 
lactose/cellobiose-specific 11B subunit 
SAOUHSC_00312 phosphoenolpyruvate-dependent 2.365 down 3.04x10'13 
sugar phosphotransferase system, eiia 
2 
SAOUHSC_00316 hypothetical protein 2.162 down 7.80x10*1° 
SAOUHSC_00317 glycerol-3-phosphate transporter 2.424 down 3.29x101° 
SAOUHSC 00324 YdaF 2.342 down 1.60x10'1 
SAOUHSC_00326 Tat-translocated enzyme 2.192 down 5.35x1011 
SAOUHSC_00334 hypothetical protein 2.161 down 6.00x10-12 
SAOUHSC_00335 low temperature requirement protein 2.187 down 1.27x10-1o 
LtrA 
SAOUHSC_00338 metE 5- 2.008 down 4.16x10-14 
methyltetrahydropteroyltrigiutamate- 
homocysteine S-methyltransferase 
SAOUHSC_00339 methylenetetrahydrofolate 2.662 down 8.54x1014 
reductase: Homocysteine S- 
methyltransf erase 
SAOUHSC_00340 trans-suIfuration enzyme family 3.115 down 2.16x10.12 
protein 
SAOUHSC_00341 cystathionine gamma-synthase (CGS) 3.340 down 2.22x101° 
(0-succinylhomoserine(thiol)-lyase) 
SAOUHSC_00356 propeptide, PepSY amd peptidase M4 2.604 down 0 
162 
Locus tag Gene name Product name/Function Fold change P value 
SAOUHSC_00358 transgiycosylase-associated protein 3.376 down 0 
SAOUHSC 00386 exotoxin 2.473 down 4.33x10-12 
SAOUHSC_00389 exotoxin 2.819 down 1.04x1010 
SAOUHSC_00390 exotoxin 10 2.314 down 2.19x1012 
SAOUHSC_00396 hypothetical protein 3.461 down 1.74x101° 
SAOUHSC_00408 hypothetical protein 2.082 down 4.33x1013 
SAOUHSC_00409 hypothetical protein 2.084 down 9.80x10 9 
SAOUHSC_00411 hypothetical protein 2.882 down 0 
SAOUHSC_00418 hypothetical protein 2.912 down 2.11x10'1° 
SAOUHSC_00420 sodium: neurotransmitter symporter 2.589 down 1.28x109 
SAOUHSC_00423 metN1 ABC transporter, ATP-binding protein 2.246 down 1.17x1014 
SAOUHSC_00424 binding-protein-dependent transport 2.018 down 2.49x1013 
systems inner membrane component 
SAOUHSC_00427 slel N-acetylmuramoyl-L-alanine amidase 2.635 down 0 
Slel 
SAOUHSC_00434 regulatory protein, LysR 2.575 down 1.44x101' 
SAOUHSC_00437 pts system, trehalose-specific iibc 2.018 down 1.36x101° 
component 
SAOUHSC_00450 Orn/Lys/Arg decarboxylase 2.241 down 5.53x1011 
SAOUHSC_00468 endoribonuclease L-PSP, putative 2.905 down 0 
SAOUHSC_00469 spoVG SpoVG superfamily 2.426 down 9.57x1013 
SAOUHSC_00541 cytidine/deoxycytidylate deaminase, 2.010 down 0 
zinc-binding region 
SAOUHSC_00544 sdrC serine-aspartate repeat-containing 2.322 down 7.59x10'9 
protein SdrC 
SAOUHSC_00583 hypothetical protein 2.291 down 6.09x10 8 
SAOUHSC_00596 staphylococcus aureus paralogous 2.017 down 9.59x10' 
family 
SAOUHSC_00608 adh alcohol dehydrogenase, propanol- 2.577 down 9.41x10-13 
preferring 
SAOUHSC_00622 hypothetical protein 2.059 down 1.90x10, '1 
SAOUHSC_00625 mnhA2 putative antiporter subunit MnhA2 2.349 down 6.77x10.14 
SAOUHSC_00628 mnhD2 putative antiporter subunit MnhD2 2.356 down 1.13x1013 
SAOUHSC_00630 hypothetical protein 2.041 down 1.18x10-14 
SAOUHSC_00632 mnhG2 putative antiporter subunit MnhG2 2.097 down 0 
SAOUHSC_00687 acetyltransferase, gnat family 2.167 down 3.73x10"1° 
SAOUHSC_00688 hypothetical protein 2.024 down 1.56x10-13 
SAOUHSC_00709 hypothetical protein 2.221 down 1.57x103 
SAOUHSC_00737 hypothetical protein 2.173 down 8.05x10-5 
SAOUHSC_00773 LysM domain protein 2.045 down 4.32x1011 
SAOUHSC_00788 hypothetical protein 2.627 down 2.63x1014 
SAOUHSC_00789 whiA putative sporulation transcription 2.337 down 2.37x10'° 
regulator WhiA 
SAOUHSC_00811 acetyltransferase, gnat family 2.070 down 2.49x1015 
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SAOUHSC_00814 truncated secreted von Willebrand 2.279 down 5.07x10-12 
factor-binding protein 
SAOUHSC_00818 thermonuclease (TNase) (Micrococcal 2.178 down 1.21x108 
nuclease)(Staphylococcal nuclease) 
SAOUHSC_00827 phosphoglycerate/bisphosphoglycerat 2.109 down 2.41x10'1 
e mutase 
SAOUHSC_00831 general stress protein 170 2.578 down 0 
SAOUHSC_00845 hypothetical protein 7.125 down 1.37x1015 
SAOUHSC_00846 integral membrane protein 3.492 down 0 
SAOUHSC_00855 2-nitropropane dioxygenase, NPD 2.357 down 1.38x10-13 
SAOUHSC_00857 hypothetical protein 2.157 down 2.67x1012 
SAOUHSC_00917 hypothetical protein 2.082 down 7.42x1012 
SAOUHSC_00918 map protein, programmed 2.274 down 0 
SAOUHSC_00923 oligopeptide transport system 2.603 down 1.88x101° 
permease protein OppB 
SAOUHSC_00924 dipeptide transport system permease 2.120 down 1.09x101° 
protein DppC 
SAOUHSC_00926 oligopeptide transport ATP-binding 2.130 down 1.79x1011 
protein OppF 
SAOUHSC_00928 oligopeptide ABC transporter, 2.645 down 4.36x10'11 
oligopeptide-binding protein 
SAOUHSC_00929 oligopeptide ABC transporter, ATP- 2.096 down 2.25x1014 
binding protein 
SAOUHSC_00949 sodium: alanine symporter 2.395 down 1.87x10'11 
SAOUHSC_00957 integral membrane protein TerC 2.798 down 7.74x1013 
SAOUHSC_00967 hypothetical protein 2.694 down 1.26x103 
SAOUHSC_00976 periplasmic binding protein 2.085 down 2.16x1011 
SAOUHSC_00986 sspC staphostatin B 2.622 down 6.65x1015 
SAOUHSC_00987 ssp8 staphopain B 2.682 down 1.49x109 
SAOUHSC_00988 sspA glutamyl endopeptidase 4.128 down 4.59x10-13 
SAOUHSC_00994 at! bifunctional autolysin 3.905 down 0 
SAOUHSC_01081 isdA iron-regulated surface determinant 2.505 down 6.02x10'1 
protein A 
SAOUHSC_01086 isdF transport system permease protein 2.541 down 1.11x10-12 
SAOUHSC_01087 iron compound ABC transporter, 2.660 down 4.58x1012 
permease protein 
SAOUHSC_01090 hypothetical protein 2.439 down 1.24x10-6 
SAOUHSC_01109 hypothetical protein 3.035 down 3.01x10.4 
SAOUHSC_01128 ornithine carbamoyltransferase 2.257 down 1.66x10'° 
SAOUHSC_01129 arcC1 carbamate kinase 2.320 down 1.02x10-12 
SAOUHSC_01130 C4-dicarboxylate anaerobic carrier 2.604 down 1.23x10-13 
SAOUHSC_01135 hypothetical protein 6.725 down 1.33x1015 
SAOUHSC_01136 hypothetical protein 4.191 down 1.24x109 
SAOUHSC_01254 UbiC transcription regulator- 2.064 down 6.74x1013 
associated 
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SAOUHSC_01257 NAD-dependent 2.093 down 4.58x1015 
epimerase/dehydratase: Short-chain 
dehydrogenase/reductase SDR: 3-beta 
hydroxysteroid 
dehydrogenase/isomerase 
SAOUHSC_01297 hypothetical protein 2.215 down 8.00x104 
SAOUHSC_01299 hypothetical protein 3.203 down 3.96x10.4 
SAOUHSC_01300 hypothetical protein 2.638 down 1.06x10.5 
SAOUHSC_01302 : NAD+--asparagine ADP- 2.228 down 0 
ribosyltransferase 
SAOUHSC_01339 hypothetical protein 2.485 down 5.42x107 
SAOUHSC_01366 anthranilate synthase component I 2.929 down 9.20x109 
SAOUHSC_01367 anthranilate synthase component li 3.503 down 1.25x10'9 
SAOUHSC_01369 trpC indole-3-glycerol phosphate synthase 2.524 down 4.91x10$ 
SAOUHSC_01370 trpF N-(5phosphoribosyl)anthranilate 2.112 down 2.87x10-7 
isomerase 
SAOUHSC_01371 trpB tryptophan synthase, beta subunit 2.751 down 2.98x101° 
SAOUHSC_01372 trpA tryptophan synthase, alpha subunit 2.159 down 3.66x10-13 
SAOUHSC_01387 phosphate ABC transporter, permease 2.783 down 3.33x101° 
protein PstC 
SAOUHSC_01389 pst5 phosphate-binding protein PstS 2.373 down 9.50x1013 
SAOUHSC_01394 aspartokinase 2 (Aspartokinase II) 2.011 down 9.92x10-12 
(Aspartate kinase 2) 
SAOUHSC_01443 cell wall enzyme EbsB 2.086 down 2.47x10-11 
SAOUHSC_01450 amino acid permease-associated 2.233 down 5.29x108 
region 
SAOUHSC_01451 tdcB threonine dehydratase 2.719 down 4.99x10.8 
SAOUHSC_01452 aldl alanine dehydrogenase 1 3.023 down 3.03x109 
SAOUHSC_01458 hypothetical protein 2.557 down 4.67x10'9 
SAOUHSC_01494 hypothetical protein 2.076 down 5.72x10.4 
SAOUHSC_01643 type II secretion system protein E 2.355 down 2.88x101° 
SAOUHSC_01794 glyceraldehyde-3-phosphate 2.093 down 0 
dehydrogenase 2 
SAOUHSC_01804 transposase (IS4 family) 2.128 down 1.52x10-7 
SAOUHSC_01854 hypothetical protein 2.189 down 2.48x1015 
SAOUHSC_01855 hypothetical protein 2.838 down 2.58x1012 
SAOUHSC_01880 transposase 2.290 down 1.13x10-13 
SAOUHSC_01905 transposase 2.569 down 8.55x10-11 
SAOUHSC_01906 transposase (IS4 family) 2.027 down 1.51x10,7 
SAOUHSC_01912 hypothetical protein 2.715 down 5.48x10-12 
SAOUHSC_01913 nucleoside triphosphatase YtkD 2.223 down 2.48x10'8 
SAOUHSC_01914 hypothetical protein 2.517 down 0 
SAOUHSC_01917 lipoprotein, putative 2.191 down 3.73x10*9 
SAOUHSC_01922 hypothetical protein 2.055 down 1.35x10-15 
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SAOUHSC_01933 type I restriction-modification system, 2.042 down 3.24x10'7 
M subunit 
SAOUHSC_01934 hypothetical protein 2.504 down 1.14x104 
SAOUHSC_01935 spiF serine protease SpIF 2.866 down 3.28x10''1 
SAOUHSC_01936 splE serine protease 2.637 down 1.08x10,1° 
SAOUHSC_01937 hypothetical protein 2.020 down 2.71x10-3 
SAOUHSC_01939 spiC serine protease SpIC 2.592 down 5.73x10-12 
SAOUHSC_01941 spiB serine protease SpIB 3.700 down 8.94x1012 
SAOUHSC_01942 splA serine protease SpIA 2.111 down 2.67x10.12 
SAOUHSC_01945 putative lantibiotic ABC transporter 4.058 down 0 
protein 
SAOUHSC_01947 membrane protein, putative 5.114 down 0 
SAOUHSC_01948 ABC transporter 5.500 down 1.35x10,15 
SAOUHSC_01949 epidermin leader peptide-processing 2.061 down 5.50x1013 
serine protease EpiP 
SAOUHSC_01954 leukocidin F subunit 2.301 down 1.52x10'11 
SAOUHSC_01955 leukotoxin LukE 2.479 down 1.66x10'9 
SAOUHSC_02000 hemL2 glutamate-l-semialdehyde-2,1- 2.008 down 1.37x10-14 
aminomutase 
SAOUHSC_02105 hypothetical protein 2.539 down 5.24x104 
SAOUHSC_02138 parallel beta-helix repeat 2.675 down 0 
SAOUHSC_02144 hypothetical protein 2.182 down 2.41x1015 
SAOUHSC_02146 acyl-coenzyme A: 6-aminopenicillanic 2.017 down 4.75x1014 
acid acyl-transferase 
SAOUHSC_02244 succinyl-diaminopimelate 2.932 down 4.33x10-14 
desuccinylase 
SAOUHSC_02260 hid delta-hemolysin 5.873 down 0 
SAOUHSC_02270 ammonium transporter 2.156 down 6.70x10'11 
SAOUHSC_02271 hypothetical protein 2.804 down 3.76x10-12 
SAOUHSC_02272 inner membrane protein YeeE 2.405 down 2.54x1014 
SAOUHSC_02281 ilvD dihydroxy-acid dehydratase 3.967 down 4.10x10-12 
SAOUHSC_02282 acetolactate synthase, large subunit, 3.102 down 1.10x10,11 
biosynthetic type 
SAOUHSC_02283 amino acid-binding ACT 2.826 down 2.38x10-9 
SAOUHSC_02284 ilvC ketol-acid reductoisomerase 2.597 down 2.57x10-1° 
SAOUHSC_02285 leuA 2-isopropylmalate synthase 2.616 down 2.40x10'1° 
SAOUHSC_02286 leuB 3-isopropylmalate dehydrogenase 2.512 down 1.09x101° 
SAOUHSC_02287 leuC 3-isopropylmalate dehydratase, large 2.699 down 2.11x10'1 
subunit 
SAOUHSC_02288 leuD 3-isopropylmalate dehydratase, small 2.763 down 2.56x10-11 
subunit 
SAOUHSC_02290 hypothetical protein 2.244 down 1.96x10'5 
SAOUHSC_02310 kdpC K+-transporting ATPase, C subunit 2.009 down 2.44x1015 
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SAOUHSC_02315 response regulator 2.022 down 1.96x10-14 
receiver: Transcriptional regulatory 
protein, C-terminal 
SAOUHSC_02324 HD domain protein 2.187 down 2.22x1012 
SAOUHSC_02325 hypothetical protein 3.178 down 2.41x10-11 
SAOUHSC_02326 hypothetical protein 3.059 down 1.60x101° 
SAOUHSC_02329 thiM hydroxyethylthiazole kinase 2.371 down 3.54x1015 
SAOUHSC_02339 hypothetical protein 2.092 down 9.42x10.4 
SAOUHSC_02357 SuaS/YciO/YrdC/YwIC family protein 2.276 down 1.32x10-12 
SAOUHSC_02387 NAD-dependent 3.552 down 4.57x10'5 
epimerase/dehydratase 
SAOUHSC_02402 mannitol-specific phosphotransferase 2.792 down 2.42x1015 
enzyme IIA component 
SAOUHSC_02403 mtID mannitol-1-phosphate 5- 2.201 down 0 
dehydrogenase 
SAOUHSC_02404 hypothetical protein 2.095 down 9.50x1013 
SAOUHSC_02438 transposase 2.373 down 2.28x10.9 
SAOUHSC_02440 transposase 2.018 down 5.22x107 
SAOUHSC_02441 asp23 alkaline shock protein 23 10.312 down 0 
SAOUHSC_02442 hypothetical protein 8.834 down 2.41x1015 
SAOUHSC_02443 hypothetical protein 13.744 down 0 
SAOUHSC_02444 glycine betaine transporter OpuD 5.240 down 0 
SAOUHSC_02450 PTS system, lactose-specific IIC 2.736 down 0 
component 
SAOUHSC_02451 lactose-specific phosphotransferase 2.601 down 9.26x10.14 
enzyme IIA component 
SAOUHSC_02452 IacD tagatose 1,6-diphosphate aldolase 2.991 down 1.29x10-12 
SAOUHSC_02453 lacC tagatose-6-phosphate kinase 2.378 down 0 
SAOUHSC_02454 lacB galactose-6-phosphate isomerase, 2.010 down 1.07x10-14 
LacB subunit 
SAOUHSC_02466 truncated MHC class II analog protein 9.104 down 0 
SAOUHSC_02551 acetyltransferase, gnat family 2.331 down 7.34x1013 
SAOUHSC_02552 BioY family protein 2.525 down 0 
SAOUHSC_02567 hypothetical protein 2.475 down 4.98x10-7 
SAOUHSC_02572 hypothetical protein 2.778 down 2.59x10 s 
SAOUHSC_02573 Na+/H+ antiporter NhaC 2.102 down 8.05x10-14 
SAOUHSC_02575 putative membrane protein 2.175 down 3.91x1014 
SAOUHSC_02576 secretory antigen precursor SsaA, 3.668 down 2.79x10-12 
putative 
SAOUHSC_02581 hypothetical protein 2.643 down 0 
SAOUHSC_02582 formate dehydrogenase, alpha 2.978 down 2.03x10-13 
subunit, putative 
SAOUHSC_02595 sodium/bile acid symporter family 2.790 down 2.81x1011 
protein 
SAOUHSC_02596 conserved hypothetical protein 2.356 down 4.64x10$ 
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SAOUHSC_02597 pts system, alpha-glucoside-specific 2.021 down 4.30x10-12 
iibc component subfamily 
SAOUHSC_02599 phosphosugar-binding transcriptional 2.251 down 9.33x10-'4 
regulator 
SAOUHSC_02604 oxidoreductase 3.587 down 3.55x10'5 
SAOUHSC_02605 amidohydrolase subfamily 2.738 down 6.38x1012 
SAOUHSC_02607 urocanate hydratase 2.198 down 7.02x10-14 
SAOUHSC_02609 fosB metallothiol transferase FosB 2.128 down 1.70x108 
SAOUHSC_02610 hutG formimidoylglutamase 2.263 down 9.04x1014 
SAOUHSC_02616 hypothetical protein 2.656 down 3.29x10' 
SAOUHSC_02618 ABC-type Na+ efflux pump permease 2.809 down 6.32x1012 
component 
SAOUHSC_02619 ABC transporter, ATP-binding protein 2.332 down 2.81x10-14 
SAOUHSC_02621 3-methyladenine DNA glycosylase 2.230 down 2.91x1014 
SAOUHSC_02622 sodium/glutamate symporter 2.082 down 1.12x1012 
SAOUHSC_02650 TpgX protein 2.006 down 1.34x1015 
SAOUHSC_02657 hypothetical protein 2.245 down 1.09x10'9 
SAOUHSC_02661 pts system, sucrose-specific iibc 2.103 down 1.11x1012 
component 
SAOUHSC_02662 PTS system sucrose-specific IIBC 2.639 down 1.27x10-12 
component 
SAOUHSC_02671 narT nitrite extrusion protein 2.098 down 1.20x1011 
SAOUHSC_02679 nitrate reductase molybdenum 2.142 down 5.22x10-14 
cofactor assembly chaperone 
SAOUHSC_02680 nitrate reductase, beta subunit 2.234 down 9.44x1013 
SAOUHSC_02681 nitrate reductase, alpha subunit 2.670 down 1.28x10-11 
SAOUHSC_02682 uroporphyrin-III C-methyltransferase 2.014 down 1.21x1011 
SAOUHSC_02684 nitrite reductase [NAD(P)H], large 2.175 down 6.73x1013 
subunit 
SAOUHSC_02685 transcriptional regulator NirR 2.050 down 1.18x10-14 
SAOUHSC_02687 formate/nitrite transporter 2.250 down 2.08x10-13 
SAOUHSC_02688 hypothetical protein 3.339 down 5.75x10_6 
SAOUHSC_02696 aminoacyltransferase FemA 2.089 down 1.17x10-13 
SAOUHSC_02711 hypothetical protein 2.172 down 7.59x10-11 
SAOUHSC_02712 bioW 6-carboxyhexanoate--CoA ligase 2.317 down 1.34x10.15 
SAOUHSC_02715 adenosylmethionine-8-amino-7- 2.835 down 2.43x10-11 
oxononanoate aminotransferase 
SAOUHSC_02717 hypothetical protein 2.256 down 3.35x10-7 
SAOUHSC_02718 ABC transporter, ATP-binding protein 2.340 down 3.51x1015 
SAOUHSC_02719 ABC transporter ATP-binding protein 2.636 down 2.77x10-9 
SAOUHSC_02720 hypothetical protein 3.665 down 3.02x10-4 
SAOUHSC_02726 transcription activator, effector 3.127 down 1.74x10'9 
binding 
SAOUHSC_02728 metallophosphoesterase 2.005 down 4.58x10-13 
SAOUHSC 02751 para-nitrobenzyl esterase 2.283 down 0 
168 
Locus tag Gene name Product name/Function Fold change P value 
SAOUHSC_02752 general substrate transporter: Major 2.057 down 0 
facilitator superfamily MFS_1 
SAOUHSC_02753 membrane protein, putative 2.668 down 3.73x1013 
SAOUHSC_02754 ABC transporter, ATP-binding protein, 3.078 down 2.13x1011 
putative 
SAOUHSC_02763 peptide ABC transporter, ATP-binding 2.042 down 5.71x10-14 
protein 
SAOUHSC_02764 peptide ABC transporter, ATP-binding 2.679 down 5.77x1012 
protein 
SAOUHSC_02765 binding-protein-dependent transport 2.891 down 3.75x1011 
systems inner membrane component 
SAOUHSC_02766 binding-protein-dependent transport 2.691 down 1.06x10'9 
systems inner membrane component 
SAOUHSC_02767 nickel ABC transporter, periplasmic 2.363 down 5.18x10-13 
nickel-binding protein 
SAOUHSC_02772 IMP dehydrogenase/GMP 3.585 down 0 
reductase: Short-chain 
dehydrogenase/reductase SDR 
SAOUHSC_02773 aminobenzoyl-glutamate transport 2.226 down 0 
protein 
SAOUHSC_02774 alkylhydroperoxidase AhpD core 2.379 down 2.25x10 7 
SAOUHSC_02787 hypothetical protein 2.786 down 1.02x10-12 
SAOUHSC_02796 hypothetical protein 2.903 down 2.95x10.4 
SAOUHSC_02797 major facilitator superfamily MFS_1 2.179 down 3.10x10'1° 
SAOUHSC_02798 sasG surface protein G 2.247 down 1.45x10" 
SAOUHSC_02799 sorT HTH-type transcriptional regulator 2.571 down 4.64x10.0 
SarT 
SAOUHSC_02800 sarU HTH-type transcriptional regulator 2.212 down 1.02x10'5 
SarU 
SAOUHSC_02805 hypothetical protein 2.700 down 1.43x10-6 
SAOUHSC_02806 gluconate permease, putative 2.919 down 5.38x1013 
SAOUHSC_02808 gluconate kinase 2.201 down 7.48x1013 
SAOUHSC_02809 gluconate operon transcriptional 2.303 down 4.43x10-12 
repressor 
SAOUHSC_02817 hypothetical protein 2.222 down 1.09x10-4 
SAOUHSC_02824 phospholipase/carboxylesterase family 2.319 down 1.01x101° 
protein 
SAOUHSC_02849 pyruvate oxidase 3.232 down 0 
SAOUHSC_02850 cidB holin-like protein CidB 2.977 down 2.44x1024 
SAOUHSC_02851 cidA holin-like protein CidA 2.002 down 1.98x10'11 
SAOUHSC_02852 regulatory protein, LysR: LysR, 2.398 down 2.90x1014 
substrate-binding 
SAOUHSC_02855 chap 2.690 down 2.46x1013 
SAOUHSC_02862 clpL ATP-dependent CIp protease, ATP- 6.058 down 0 
binding subunit ClpL 
SAOUHSC_02866 mmpl family 2.244 down 2.81x10-12 
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SAOUHSC_02871 maltose 0-acetyltransferase 2.270 down 0 
SAOUHSC_02877 crtN dehydrosqualene desaturase 3.989 down 1.37x1015 
SAOUHSC_02879 crtM dehydrosqualene synthase 3.233 down 2.41x1015 
SAOUHSC_02880 crtQ 4,4'-diaponeurosporenoate 4.095 down 2.50x1013 
glycosyltransferase 
SAOUHSC_02881 crtP 4,4'-diaponeurosporene oxidase 3.883 down 6.76x10-12 
SAOUHSC_02882 crtO glycosyl-4,4'-diaponeurosporenoate 2.569 down 3.95x10-" 
acyltransferase 
SAOUHSC_02883 ssaA staphylococcal secretory antigen SsaA 2.741 down 2.74x1012 
SAOUHSC_02887 isaA probable transglycosylase IsaA 2.183 down 1.30x10-15 
SAOUHSC_02888 membrane protein, putative 3.550 down 4.06x1012 
SAOUHSC_02889 hypothetical protein 3.194 down 1.38x10-3 
SAOUHSC_02890 hypothetical protein 2.925 down 4.28x10-5 
SAOUHSC_02894 glyoxalase/bleomycin resistance 2.623 down 4.54x1010 
protein/dioxygenase 
SAOUHSC_02895 hypothetical protein 2.107 down 1.27x10-14 
SAOUHSC_02896 hypothetical protein 2.496 down 2.86x1013 
SAOUHSC_02900 hydrolase, alpha/beta hydrolase fold 3.799 down 0 
family 
SAOUHSC_02901 cobalamin synthesis 2.392 down 1.06x1011 
protein/P47K: Cobalamin synthesis 
CobW, C-terminal 
SAOUHSC_02902 nucleoside recognition 2.668 down 1.13x10'1° 
SAOUHSC_02903 nucleoside recognition 2.260 down 4.71x1013 
SAOUHSC_02904 flavin-containing monooxygenase 2.615 down 7.45x1014 
FMO: FAD-dependent pyridine 
nucleotide-disulphide oxidoreductase 
SAOUHSC_02906 hypothetical protein 2.364 down 0 
SAOUHSC_02908 aminoglycoside 3.650 down 1.56x1012 
phosphotransferase: Fructosamine 
kinase 
SAOUHSC_02911 hypothetical protein 2.113 down 1.87x1011 
SAOUHSC_02915 peptidase S15 2.099 down 4.33x10'11 
SAOUHSC_02921 alpha-acetolactate decarboxylase 2.397 down 1.66x1012 
SAOUHSC_02923 amino acid permease-associated 2.074 down 4.06x10-12 
region 
SAOUHSC_02924 4-aminobutyrate aminotransferase 3.057 down 4.75x101° 
SAOUHSC_02925 hypothetical protein 2.069 down 1.73x1012 
SAOUHSC_02930 antibiotic biosynthesis 2.075 down 1.37x1015 
monooxygenase 
SAOUHSC_02932 betA choline dehydrogenase 3.335 down 1.31x101° 
SAOUHSC_02933 betaine aldehyde dehydrogenase 2.301 down 1.79x1012 
SAOUHSC_02934 hypothetical protein 3.192 down 1.82x10 6 
SAOUHSC_02936 hypothetical protein 2.571 down 3.71x10 9 
SAOUHSC_02937 bcct transporter 2.525 down 8.34x10,12 
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SAOUHSC_02939 hypothetical protein 2.736 down 4.39x10-4 
SAOUHSC_02940 hypothetical protein 2.421 down 2.52x10-' 
SAOUHSC_02941 anaerobic ribonucleoside-triphosphate 2.158 down 2.07x10-11 
reductase activating protein 
SAOUHSC_02943 citrate transporter 2.047 down 9.13x10-11 
SAOUHSC_02948 hypothetical protein 2.424 down 1.23x103 
SAOUHSC_02950 hypothetical protein 2.943 down 1.22x10'4 
SAOUHSC_02958 alkaline phosphatase 3 2.326 down 8.17x10"11 
SAOUHSC_02971 zinc meta lloproteinase aureolysin 3.052 down 5.20x1011 
SAOUHSC_02973 hypothetical protein 3.008 down 2.03x10'1° 
SAOUHSC_02983 hypothetical protein 2.519 down 2.30x10-11 
SAOUHSC_02984 hypothetical protein 3.000 down 2.47x1015 
SAOUHSC_02985 secA2 protein translocase subunit SecA2 2.671 down 3.17x10-14 
SAOUHSC_02986 accessory secretory protein Asp3, 2.099 down 1.30x1012 
putative 
SAOUHSC_02987 accessory secretory protein Asp2 2.414 down 2.81x1012 
SAOUHSC_02988 hypothetical protein 2.670 down 6.23x1011 
SAOUHSC_02994 hypothetical protein 2.300 down 0 
SAOUHSC 02995 YwrF 2.466 down 1.02x1013 
SAOUHSC_02996 peptide methionine sulfoxide 2.703 down 6.83x1011 
reductase MsrA/msrB 
SAOUHSC_02997 acetyltransferase 2.522 down 1.03x10-8 
SAOUHSC_02998 putative tyrosine-protein phosphatase 2.402 down 4.89x109 
CapC 
SAOUHSC_02999 exopolysaccharide synthesis protein 2.595 down 3.33x101° 
SAOUHSC_03002 icaA poly-beta-1,6-N-acetyl-D-glucosamine 2.775 down 5.23x10-" 
synthase 
SAOUHSC_03003 icaD poly-beta-1,6-N-acetyl-D-glucosamine 2.236 down 4.80x108 
synthesis protein IcaD 
SAOUHSC_03004 icaB biofilm PIA synthesis deacetylase IcaB 2.019 down 8.94x1011 
SAOUHSC_03008 imidazole glycerol phosphate synthase 2.971 down 1.17x1011 
subunit HisF, putative 
SAOUHSC_03009 hisA phosphoribosylformimino-5- 3.831 down 3.39x10-10 
aminoimidazole carboxamide ribotide 
isomerase 
SAOUHSC_03010 hisH imidazole glycerol phosphate 3.393 down 9.20x101° 
synthase, glutamine amidotransferase 
subunit 
SAOUHSC_03011 hiss imidazoleglycerol-phosphate 3.178 down 2.19x10-'o 
dehydratase 
SAOUHSC_03012 histidinol-phosphate 2.914 down 2.73x10 9 
aminotransferase, putative 
SAOUHSC_03013 histidinol dehydrogenase 3.271 down 1.58x10-9 
SAOUHSC_03014 hisG ATP phosphoribosyltransferase 3.043 down 7.97x101° 
catalytic subunit 
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SAOUHSC_03015 hisZ ATP phosphoribosyltransferase 3.478 down 7.04x10'9 
regulatory subunit 
SAOUHSC_03019 ATP-binding ABC transporter 2.604 down 4.04x1011 
SAOUHSC_03020 integral membrane protein 2.511 down 6.67x101° 
SAOUHSC_03021 hypothetical protein 2.519 down 4.17x101° 
SAOUHSC_03025 pcp pyrrolidone-carboxylate peptidase 2.211 down 8.72x1013 
SAOUHSC_03030 anion transporter family protein 2.038 down 5.62x1015 
SAOUHSC_03032 hypothetical protein 2.917 down 4.04x101° 
SAOUHSC_03036 bacitracin export ATP-binding protein 2.246 down 0 
BceA 
SAOUHSC_03047 hypothetical protein 3.248 down 6.07x10-13 
SAOUHSC_03048 hypothetical protein 2.380 down 2.18x10-12 
SAOUHSC_A00084 hypothetical protein 3.189 down 1.50x10 9 
SAOUHSC_AO0283 hypothetical protein 2.035 down 2.44x10-9 
SAOUHSC_AO0354 hypothetical protein 3.104 down 1.49x10'5 
SAOUHSC_AO0379 hypothetical protein 3.288 down 3.11x10-4 
SAOUHSC_AO0526 hypothetical protein 2.287 down 2.49x10 5 
SAOUHSC_AO2169 hypothetical protein 2.586 down 4.91x108 
SAOUHSC_AO2445 hypothetical protein 2.471 down 1.14x10 9 
SAOUHSC_AO2577 hypothetical protein 2.769 down 2.63x10.6 
SAOUHSC_AO2635 hypothetical protein 2.211 down 1.30x101° 
SAOUHSC_AO2795 hypothetical protein 2.830 down 2.06x105 
SAOUHSC_A02811 hypothetical protein 2.624 down 2.28x1012 
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Table A. 2 Differentially expressed genes in 144 hr biofilm cultures versus planktonic cultures of S. 
aureus SH1000. Data are the average of three experimental replicates. P values were determined 
using a Student's t-test in ArrayStar'M (DNASTAR). 
Locus tag Gene name Product name/function Fold change P value 
Up-regulated genes 
SAOUHSC_00001 dnaA chromosomal replication initiator 2.686 up 6.24x10.22 
protein DnaA 
SAOUHSC_00003 hypothetical protein 2.857 up 7.31x10 24 
SAOUHSC_00004 recF DNA replication and repair protein RecF 2.233 up 9.04x10.20 
SAOUHSC_00032 hypothetical protein 2.605 up 1.30x10'8 
SAOUHSC_00035 pyridine nucleotide-disulphide 2.210 up 5.06x10.12 
oxidoreductase family protein 
SAOUHSC_00036 metallo-beta-lactamase family protein 2.290 up 1.99x1015 
SAOUHSC_00037 sulfide: quinone oxidoreductase 2.221 up 2.35x101° 
SAOUHSC_00094 hypothetical protein 2.154 up 3.52x10'1° 
SAOUHSC_00141 hypothetical protein 2.612 up 6.88x1021 
SAOUHSC_00173 azoR azoreductase 2.378 up 1.58x10-24 
SAOUHSC_00345 hypothetical protein 2.216 up 7.72x1019 
SAOUHSC_00348 rpsF ribosomal protein S6 4.904 up 4.11x10.21 
SAOUHSC_00349 single-stranded DNA-binding protein 3.045 up 3.85x1019 
SAOUHSC_00472 prs ribose-phosphate pyrophosphokinase 2.271 up 7.33x10.21 
SAOUHSC_00473 hypothetical protein 2.453 up 4.46x10 
25 
SAOUHSC_00491 2-amino-4-hydroxy-6- 2.044 up 2.97x10'1° 
hydroxymethyldihydropteridine 
pyrophosphokinase 
SAOUHSC_00492 hypothetical protein 2.678 up 1.80x1012 
SAOUHSC_00502 ctsR transcriptional regulator CtsR 10.829 up 5.00x10.32 
SAOUHSC_00503 UvrB/UvrC motif-containing protein 2.982 up 1.32x10-22 
SAOUHSC_00504 ATP: guanido phosphotransferase 4.651 up 2.05x10-23 
SAOUHSC_00505 c/pC ATP-dependent Clp protease ATP- 5.157 up 6.20x10,28 
binding subunit CIpC 
SAOUHSC_00535 hypothetical protein 2.290 up 3.57x1017 
SAOUHSC_00550 GIcNAc-PI de-N-acetylase family protein 2.048 up 5.84x1012 
SAOUHSC_00555 HAD-superfamily hydrolase, subfamily 2.234 up 3.96x10.12 
IA, variant 1 
SAOUHSC_00556 proline/betaine transporter, putative 3.393 up 8.60x10'23 
SAOUHSC_00559 hypothetical protein 2.436 up 2.15x10'" 
SAOUHSC_00560 hypothetical protein 3.455 up 4.38x10'19 
SAOUHSC_00561 hypothetical protein 4.542 up 1.42x1014 
SAOUHSC_00574 eutD phosphotransacetylase 2.834 up 1.73x10.24 
SAOUHSC_00575 lipoate-protein ligase A family protein 2.960 up 2.47x10.25 
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SAOUHSC_00604 hypothetical protein 2.088 up 2.62x10,20 
SAOUHSC_00641 tagH teichoic acids export protein ATP- 2.145 up 1.46x10*23 
binding subunit 
5AOUHSC_00694 mgrA HTH-type transcriptional regulator MgrA 2.189 up 1.47x10,22 
SAOUHSC_00714 saes sensor histidine kinase SaeS 2.750 up 1.14x1014 
SAOUHSC_00715 saeR response regulator SaeR 2.361 up 2.06x10'8 
SAOUHSC_00717 hypothetical protein 2.836 up 1.34x10 8 
SAOUHSC_00728 ItaS glycerol phosphate lipoteichoic acid 2.989 up 2.62x10,21 
synthase 
SAOUHSC_00741 nrdl ribonucleotide reductase stimulatory 5.433 up 1.12x1019 
protein 
SAOUHSC_00742 ribonucleotide-diphosphate reductase 3.308 up 4.62x10,21 
subunit alpha 
SAOUHSC_00790 clpP ATP-dependent Clp protease, proteolytic 2.369 up 6.66x1028 
subunit CIpP 
SAOUHSC_00819 hypothetical protein 2.043 up 8.18x10*12 
SAOUHSC_00833 nitroreductase 2.710 up 2.67x10,22 
SAOUHSC_00867 hypothetical protein 2.002 up 8.81x1013 
SAOUHSC_00868 hypothetical protein 2.765 up 1.96x1017 
SAOUHSC_00869 dltA D-alanine activating enzyme 2.032 up 8.13x10'15 
SAOUHSC_00870 DItB protein, putative 2.720 up 1.23x10'16 
SAOUHSC_00871 dltC D-alanyl carrier protein 2.401 up 2.38x1015 
SAOUHSC_00900 pgi glucose-6-phosphate isomerase 2.055 up 1.63x10,27 
SAOUHSC_00912 ATP-dependent Cip protease, ATP- 4.351 up 7.00x10,32 
binding subunit CIpB 
SAOUHSC_00934 spxA transcriptional regulator Spx 2.226 up 3.53x10,26 
SAOUHSC_00935 mecA adaptor protein 3.007 up 9.52x10-24 
SAOUHSC_00942 GTP pyrophosphokinase 2.099 up 6.29x1023 
SAOUHSC_00997 transcriptional regulator, putative 2.362 up 3.26x1018 
SAOUHSC_00998 fmtA Protein FmtA 2.005 up 6.84x1013 
SAOUHSC_01005 hypothetical protein 6.356 up 9.14x10,36 
SAOUHSC_01007 folD FoID bifunctional protein 2.025 up 1.43x10'11 
SAOUHSC_01008 phosphoribosylaminoimidazole 3.228 up 1.20x10,27 
carboxylase, catalytic subunit 
SAOUHSC_01009 phosphoribosylaminoimidazole 2.639 up 8.43x10,24 
carboxylase ATPase subunit 
SAOUHSC_01010 purC phosphoribosylaminoimidazole- 2.389 up 0 
succinocarboxamide synthase 
SAOUHSC_01011 phosphoribosylformylglycinamidine 2.075 up 2.95x10,26 
synthase, PurS protein 
SAOUHSC_01025 membrane protein, putative 3.621 up 7.19x10,22 
SAOUHSC_01055 inositol monophosphatase family 2.168 up 1.24x10,27 
protein, putative 
SAOUHSC_01077 hypothetical protein 5.286 up 2.17x10.27 
SAOUHSC_01078 rpmF ribosomal protein L32 2.519 up 6.68x10,27 
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SAOUHSC_01098 DNA-dependent DNA polymerase beta 4.058 up 6.18x10-24 
chain 
SAOUHSC_01099 mutS2 MutS2 protein 2.440 up 4.46x10,21 
SAOUHSC_01100 trxA thioredoxin 2.124 up 8.65x10"16 
SAOUHSC_01139 hypothetical protein 2.583 up 6.33x1016 
SAOUHSC_01140 hypothetical protein 3.042 up 3.17x10*16 
SAOUHSC_01141 hypothetical protein 2.930 up 9.59x10-21 
SAOUHSC_01142 mraZ cell division protein MraZ 2.206 up 3.34x10'16 
SAOUHSC_01158 hypothetical protein 3.655 up 1.66x10-26 
SAOUHSC_01164 pyrR PyrR bifunctional protein 2.608 up 9.63x1019 
SAOUHSC_01165 uracil permease 2.252 up 5.25x1016 
SAOUHSC_01166 pyrB aspartate carbamoyltransferase catalytic 4.406 up 7.24x1028 
subunit 
SAOUHSC_01168 pyrC dihydroorotase 2.511 up 3.08x1019 
SAOUHSC_01169 carbamoyl phosphate synthase small 3.188 up 5.18x10-25 
subunit 
SAOUHSC_01176 gmk guanylate kinase 2.434 up 6.28x10*23 
SAOUHSC_01192 hypothetical protein 2.515 up 2.02x10,20 
SAOUHSC_01216 sucC succinyl-CoA synthetase subunit beta 2.112 up 7.00x10'9 
SAOUHSC_01232 rpsB ribosomal protein S2 2.571 up 2.78x10'9 
SAOUHSC_01233 hypothetical protein 2.348 up 2.29x1017 
SAOUHSC_01242 rime ribosome maturation factor RimP 2.760 up 9.59x10-24 
SAOUHSC_01330 guaC guanosine 5'-monophosphate 2.412 up 6.52x10719 
oxidoreductase 
SAOUHSC_01331 hypothetical protein 3.568 up 4.66x1019 
SAOUHSC_01332 hypothetical protein 2.132 up 2.90x10.14 
SAOUHSC_01337 transketolase 2.260 up 2.66x10'16 
SAOUHSC_01392 ABC transporter, ATP-binding protein, 2.238 up 2.29x10'16 
putative 
SAOUHSC_01403 cspA cold shock protein CspA 3.003 up 1.04x10'31 
SAOUHSC_01404 hypothetical protein 2.519 up 9.24x10 28 
SAOUHSC_01405 hypothetical protein 2.343 up 1.43x1024 
SAOUHSC_01406 acyP acylphosphatase 2.283 up 3.49x10'8 
SAOUHSC_01407 5-bromo-4-chloroindolyl phosphate 2.586 up 2.12x10° 
hydrolysis protein XpaC 
SAOUHSC_01408 hypothetical protein 2.392 up 2.60x10' 
SAOUHSC_01462 gpsB cell cycle protein GpsB 2.126 up 8.34x107 
SAOUHSC_01463 hypothetical protein 2.249 up 4.06x10'9 
SAOUHSC_01464 hypothetical protein 2.702 up 3.69x1015 
SAOUHSC_01466 recU recombination protein U 4.832 up 1.62x1018 
SAOUHSC_01467 penicillin-binding protein 2 3.423 up 5.72x1022 
SAOUHSC_01469 endonuclease III, putative 2.235 up 7.15x10'22 
SAOUHSC_01477 Zn-dependent protease 3.227 up 1.29x109 
SAOUHSC_01504 ferredoxin 4.754 up 2.64x1018 
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SAOUHSC_01505 riboflavin transporter 2.272 up 3.18x1018 
SAOUHSC_01599 glucose-6-phosphate 1-dehydrogenase 2.609 up 2.98x10,26 
SAOUHSC_01656 hydrophobic membrane protein ZurM 2.502 up 5.60x1018 
SAOUHSC_01657 ABC transporter, putative 2.387 up 5.81x1016 
SAOUHSC_01663 DNA primase 2.245 up 4.31x10"14 
SAOUHSC_01681 prmA ribosomal protein L11 methyltransferase 3.734 up 6.76x10,32 
SAOUHSC_01682 dnaJ DnaJ protein 2.760 up 2.75x10 28 
SAOUHSC_01683 dnaK molecular chaperone DnaK 3.320 up 2.59x10,24 
SAOUHSC_01684 grpE co-chaperone GrpE 13.687 up 3.09x1027 
SAOUHSC_01685 hrcA heat-inducible transcription repressor 18.112 up 5.24x1031 
HrcA 
SAOUHSC_01715 udk uridine kinase 2.115 up 7.01x10'20 
SAOUHSC_01716 peptidase U32 2.003 up 2.53x1015 
SAOUHSC_01717 peptidase U32 2.189 up 6.43x10" 
SAOUHSC_01725 mnmA tRNA-specific 2-thiouridylase MnmA 2.022 up 1.05x1017 
SAOUHSC_01726 mnmA tRNA-specific 2-thiouridylase MnmA 2.143 up 4.08x10,15 
SAOUHSC_01727 aminotransferase, class V 2.176 up 1.36x1019 
SAOUHSC_01751 ruvA Holliday junction DNA helicase RuvA 2.016 up 4.87x1010 
SAOUHSC_01752 ACT domain protein PheB 2.523 up 2.79x1017 
SAOUHSC_01755 rpmA ribosomal protein L27 2.228 up 7.47x1019 
SAOUHSC_01756 hypothetical protein 9.109 up 7.02x10,29 
SAOUHSC_01757 rplU ribosomal protein L21 8.042 up 9.86x10'34 
SAOUHSC_01758 rod shape-determining protein MreD 3.195 up 5.78x10,2° 
SAOUHSC_01759 rod shape-determining protein MreC 3.171 up 1.11x10-15 
SAOUHSC_01760 hypothetical protein 4.878 up 1.06x10,28 
SAOUHSC_01761 hypothetical protein 5.525 up 0 
SAOUHSC_01762 hypothetical protein 2.610 up 5.94x10'13 
SAOUHSC_01778 clpX ATP-dependent protease ATP-binding 2.650 up 4.48x10.17 
subunit ClpX 
SAOUHSC_01779 tig trigger factor 3.431 up 2.93x1027 
SAOUHSC_01785 rpml ribosomal protein L35 2.933 up 2.58x10,25 
SAOUHSC_01786 infC translation initiation factor IF-3 3.398 up 1.97x1022 
SAOUHSC_01792 replication initiation and membrane 2.369 up 3.61x10" 
attachment protein 
SAOUHSC_01793 nrdR transcriptional regulator NrdR 2.429 up 2.88x1019 
SAOUHSC_01801 isocitrate dehydrogenase 2.316 up 3.83x1011 
SAOUHSC_01850 catabolite control protein A 2.703 up 7.72x10'15 
SAOUHSC_01865 trmB tRNA (guanine-N(7)-)-methyltransferase 2.491 up 2.61x1015 
SAOUHSC_01957 hypothetical protein 2.937 up 1.50x1022 
SAOUHSC_01972 prsA foldase protein PrsA 2.782 up 2.22x10.24 
SAOUHSC_01997 perR peroxide-responsive repressor PerR 3.763 up 2.70x1028 
SAOUHSC_02001 hypothetical protein 2.631 up 1.07x1024 
SAOUHSC_02012 mgt monofunctional glycosyltransferase 3.802 up 1.82x1032 
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SAOUHSC_02098 DNA-binding response regulator VraR, 3.578 up 1.67x10'5 
putative 
SAOUHSC_02099 sensor protein VraS 5.797 up 6.66x10,26 
SAOUHSC_02100 hypothetical protein 8.010 up 1.16x10,25 
SAOUHSC_02101 hypothetical protein 6.499 up 1.48x10-27 
SAOUHSC_02108 ftnA ferritin 4.142 up 7.52x10-25 
SAOUHSC_02109 hypothetical protein 2.911 up 2.53x1014 
SAOUHSC_02110 exonuclease 2.368 up 1.12x10'11 
SAOUHSC_02112 hypothetical protein 3.815 up 6.80x10-26 
SAOUHSC_02152 ABC transporter, ATP-binding protein, 2.107 up 1.66x10'8 
putative 
SAOUHSC_02153 membrane protein, putative 2.678 up 2.04x10-7 
SAOUHSC_02154 ABC transporter, ATP-binding protein, 2.644 up 1.25x10-7 
putative 
SAOUHSC_02254 groEL chaperonin GroEL 3.223 up 1.93x10,23 
SAOUHSC_02255 groES co-chaperonin GroES 9.288 up 6.68x10'31 
SAOUHSC_02258 nitroreductase 3.350 up 7.59x10*12 
SAOUHSC_02294 hypothetical protein 3.556 up 4.92x1018 
SAOUHSC_02302 sigmaB regulation protein RsbU, 2.232 up 2.28x10'5 
putative 
SAOUHSC_02316 DEAD-box ATP dependent DNA helicase 2.904 up 1.44x10-25 
SAOUHSC_02346 otpH ATP synthase Fl, delta subunit 2.345 up 7.95x10'8 
SAOUHSC_02350 atp8 ATP synthase FO, A subunit 2.779 up 4.75x10'' 
SAOUHSC_02351 hypothetical protein 2.596 up 2.59x109 
SAOUHSC_02364 hypothetical protein 3.772 up 8.13x10'26 
SAOUHSC_02365 UDP-N-acetylglucosamine 1- 4.018 up 3.24x10-25 
carboxyvinyltransferase 
SAOUHSC_02368 pyrG CTP synthetase 2.014 up 9.37x10' 
SAOUHSC_02381 general stress protein 20U 3.464 up 6.01x1011 
SAOUHSC_02430 ABC transporter periplasmic binding 2.224 up 1.49x10,23 
protein, putative 
SAOUHSC_02478 rpIM ribosomal protein L13 2.690 up 9.92x10*26 
SAOUHSC_02563 ureF urease accessory protein UreF 2.008 up 1.51x10.14 
SAOUHSC_02583 transcriptional regulator, putative 3.135 up 2.77x10*23 
SAOUHSC_02589 phosphosugar-binding transcriptional 2.830 up 9.23x10'31 
regulator, RpiR family 
SAOUHSC_02629 EmrB/QacA family drug resistance 2.651 up 7.35x1011 
transporter 
SAOUHSC_02630 hypothetical protein 2.303 up 2.10x10'1° 
SAOUHSC_02645 LytTr DNA-binding region 4.910 up 4.01x10'31 
SAOUHSC_02646 hypothetical protein 4.464 up 6.40x10,28 
SAOUHSC_02659 regulatory protein, TetR 4.433 up 2.75x10*18 
SAOUHSC_02660 cationic transporter 2.902 up 3.53x10"2' 
SAOUHSC_02691 addiction module toxin, Txe/yoeB family 2.972 up 1.70x10'30 
SAOUHSC_02692 prevent-host-death protein 3.058 up 1.99x102' 
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SAOUHSC_02708 gamma-hemolysin h-gamma-II subunit, 2.210 up 1.07x1014 
putative 
SAOUHSC_02724 hypothetical protein 3.053 up 2.78x10 23 
SAOUHSC_02747 hypothetical protein 2.125 up 2.89x10 2° 
SAOUHSC_02756 addiction module toxin, Txe/YoeB family 2.019 up 9.01x10'5 
SAOUHSC_02757 prevent-host-death protein 2.737 up 6.89x10*17 
SAOUHSC_02841 regulatory protein PfoR 2.338 up 1.34x10'13 
SAOUHSC_02845 thioredoxin 2.134 up 1.16x10,29 
SAOUHSC_02846 hypothetical protein 2.252 up 9.63x10c23 
SAOUHSC_02848 glc8 pts system, glucose-specific iibc 2.760 up 3.67x10 22 
component 
SAOUHSC_02872 hypothetical protein 3.406 up 5.21x10,21 
SAOUHSC_02873 copA cation transporter E1-E2 family ATPase 2.278 up 1.61x10,12 
SAOUHSC_03001 icaR biofilm operon icaabcd hth-type 2.089 up 1.41x10,23 
negative transcriptional regulator IcaR 
SAOUHSC A01041 hypothetical protein 4.826 up 8.05x10.24 
SAOUHSC_A01912 hypothetical protein 3.558 up 6.65x10 26 
SAOUHSC_AO2189 hypothetical protein 2.089 up 6.97x1012 
Down-regulated genes 
SAOUHSC_00114 capsular polysaccharide biosynthesis 5.249 down 4.43x10'5 
protein, putative 
SAOUHSC_00115 capsular polysaccharide synthesis 5.894 down 0 
enzyme Cap5B 
SAOUHSC_00116 capsular polysaccharide synthesis 4.645 down 0 
enzyme Cap8C 
SAOUHSC_00117 capsular polysaccharide biosynthesis 4.641 down 0 
protein Cap5D, putative 
SAOUHSC_00118 capsular polysaccharide biosynthesis 4.190 down 0 
protein CapSE, putative 
SAOUHSC_00119 capsular polysaccharide synthesis 4.032 down 0 
enzyme Cap8F 
SAOUHSC_00120 UDP-N-acetylglucosamine 2-epimerase 3.680 down 4.35x1015 
SAOUHSC_00121 capsular polysaccharide synthesis 4.126 down 5.28x1011 
enzyme 0-acetyl transferase CapSH, 
putative 
SAOUHSC_00122 capsular polysaccharide biosynthesis 3.323 down 4.43x101° 
protein CapSl, putative 
SAOUHSC_00123 capsular polysaccharide biosynthesis 2.648 down 1.60x10 6 
protein CapSJ, putative 
SAOUHSC_00124 capsular polysaccharide biosynthesis 2.788 down 4.88x10 7 
protein CapSK, putative 
SAOUHSC_00125 CapSL protein/glycosyltransferase, 3.508 down 7.01x10" 
putative 
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SAOUHSC_00126 capsular polysaccharide biosynthesis 3.235 down 2.38x10-13 
protein Cap8M 
SAOUHSC_00127 CapSN protein/UDP-glucose 4- 3.349 down 3.30x1013 
epimerase, putative 
SAOUHSC_00128 Cap5O protein/UDP-N-acetyl-D- 3.277 down 0 
mannosaminuronic acid dehydrogenase 
SAOUHSC_00144 surfactin synthetase subunit 2 2.008 down 1.41x10'8 
SAOUHSC_00285 ABC transporter, permease protein 2.734 down 0 
SAOUHSC_00287 ABC transporter, ATP-binding protein, 2.314 down 2.28x10'15 
putative 
SAOUHSC_00300 lipase precursor 3.584 down 2.34x1013 
SAOUHSC_00358 transglycosylase-associated protein 2.007 down 0 
SAOUHSC_00411 hypothetical protein 2.015 down 8.52x10.14 
SAOUHSC_00468 endoribonuclease L-PSP, putative 3.313 down 0 
SAOUHSC_00469 spoVG SpoVG superfamily 2.677 down 1.07x10-13 
SAOUHSC_00788 hypothetical protein 2.574 down 2.39x10.13 
SAOUHSC_00789 whiA putative sporulation transcription 2.314 down 7.70x10'1° 
regulator WhiA 
SAOUHSC_00812 clfA clumping factor A 2.391 down 0 
SAOUHSC_00825 hypothetical protein 2.421 down 2.62x10*'° 
SAOUHSC_00845 hypothetical protein 10.601 down 2.34x1015 
SAOUHSC_00846 integral membrane protein 2.003 down 4.21x10'15 
SAOUHSC_00987 sspB staphopain B 2.483 down 1.28x108 
SAOUHSC_00988 sspA glutamyl endopeptidase 2.841 down 1.89x101° 
SAOUHSC_00994 ad bifunctional autolysin 5.048 down 0 
SAOUHSC_01135 hypothetical protein 6.344 down 0 
SAOUHSC_01136 hypothetical protein 3.965 down 4.41x109 
SAOUHSC_01794 glyceraldehyde 3-phosphate 2.050 down 0 
dehydrogenase 2 
SAOUHSC_01854 hypothetical protein 2.170 down 2.84x10-'4 
SAOUHSC_01855 hypothetical protein 4.553 down 0 
SAOUHSC_01945 putative lantibiotic ABC transporter 4.396 down 0 
protein 
SAOUHSC_01947 membrane protein, putative 5.253 down 0 
SAOUHSC_01948 ABC transporter 5.350 down 0 
SAOUHSC_02244 succinyl-diaminopimelate desuccinylase 2.047 down 7.70x1012 
SAOUHSC_02260 hid delta-hemolysin 10.936 down 0 
SAOUHSC_02387 NAD-dependent epimerase/dehydratase 2.116 down 0 
SAOUHSC_02402 mannitol-specific phosphotransferase 2.421 down 0 
enzyme IIA component 
SAOUHSC_02403 mtlD mannitol-1-phosphate 5-dehydrogenase 2.152 down 2.32x10'15 
SAOUHSC_02441 asp23 alkaline shock protein 23 7.979 down 2.36x10'15 
SAOUHSC_02442 hypothetical protein 11.232 down 0 
SAOUHSC_02443 hypothetical protein 15.691 down 0 
SAOUHSC_02444 glycine betaine transporter OpuD 3.402 down 0 
179 
Locus tag Gene name Product name/function Fold change P value 
SAOUHSC_02466 truncated MHC class II analog protein 10.464 down 0 
SAOUHSC_02582 formate dehydrogenase, alpha subunit, 3.210 down 4.73x10-14 
putative 
SAOUHSC_02604 oxidoreductase 2.160 down 0 
SAOUHSC_02650 TpgX protein 2.430 down 0 
SAOUHSC_02751 para-nitrobenzyl esterase 2.051 down 5.65x1014 
SAOUHSC_02772 IMP dehydrogenase/GMP 2.207 down 0 
reductase: Short-chain 
dehydrogenase/reductase SDR 
SAOUHSC_02774 alkylhydroperoxidase AhpD core 2.488 down 6.15x10-8 
SAOUHSC_02849 pyruvate oxidase 3.272 down 7.80x1015 
SAOUHSC_02850 cidB holin-like protein CidB 2.813 down 2.29x10.12 
SAOUHSC_02862 clpL ATP-dependent CIp protease, ATP- 5.460 down 0 
binding subunit CIpL 
SAOUHSC_02877 crtN dehydrosqualene desaturase 2.654 down 2.01x10.13 
SAOUHSC_02879 crtM dehydrosqualene synthase 2.717 down 6.28x1013 
SAOUHSC_02880 crtQ 4,4'-diaponeurosporenoate 2.409 down 7.40x10-'2 
glycosyltransferase 
SAOUHSC_02881 crtP 4,4'-diaponeurosporene oxidase 2.022 down 0 
SAOUHSC_02887 isaA probable transglycosylase IsaA 2.275 down 0 
SAOUHSC_02900 hydrolase, alpha/beta hydrolase fold 2.933 down 0 
family 
SAOUHSC_02983 hypothetical protein 3.086 down 4.87x10.14 
SAOUHSC_02984 hypothetical protein 2.578 down 2.34x10'15 
SAOUHSC 02985 secA2 protein translocase subunit SecA2 2.352 down 3.39x1012 
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Table A. 3 Differentially expressed genes in 144 hr versus 48 hr biofilm cultures of S. oureus SH1000. 
Data are the average of three experimental replicates. P values were determined using a Student's t- 
test in ArrayStar"M (DNASTAR). 
locus tag Gene name Product name/function Fold change P value 
Up-regulated genes 
SAOUHSC_00025 Ser/Thr protein phosphatase family 2.298 up 1.16x105 
protein 
SAOUHSC_00051 1-phosphatidylinositol 2.106 up 1.64x105 
phosphodiesterase precursor, putative 
SAOUHSC_00076 ornithine cyclodeaminase, putative 2.081 up 1.05x1075 
SAOUHSC_00078 general substrate transporter: Major 2.003 up 5.17x10_6 
facilitator superfamily MFS_1 
SAOUHSC_00089 sugar transferase 2.277 up 7.46x106 
SAOUHSC_00106 : PPE-repeat proteins 2.041 up 8.71x107 
SAOUHSC_00136 nitrate transport ATP-binding protein 2.103 up 2.85x10'7 
NrtD 
SAOUHSC_00138 ABC transporter, permease protein 2.288 up 1.70x106 
SAOUHSC_00154 hypothetical protein 2.086 up 4.87x104 
SAOUHSC_00182 membrane protein, putative 2.112 up 6.6740-5 
SAOUHSC_00209 PTS system, glucose-specific IIBC 2.319 up 3.25x106 
component, putative 
SAOUHSC_00254 membrane protein, putative 2.677 up 1.12x10,3 
SAOUHSC_00289 hypothetical protein 2.875 up 3.42x10,3 
SAOUHSC_00296 ROK family protein 2.029 up 1.26x107 
SAOUHSC_00298 nanE N-acetylmannosamine-6-phosphate 2- 2.136 up 5.16x10,7 
epimerase 
SAOUHSC_00341 cystathionine gamma-synthase (CGS) 2.096 up 6.14x10,6 
(0-succinylhomoserine(thiol)-lyase) 
SAOUHSC_00396 hypothetical protein 2.158 up 6.71x10'6 
SAOUHSC_00418 hypothetical protein 2.189 up 5.84x10,7 
SAOUHSC_00709 hypothetical protein 2.001 up 6.15x10,3 
SAOUHSC_00967 hypothetical protein 2.310 up 6.46x103 
SAOUHSC_01090 hypothetical protein 2.092 up 4.01x10,5 
SAOUHSC_01109 hypothetical protein 2.595 up 1.81x10.3 
SAOUHSC_01299 hypothetical protein 2.651 up 2.84x10,3 
SAOUHSC_01300 hypothetical protein 2.247 up 1.84x10'4 
SAOUHSC_01339 hypothetical protein 2.164 up 1.74x10'5 
SAOUHSC_01366 anthranilate synthase component I 2.062 up 2.20x10'5 
SAOUHSC_01367 anthranilate synthase component II 2.249 up 1.02x10'5 
SAOUHSC_01452 oldl alanine dehydrogenase 1 2.093 up 1.32x105 
SAOUHSC_01458 hypothetical protein 2.005 up 7.32x104 
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SAOUHSC_01934 hypothetical protein 2.325 up 4.37x10-4 
SAOUHSC_01941 spiB serine protease SpIB 2.140 up 2.72x106 
SAOUHSC_02105 hypothetical protein 2.318 up 1.86x10 3 
SAOUHSC_02281 ilvD dihydroxy-acid dehydratase 2.233 up 9.57x10 7 
SAOUHSC_02325 hypothetical protein 2.082 up 3.05x10 7 
SAOUHSC_02326 hypothetical protein 2.181 up 6.03x10 7 
SAOUHSC_02567 hypothetical protein 2.241 up 8.5740-6 
SAOUHSC_02572 hypothetical protein 2.268 up 5.70x10'4 
SAOUHSC_02576 secretory antigen precursor SsaA, 2.076 up 2.9240-6 
putative 
SAOUHSC_02616 hypothetical protein 2.355 up 1.61x103 
SAOUHSC_02645 LytTr DNA-binding region 2.208 up 9.89x10 21 
SAOUHSC 02646 hypothetical protein 2.050 up 2.70x1016 
SAOUHSC_02662 PTS system sucrose-specific IIBC 2.020 up 1.25x108 
component 
SAOUHSC 02688 hypothetical protein 2.739 up 1.02x104 
SAOUHSC_02715 adenosylmethionine-8-amino-7- 2.024 up 3.34x107 
oxononanoate aminotransferase 
SAOUHSC_02720 hypothetical protein 3.085 up 1.67x103 
SAOUHSC_02726 transcription activator, effector binding 2.239 up 4.12x106 
SAOUHSC_02754 ABC transporter, ATP-binding protein, 2.045 up 6.6440-7 
putative 
SAOUHSC 02796 hypothetical protein 2.327 up 3.55x10 10,3 
SAOUHSC_02799 sarT HTH-type transcriptional regulator SarT 2.205 up 3.22x10 
3 
SAOUHSC_02805 hypothetical protein 2.136 up 1.18x10' 
SAOUHSC_02806 gluconate permease, putative 2.150 up 2.82x109 
SAOUHSC_02888 membrane protein, putative 2.268 up 2.49x10' 
SAOUHSC 02889 hypothetical protein 2.784 up 4.93x10 3 
SAOUHSC 02890 hypothetical protein 2.264 up 1.28x10'3 
SAOUHSC_02908 aminoglycoside 2.073 up 2.03x106 
phosphotransferase: Fructosamine 
kinase 
SAOUHSC_02924 4-aminobutyrate aminotransferase 2.252 up 7.82x10 
7 
SAOUHSC_02932 betA choline dehydrogenase 2.084 up 6.02x104 
SAOUHSC_02934 hypothetical protein 2.168 up 1.34x10 10,3 
SAOUHSC_02939 hypothetical protein 2.118 up 7.31x103 
SAOUHSC_02940 hypothetical protein 2.161 up 1.27x10 3 
SAOUHSC_02950 hypothetical protein 2.321 up 2.23x103 
SAOUHSC_02973 hypothetical protein 2.075 up 1.94x106 
SAOUHSC_03009 hisA phosphoribosylformimino-5- 2.468 up 3.36x106 
aminoimidazole carboxamide ribotide 
isomerase 
SAOUHSC_03010 hisH imidazole glycerol phosphate synthase, 2.304 up 4.74x104 
glutamine amidotransferase subunit 
182 
Locus tag Gene name Product name/function Fold change P value 
SAOUHSC_03012 histidinol-phosphate aminotransferase, 2.011 up 9.14x10 6 
putative 
SAOUHSC_03013 histidinol dehydrogenase 2.099 up 2.03x10*5 
SAOUHSC_03014 hisG ATP phosphoribosyltransferase catalytic 2.009 up 1.33x10'5 
subunit 
SAOUHSC_03015 hisZ ATP phosphoribosyltransferase 2.328 up 1.74x10'5 
regulatory subunit 
SAOUHSC_03047 hypothetical protein 2.055 up 1.63x10'7 
SAOUHSC_A00084 hypothetical protein 2.159 up 8.17x10-6 
SAOUHSC_AO0354 hypothetical protein 2.608 up 1.97x10"4 
SAOUHSC_AO0379 hypothetical protein 2.637 up 3.00x10'3 
SAOUHSC_AO2169 hypothetical protein 2.070 up 1.01x10-5 
SAOUHSC_AO2577 hypothetical protein 2.124 up 2.74x10r4 
SAOUHSC_AO2795 hypothetical protein 2.308 up 4.60x10.4 
Downregulated genes 
SAOUHSC_00017 rpll ribosomal protein L9 2.040 down 1.17x1012 
SAOUHSC 00029 hypothetical protein 2.472 down 1.04x10-6 
SAOUHSC_00440 hypothetical protein 2.281 down 1.16x10-13 
SAOUHSC_00441 acetyltransferase family protein 2.008 down 9.66x10,12 
SAOUHSC_00663 acetyltransferase, gnat family 2.575 down 6.28x109 
SAOUHSC_00680 hypothetical protein 2.622 down 2.48x108 
SAOUHSC_00694 mgrA HTH-type transcriptional regulator 2.391 down 3.06x10.14 
MgrA 
SAOUHSC_00718 membrane protein, putative 2.211 down 4.46x10'9 
SAOUHSC_00735 hypothetical protein 2.402 down 7.19x10'8 
SAOUHSC 00867 hypothetical protein 4.425 down 2.14x1014 
SAOUHSC 00868 hypothetical protein 2.668 down 2.57x107" 
SAOUHSC_00871 dltC D-alanine--poly(phosphoribitol) ligase 2.090 down 2.79x10-'4 
subunit 2 
SAOUHSC_00938 hypothetical protein 2.083 down 8.16x10.14 
SAOUHSC_01036 hypothetical protein 2.400 down 2.36x10'13 
SAOUHSC_01037 hypothetical protein 3.265 down 4.95x10'' 
SAOUHSC_01155 hypothetical protein 2.124 down 2.92x10'9 
SAOUHSC_01173 hypothetical protein 2.017 down 2.85x10.7 
SAOUHSC_01285 regulatory protein, MerR 2.194 down 5.13x10-14 
SAOUHSC_01309 hypothetical protein 2.420 down 4.67x10'6 
SAOUHSC_01404 hypothetical protein 2.530 down 4.81x10.6 
SAOUHSC_01468 hypothetical protein 2.224 down 9.99x10,1° 
SAOUHSC_01736 hypothetical protein 2.240 down 2.18x10'7 
SAOUHSC_01780 hypothetical protein 2.108 down 1.08x10'6 
SAOUHSC_01851 hypothetical protein 2.354 down 2.64x10'6 
SAOUHSC_01927 transposase, IS3 family, truncation- 2.044 down 3.06x10'9 
related protein, putative 
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SAOUHSC_02176 hypothetical protein 2.105 down 1.25x1012 
SAOUHSC_02294 hypothetical protein 2.847 down 3.70x10 8 
SAOUHSC_02416 hypothetical protein 3.732 down 3.74x101° 
SAOUHSC_02461 transcriptional regulator, MerR family 2.443 down 0 
SAOUHSC_02471 hypothetical protein 2.072 down 1.89x10'5 
SAOUHSC_02565 ureD urease accessory protein UreD 2.645 down 3.21x10-'4 
SAOUHSC_02781 hypothetical protein 2.240 down 9.90x10.12 
SAOUHSC_02830 D-lactate dehydrogenase 2.077 down 2.79x10-14 
SAOUHSC_03001 icaR biofilm operon icaabcd hth-type 2.644 down 4.11x1012 
negative transcriptional regulator IcaR 
SAOUHSC A02189 hypothetical protein 2.036 down 2.88x10,7 
184 
References 
Agarwal, H., Verrall, R., Singh, S. P., Tang, Y. W. & Wilson, G. (2007) Small colony variant 
Staphylococcus aureus multiorgan infection. Pediatr Infect Dis J 26: 269-271. 
Aizenman, E., Engelberg-Kulka, H. & Glaser, G. (1996) An Escherichia coli chromosomal 
"addiction module" regulated by guanosine 3', S'-bispyrophosphate: a model for 
programmed bacterial cell death. Proc Nat! Acad Sci USA 93: 6059-6063. 
Akiyama, H., Hamada, T., Huh, W. K., Yamasaki, 0., Oono, T., Fujimoto, W., et al. (2003) 
Confocal laser scanning microscopic observation of glycocalyx production by 
Staphylococcus aureus in skin lesions of bullous impetigo, atopic dermatitis and pemphigus 
foliaceus. Br J Dermatol 148: 526-532. 
Akiyama, H., Huh, W. K., Yamasaki, 0., Oono, T. & Iwatsuki, K. (2002) Confocal laser 
scanning microscopic observation of glycocalyx production by Staphylococcus aureus in 
mouse skin: does S. aureus generally produce a biofiim on damaged skin? Br J Dermatol 
147: 879-885. 
Allegrucci, M. & Sauer, K. (2007) Characterization of colony morphology variants isolated 
from Streptococcus pneumoniae biofilms. J Bacteriol 189: 2030-2038. 
Allegrucci, M. & Sauer, K. (2008) Formation of Streptococcus pneumoniae non-phase- 
variable colony variants is due to increased mutation frequency present under biofilm 
growth conditions. J Bacteriol 190: 6330-6339. 
Allison, D. G., Brown, M. R., Evans, D. E. & Gilbert, P. (1990a) Surface hydrophobicity and 
dispersal of Pseudomonas aeruginosa from biofiims. FEMS Microbiol Lett 59: 101-104. 
Allison, D. G., Evans, D. J., Brown, M. R. & Gilbert, P. (1990b) Possible involvement of the 
division cycle in dispersal of Escherichia coil from biofilms. J Bacteriol 172: 1667-1669. 
Ananthaswamy, H. N. & Eisenstark, A. (1977) Repair of hydrogen peroxide-induced single- 
strand breaks in Escherichia coli deoxyribonucleic acid. J Bacteriol 130: 187-191. 
Antonio, M., McFerran, N. & Pallen, M. J. (2002) Mutations affecting the Rossman fold of 
isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in 
Staphylococcus aureus. Antimicrob Agents Chemother 46: 438-442. 
Armel, P. R., Strniste, G. F. & Wallace, S. S. (1977) Studies on Escherichia coli X-ray 
endonuclease specificity. Roles of hydroxyl and reducing radicals in the production of DNA 
lesions. Radiat Res 69: 328-338. 
Armstrong-Buisseret, L., Cole, M. B. & Stewart, G. S. (1995) A homologue to the 
Escherichia coli alkyl hydroperoxide reductase AhpC is induced by osmotic upshock in 
Staphylococcus aureus. Microbiology 141 ( Pt 7): 1655-1661. 
Arrecubieta, C., Lee, M. H., Macey, A., Foster, T. J. & Lowy, F. D. (2007) SdrF, a 
Staphylococcus epidermidis surface protein, binds type I collagen. J Biol Chem 282: 18767- 
18776. 
185 
Aruoma, 0. I., Halliwell, B., Hoey, B. M. & Butler, J. (1988) The antioxidant action of 
taurine, hypotaurine and their metabolic precursors. Biochem J 256: 251-255. 
Ashby, M. J., Neale, J. E., Knott, S. J. & Critchley, 1. A. (1994) Effect of antibiotics on non- 
growing planktonic cells and biofilms of Escherichia coli. J Antimicrob Chemother 33: 443- 
452. 
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K., Oguchi, A., et al. (2002) Genome 
and virulence determinants of high virulence community-acquired MRSA. Lancet 359: 1819- 
1827. 
Baddiley, J., Buchanan, J. G., Hardy, F. E., Martin, R. 0., Rajbhandary, U. L. & Sanderson, 
A. R. (1961) The structure of the ribitol teichoic acid of Staphylococcus aureus H. Biochim 
Biophys Acta 52: 406-407. 
Baddiley, J., Buchanan, J. G., Rajbhandary, U. L. & Sanderson, A. R. (1962) Teichoic acid 
from the walls of Staphylococcus aureus H. Structure of the N-acetylglucosaminyl-ribitol 
residues. Biochem J 82: 439-448. 
Balaban, N., Giacometti, A., Cirioni, 0., Gov, Y., Ghiselli, R., Mocchegiani, F., et al. (2003a) 
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation 
in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 187: 625-630. 
Balaban, N., Goldkorn, T., Gov, Y., Hirshberg, M., Koyfman, N., Matthews, H. R., et al. 
(2001) Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating 
Protein (TRAP). J Biol Chem 276: 2658-2667. 
Balaban, N., Gov, Y., Bitter, A. & Boelaert, J. R. (2003b) Prevention of Staphylococcus 
aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int 63: 340-345. 
Baldassarri, L., Donnelli, G., Gelosia, A., Voglino, M. C., Simpson, A. W. & Christensen, G. 
D. (1996) Purification and characterization of the staphylococcal slime-associated antigen 
and its occurrence among Staphylococcus epidermis clinical isolates. Infect Immun 64: 3410- 
3415. 
Ballal, A. & Manna, A. C. (2009) Regulation of superoxide dismutase (sod) genes by SarA in 
Staphylococcus aureus. J Bacteriol 191: 3301-3310. 
Bayston, R., Ashraf, W. & Smith, T. (2007) Triclosan resistance in methicillin-resistant 
Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of 
susceptibility to antiseptics. J Antimicrob Chemother 59: 848-853. 
Beenken, K. E., Dunman, P. M., McAleese, F., Macapagal, D., Murphy, E., Projan, S. J., et 
al. (2004) Global Gene Expression in Staphylococcus aureus Biofilms. J Bacteriol 186: 4665- 
4684. 
Beenken, K. E., Mrak, L. N., Griffin, L. M., Zielinska, A. K., Shaw, L. N., Rice, K. C., et al. 
(2010) Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm 
formation. PLoS One 5: e10790. 
186 
Benoit, M. R., Conant, C. G., lonescu-Zanetti, C., Schwartz, M. & Matin, A. (2010) New 
device for high-throughput viability screening of flow biofilms. Appl Environ Microbiol76: 
4136-4142. 
Berg, T., Firth, N., Apisiridej, S., Hettiaratchi, A., Leelaporn, A. & Skurray, R. A. (1998) 
Complete nucleotide sequence of pSK41: evolution of staphylococcal conjugative 
multiresistance plasmids. J Bacterial 180: 4350-4359. 
Bhattacharyya, S., Dutta, D., Ghosh, A. K. & Das, A. K. (2009) Cloning, overexpression, 
purification, crystallization and preliminary X-ray diffraction analysis of an atypical two- 
cysteine peroxiredoxin (SAOUHSC_01822) from Staphylococcus aureus NCTC 8325. Acta 
Crystallogr Sect F Struct Biol Cryst Commun 65: 1113-1115. 
Bigger, J. (1944) Treatment of staphylococcal infections with penicillin by intermittent 
sterilisation. Lancet 244: 497-500. 
Bischoff, M., Dunman, P., Kormanec, J., Macapagal, D., Murphy, E., Mounts, W., et al. 
(2004) Microarray-based analysis of the Staphylococcus aureus a8 regulon. J Bacterial 186: 
4085-4099. 
Biswas, R., Voggu, L., Simon, U. K., Hentschel, P., Thumm, G. & Gotz, F. (2006) Activity of 
the major staphylococcal autolysin AtI. FEMS Microbial Lett 259: 260-268. 
Blokesch, M. & Schoolnik, G. K. (2008) The extracellular nuclease Dns and its role in natural 
transformation of Vibrio cholerae. J Bacterial 190: 7232-7240. 
Boles, B. R. & Horswill, A. R. (2008) agr-mediated dispersal of Staphylococcus aureus 
biofilms. PLoS Pathog 4: e1000052. 
Boles, B. R. & Singh, P. K. (2008) Endogenous oxidative stress produces diversity and 
adaptability in biofilm communities. Proc Notl Acad Sci USA 105: 12503-12508. 
Borchardt, S. A., Allain, E. J., Michels, J. J., Stearns, G. W., Kelly, R. F. & McCoy, W. F. 
(2001) Reaction of acylated homoserine lactone bacterial signaling molecules with oxidized 
halogen antimicrobials. App/ Environ Microbiol 67: 3174-3179. 
Bordello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D. & Stewart, P. S. (2004) Oxygen 
limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. 
Antimicrob Agents Chemother 48: 2659-2664. 
Boyd, A. & Chakrabarty, A. M. (1994) Role of alginate lyase in cell detachment of 
Pseudomonas aeruginosa. App/ Environ Microbiol 60: 2355-2359. 
Bozzini, S., Visai, L., Pignatti, P., Petersen, T. E. & Speziale, P. (1992) Multiple binding sites 
in fibronectin and the staphylococcal fibronectin receptor. EurJ Biochem 207: 327-333. 
Brady, R. A., Leid, J. G., Calhoun, J. H., Costerton, J. W. & Shirtliff, M. E. (2008) 
Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 
52: 13-22. 
187 
Brady, R. A., leid, J. G., Camper, A. K., Costerton, J. W. & Shirtliff, M. E. (2006) 
Identification of Staphylococcus aureus proteins recognized by the antibody-mediated 
immune response to a biofiim infection. Infect Immun 74: 3415-3426. 
Brennan, M. P., Loughman, A., Devocelle, M., Arasu, S., Chubb, A. J., Foster, T. J., et al. 
(2009) Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G 
in platelet activation. J Thromb Haemost 7: 1364-1372. 
Brent, R. & Ptashne, M. (1980) The lexA gene product represses its own promoter. Proc 
Natl Acad Sci USA 77: 1932-1936. 
Brock, T. D., Madigan, M. T., Martinko, J. M. & Parker, J. (1994) Introduction: An overview 
of microbiology and cell biology. In: Biology of Microorganisms. Englewood Cliffs, New 
Jersery: Prentice-Hall Inc, pp. 1-22. 
BSAC (1991) A guide to sensitivity testing. Report of the Working Party on Antibiotic 
Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. J Antimicrob 
Chemother 27 Suppl D: 1-50. 
Burmolle, M., Bahl, M. I., Jensen, L. B., Sorensen, S. J. & Hansen, L. H. (2008) Type 3 
fimbriae, encoded by the conjugative plasmid pOLA52, enhance biofilm formation and 
transfer frequencies in Enterobacteriaceae strains. Microbiology 154: 187-195. 
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., et al. 
(2001) Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 
104: 901-912. 
Carrasco, B., Canas, C., Sharples, G. J., Alonso, J. C. & Ayora, S. (2009) The N-terminal 
region of the RecU holliday junction resolvase is essential for homologous recombination. J 
Mol Bio/ 390: 1-9. 
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D. & Buret, A. (1999) The Calgary 
Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of 
bacterial biofilms. J Clin Microbiol 37: 1771-1776. 
Cescutti, P., Toffanin, R., Fett, W. F., Osman, S. F., Pollesello, P. & Paolettl, S. (1998) 
Structural investigation of the exopolysaccharide produced by Pseudomonas flavescens 
strain B62 - degradation by a fungal cellulase and isolation of the oligosaccharide repeating 
unit. EurJ Biochem 251: 971-979. 
Chaignon, P., Sadovskaya, I., Ragunah, C., Ramasubbu, N., Kaplan, J. B. & Jabbourl, S. 
(2007) Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their 
chemical composition. Appl Microbiol Biotechnol75: 125-132. 
Chang, Y. M., Jeng, W. Y., Ko, T. P., Yeh, Y. J., Chen, C. K. & Wang, A. H. (2010) Structural 
study of TcaR and its complexes with multiple antibiotics from Staphylococcus epidermidis. 
Proc Nat/ Acad Sci USA 107: 8617-8622. 
Cheng, K. J., Fay, J. P., Coleman, R. N., Milligan, L P. & Costerton, J. W. (1981) Formation 
of bacterial microcolonies on feed particles in the rumen. Appl Environ Microbiol 41: 298- 
305. 
188 
Chopra, I., O'Neill, A. J. & Miller, K. (2003) The role of mutators in the emergence of 
antibiotic-resistant bacteria. Drug Resistance Updates 6: 137-145. 
Christensen, S. K., Mikkelsen, M., Pedersen, K. & Gerdes, K. (2001) ReIE, a global inhibitor 
of translation, is activated during nutritional stress. Proc Natl Acad Sci USA 98: 14328- 
14333. 
Christie, G. E., Matthews, A. M., King, D. G., Lane, K. D., Olivarez, N. P., Tallent, S. M., et 
al. (2010) The complete genomes of Staphylococcus aureus bacteriophages 80 and 80alpha- 
-implications for the specificity of SaPI mobilization. Virology 407: 381-390. 
Clarke, S. R., Harris, L. G., Richards, R. G. & Foster, S. J. (2002) Analysis of Ebh, a 1.1- 
megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. 
Infect Immun 70: 6680-6687. 
Clauditz, A., Resch, A., Wieland, K. P., Peschel, A. & Gotz, F. (2006) Staphyloxanthin plays a 
role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. 
Infect Immun 74: 4950-4953. 
Cochran, W. L., Suh, S. J., McFeters, G. A. & Stewart, P. S. (2000) Role of RpoS and AIgT in 
Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide and monochloramine. J 
App/ Microbial 88: 546-553. 
Coenye, T., De Prijck, K., De Wever, B. & Nelis, H. J. (2008) Use of the modified Robbins 
device to study the in vitro biofilm removal efficacy of NitrAdine, a novel disinfecting 
formula for the maintenance of oral medical devices. J Appl Microbiol 105: 733-740. 
Cohen, S., Sweeney, H. M. & Basu, S. K. (1977) Mutations in prophage phill that impair 
the transducibility of their Staphylococcus aureus lysogens for methicillin resistance. J 
Bacteriol 129: 237-245. 
Conen, A., Walti, L. N., Merlo, A., Fluckiger, U., Battegay, M. & Trampuz, A. (2008) 
Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in 
adults: a retrospective analysis over an 11-year period. Clin Infect Dis 47: 73-82. 
Conlon, K. M., Humphreys, H. & O'Gara, J. P. (2002a) icaR encodes a transcriptional 
repressor involved in environmental regulation of ica operon expression and biofilm 
formation in Staphylococcus epidermidis. J Bacteriol 184: 4400-4408. 
Conlon, K. M., Humphreys, H. & O'Gara, J. P. (2002b) Regulation of icaR gene expression in 
Staphylococcus epidermidis. FEMS Microbiol Lett 216: 171-177. 
Conlon, K. M., Humphreys, H. & O'Gara, J. P. (2004) Inactivations of rsbU and sarA by IS256 
represent novel mechanisms of biofilm phenotypic variation in Staphylococcus epidermidis. 
J Bacteriol 186: 6208-62 19. 
Corrigan, R. M., Miajlovic, H. & Foster, T. J. (2009) Surface proteins that promote 
adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC 
Microbiol 9: 22. 
189 
Corrigan, R. M., Rigby, D., Handley, P. & Foster, T. J. (2007) The role of Staphylococcus 
aureus surface protein SasG in adherence and biofilm formation. Microbiology 153: 2435- 
2446. 
Cosgrove, K., Coutts, G., Jonsson, I. M., Tarkowski, A., Kokai-Kun, J. F., Mond, J. J., et al. 
(2007) Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles 
in peroxide stress resistance and are required for survival, persistence, and nasal 
colonization in Staphylococcus aureus. J Bacterial 189: 1025-1035. 
Costerton, J. W., Geesey, G. G. & Cheng, K. J. (1978) How bacteria stick. Sci Am 238: 86-95. 
Cramton, S. E., Gerke, C., Schnell, N. F., Nichols, W. W. & Gotz, F. (1999) The intercellular 
adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm 
formation. Infect Immun 67: 5427-5433. 
Cramton, S. E. & Götz, F. (2004) Biofilm development in Staphylococcus. In: Microbial 
Biofilms. Ghannoum, M. & O'Toole, G. A. (eds). Washington: ASM Press, pp. 64-84. 
Cramton, S. E., Ulrich, M., Gotz, F. & Doring, G. (2001) Anaerobic conditions induce 
expression of polysaccharide intercellular adhesin in Staphylococcus aureus and 
Staphylococcus epidermidis. Infect Immun 69: 4079-4085. 
Cucarella, C., Solano, C., Valle, J., Amorena, B., Lasa, I. & Penades, J. R. (2001) Bap, a 
Staphylococcus aureus surface protein involved in biofilm formation. J Bacterial 183: 2888- 
2896. 
Cucarella, C., Tormo, M. A., Ubeda, C., Trotonda, M. P., Monzon, M., Peris, C., et al. (2004) 
Role of biofiim-associated protein Bap in the pathogenesis of bovine Staphylococcus 
aureus. Infect Immun 72: 2177-2185. 
Cvitkovitch, D. G. (2004) Genetic Exchange in Biofilms. In: Microbial Biofilms. Ghannoum, 
M. & O'Toole, G. A. (eds). Washington DC: ASM Press, pp. 192-205. 
Darby, C., Hsu, J. W., Ghori, N. & Falkow, S. (2002) Caenorhabditis elegans: plague bacteria 
biofilm blocks food intake. Nature 417: 243-244. 
David, M. Z. & Daum, R. S. (2010) Community-associated methicillin-resistant 
Staphylococcus oureus: epidemiology and clinical consequences of an emerging epidemic. 
Clin Microbiol Rev 23: 616-687. 
Davies, D. G. & Geesey, G. G. (1995) Regulation of the alginate biosynthesis gene algC in 
Pseudomonas aeruginosa during biofilm development in continuous culture. App! Environ 
Microbiol 61: 860-867. 
Debeer, D., Stoodley, P., Roe, F. & Lewandowski, Z. (1994) Effects of biofilm structures on 
oxygen distribution and mass-transport. Biotechnol Bioeng 43: 1131-1138. 
Deighton, M. & Borland, R. (1993) Regulation of slime production in Staphylococcus 
epidermidis by iron limitation. Infect Immun 61: 4473-4479. 
190 
Dice, B., Stoodley, P., Buchinsky, F., Metha, N., Ehrlich, G. D. & Hu, F. Z. (2009) Biofilm 
formation by ica-positive and ica-negative strains of Staphylococcus epidermidis in vitro. 
Biofouling 25: 367-375. 
Donlan, R. M. (2001a) Biofilm formation: a clinically relevant microbiological process. Clin 
Infect Dis 33: 1387-1392. 
Donlan, R. M. (2001b) Biofilms and device-associated infections. Emerg Infect Dis 7: 277- 
281. 
Donlan, R. M. (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8: 881-890. 
Dougherty, B. A., Hill, C., Weidman, J. F., Richardson, D. R., Venter, J. C. & Ross, R. P. 
(1998) Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid 
pMRCO1 from Lactococcus lactis DPC3147. Mol Microbiol 29: 1029-1038. 
Dow, J. M., Crossman, L., Findlay, K., He, Y. Q., Feng, J. X. & Tang, J. L. (2003) Biofilm 
dispersal in Xanthomonas campestris is controlled by cell-cell signaling and is required for 
full virulence to plants. Proc Natl Acad Sci USA 100: 10995-11000. 
Driffield, K., Miller, K., Bostock, J. M., O'Neill, A. J. & Chopra, I. (2008) Increased mutability 
of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother 61: 1053-1056. 
Dunne, W. M., Jr. & Burd, E. M. (1992) The effects of magnesium, calcium, EDTA, and pH 
on the in vitro adhesion of Staphylococcus epidermidis to plastic. Microbiol Immunol 36: 
1019-1027. 
Elasri, M. 0., Thomas, J. R., Skinner, R. A., Blevins, J. S., Beenken, K. E., Nelson, C. L., et al. 
(2002) Staphylococcus aureus collagen adhesin contributes to the pathogenesis of 
osteomyelitis. Bone 30: 275-280. 
Espinosa-Urgel, M., Salido, A. & Ramos, J. L. (2000) Genetic analysis of functions involved 
in adhesion of Pseudomonas putida to seeds. J Bacteriol 182: 2363-2369. 
Estes, R. J. & Meduri, G. U. (1995) The pathogenesis of ventilator-associated pneumonia: I. 
Mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med 21: 
365-383. 
Esther, C. R., Jr., Esserman, D. A., Gilligan, P., Kerr, A. & Noone, P. G. (2010) Chronic 
Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 
9: 117-123. 
Evans, D. J., Allison, D. G., Brown, M. R. & Gilbert, P. (1991) Susceptibility of Pseudomonas 
aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth 
rate. J Antimicrob Chemother 27: 177-184. 
Evans, R. C. & Holmes, C. J. (1987) Effect of vancomycin hydrochloride on Staphylococcus 
epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother 31: 
889-894. 
191 
Faridani, 0. R., Nikravesh, A., Pandey, D. P., Gerdes, K. & Good, L. (2006) Competitive 
inhibition of natural antisense Sok-RNA interactions activates Hok-mediated cell killing in 
Escherichia coli. Nucleic Acids Res 34: 5915-5922. 
Feig, D. I., Reid, T. M. & Loeb, L. A. (1994) Reactive oxygen species in tumorigenesis. Cancer 
Res 54: 1890s-1894s. 
Fitzpatrick, F., Humphreys, H. & O'Gara, J. P. (2005) Evidence for icoADBC-inde pendent 
biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical 
isolates. J Clin Microbiol 43: 1973-1976. 
Fitzpatrick, F., Humphreys, H., Smyth, E., Kennedy, C. A. & O'Gara, J. P. (2002) 
Environmental regulation of biofilm formation in intensive care unit isolates of 
Staphylococcus epidermidis. J Hosp Infect 52: 212-218. 
Foley, I., Marsh, P., Wellington, E. M. H., Smith, A. W. & Brown, M. R. W. (1999) General 
stress response master regulator rpoS is expressed in human infection: a possible role in 
chronicity. J Antimicrob Chemother 43: 164-165. 
Foster, T. J. & Hook, M. (1998) Surface protein adhesins of Staphylococcus aureus. Trends 
Microbiol 6: 484-488. 
Fournier, B. & Hooper, D. C. (2000) A new two-component regulatory system involved in 
adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J 
Bacteriol 182: 3955-3964. 
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., 
et aL (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N 
Eng/ J Med 352: 1436-1444. 
Fridovich, I. (1978) The biology of oxygen radicals. Science 201: 875-880. 
Gander, S., Kinnaird, A. & Finch, R. (2005) Telavancin: in vitro activity against staphylococci 
in a biofilm model. JAntimicrob Chemother 56: 337-343. 
Garcia-Alvarez, F., Monzon, M., Grasa, J. M., Lacleriga, A., Amorena, B., Garcia-Alvarez, l., 
et al. (2006) Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic 
treatment in experimental chronic Staphylococcus aureus osteomyelitis. J Orthop Sci 11: 
370-374. 
Gerdes, K., Christensen, S. K. & Lobner-Olesen, A. (2005) Prokaryotic toxin-antitoxin stress 
response loci. Not Rev Microbiol 3: 371-382. 
Gerke, C., Kraft, A., Sussmuth, R., Schweitzer, 0. & Gotz, F. (1998) Characterization of the 
N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus 
epidermidis polysaccharide intercellular adhesin. J Biol Chem 273: 18586-18593. 
Gillaspy, A. F., Hickmon, S. G., Skinner, R. A., Thomas, J. R., Nelson, C. L& Smeltzer, M. S. 
(1995) Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal 
osteomyelitis. Infect Immun 63: 3373-3380. 
192 
Gordon, C. A., Hodges, N. A. & Marriott, C. (1988) Antibiotic interaction and diffusion 
through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. 
J Antimicrob Chemother 22: 667-674. 
Gov, Y., Bitler, A., DeII'Acqua, G., Torres, J. V. & Balaban, N. (2001) RNAIII inhibiting 
peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and 
function analysis. Peptides 22: 1609-1620. 
Green, M., Apel, A. & Stapleton, F. (2008) Risk factors and causative organisms in microbial 
keratitis. Cornea 27: 22-27. 
Greene, C., McDevitt, D., Francois, P., Vaudaux, P. E., Lew, D. P. & Foster, T. J. (1995) 
Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding 
proteins and studies on the expression of fnb genes. Mo/ Microbial 17: 1143-1152. 
Griffiths, J. & O'Neill, A. J. (2009) Identification and preliminary characterisation of 
Staphylococcus aureus mutants showing reduced tolerance to antibiotics during biofilm 
growth. ASM Conference on Biofilms, Cancun, Mexico. 
Grohmann, E., Muth, G. & Espinosa, M. (2003) Conjugative plasmid transfer in Gram- 
positive bacteria. Microbial Mal Biol Rev 67: 277-301. 
Gross, M., Cramton, S. E., Gotz, F. & Peschel, A. (2001) Key role of teichoic acid net charge 
in Staphylococcus aureus colonization of artificial surfaces. Infect Immun 69: 3423-3426. 
Hall, A. E., Patel, P. R., Domanski, P. J., Prater, B. D., Gorovits, E. L., Syribeys, P. J., et al. 
(2007) A panel of monoclonal antibodies recognizing the Staphylococcus epidermidis 
fibrinogen-binding MSCRAMM SdrG. Hybridoma (Larchmt) 26: 28-34. 
Halliwell, B. & Gutteridge, J. M. C. (1989) Free Radicals in Biology and Medicine. Clarendon 
Press, Oxford, UK. 
Harmsen, M., Lappann, M., Knochel, S. & Molin, S. (2010) Role of extracellular DNA during 
biofilm formation by Listeria monocytogenes. App/ Environ Microbiol 76: 2271-2279. 
Harris, E. D. (1992) Regulation of antioxidant enzymes. FASEB J. 6: 2675-2683. 
Harrison, J. J., Wade, W. D., Akierman, S., Vacchi-Suzzi, C., Stremick, C. A., Turner, R. J., et 
al. (2009) The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for 
Escherichia coli growing in a biofilm. Antimicrob Agents Chemother 53: 2253-2258. 
He, A. S., Rohatgi, P. R., Hersh, M. N. & Rosenberg, S. M. (2006) Roles of E. coli double- 
strand-break-repair proteins in stress-induced mutation. DNA Repair (Amst) 5: 258-273. 
Heilmann, C., Gerke, C., Perdreau-Remington, F. & Gotz, F. (1996a) Characterization of 
Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect 
Immun 64: 277-282. 
Heilmann, C., Hussain, M., Peters, G. & Gotz, F. (1997) Evidence for autolysin-mediated 
primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mal Microbial 
24: 1013-1024. 
193 
Heilmann, C. & Peters, G. (2006) Biology and pathogenicity of Staphylococcus epidermidis. 
In: Gram-Positive Pathogens. Fischetti, V. A., Novick, R. P., Ferretti, J. J., Portnoy, D. A. & 
Rood, J. I. (eds). Washington DC: ASM Press, pp. 
Heilmann, C., Schweitzer, 0., Gerke, C., Vanittanakom, N., Mack, D. & Gotz, F. (1996b) 
Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. 
Mol Microbial 20: 1083-1091. 
Heimberger, T. S. & Duma, R. J. (1989) Infections of prosthetic heart valves and cardiac 
pacemakers. Infect Dis Clin North Am 3: 221-245. 
Herles, S., Olsen, S., Afflitto, J. & Gaffar, A. (1994) Chemostat flow cell system: an in vitro 
model for the evaluation of antiplaque agents. J Dent Res 73: 1748-1755. 
Hodgson, A. E., Nelson, S. M., Brown, M. R. & Gilbert, P. (1995) A simple in vitro model for 
growth control of bacterial biofilms. J App! Bacteriol 79: 87-93. 
Holland, D. B., Bojar, R. A., Jeremy, A. H. T., Ingham, E. & Holland, K. T. (2008) Microbial 
colonization of an in vitro model of a tissue engineered human skin equivalent -a novel 
approach. FEMS Microbiol Lett 279: 110-115. 
Horii, T., Ogawa, T., Nakatani, T., Hase, T., Matsubara, H. & Ogawa, H. (1981) Regulation 
of SOS functions: purification of E. coli LexA protein and determination of its specific site 
cleaved by the RecA protein. Cell 27: 515-522. 
Horsburgh, M. J., Aish, J. L., White, I. J., Shaw, L., Lithgow, J. K. & Foster, S. J. (2002a) CFO 
modulates virulence determinant expression and stress resistance: Characterization of a 
functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184: 5457- 
5467. 
Horsburgh, M. J., Ingham, E. & Foster, S. J. (2001) In Staphylococcus aureus, Fur is an 
interactive regulator with PerR, contributes to virulence, and is necessary for oxidative 
stress resistance through positive regulation of catalase and iron homeostasis. J Bacteriol 
183: 468-475. 
Horsburgh, M. J., Wharton, S. J., Cox, A. G., Ingham, E., Peacock, S. & Foster, S. J. (2002b) 
MntR modulates expression of the PerR regulon and superoxide resistance in 
Staphylococcus aureus through control of manganese uptake. Mol Microbiol 44: 1269-1286. 
Huesca, M., Peralta, R., Sauder, D. N., Simor, A. E. & McGavin, M. J. (2002) Adhesion and 
virulence properties of epidemic Canadian methicillin-resistant Staphylococcus aureus 
strain 1: identification of novel adhesion functions associated with plasmin-sensitive 
surface protein. J Infect Dis 185: 1285-1296. 
Hughes, J. & Mellows, G. (1980) Interaction of pseudomonic acid A with Escherichia co/i B 
isoleucyl-tRNA synthetase. Biochem J 191: 209-219. 
Huseby, M. J., Kruse, A. C., Digre, J., Kohler, P. L., Vocke, J. A., Mann, E. E., et al. (2010) 
Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc Natl 
Acad Sci USA 107: 14407-14412. 
194 
Hussain, M., Becker, K., von Eiff, C., Schrenzel, J., Peters, G. & Herrmann, M. (2001a) 
Identification and characterization of a novel 38.5-kilodalton cell surface protein of 
Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and 
plasma proteins. J Bacteriol 183: 6778-6786. 
Hussain, M., Heilmann, C., Peters, G. & Herrmann, M. (2001b) Teichoic acid enhances 
adhesion of Staphylococcus epidermidis to immobilized fibronectin. Microb Pathog 31: 261- 
270. 
Hussain, M., Herrmann, M., von Eiff, C., Perdreau-Remington, F. & Peters, G. (1997) A 
140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus 
epidermidis strains on surfaces. Infect Immun 65: 519-524. 
Ingavale, S., van Wamel, W., Luong, T. T., Lee, C. Y. & Cheung, A. L. (2005) Rat/MgrA, a 
regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect 
Immun 73: 1423-1431. 
Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P., et al. (1984) 
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104: 206- 
210. 
Ito, A., May, T., Kawata, K. & Okabe, S. (2007) Significance of rpoS during maturation of 
Escherichia coli biofilms. Biotechnol Bioeng 99: 1462-1471. 
Ito, A., Taniuchi, A., May, T., Kawata, K. & Okabe, S. (2009) Increased antibiotic resistance 
of Escherichia coli in mature biofilms. App! Environ Microbiol 75: 4093-4100. 
Jacob, R. A. & Burri, B. J. (1996) Oxidative damage and defense. Am J Clin Nutr 63: 9855- 
9905. 
Janzon, L., Lofdahl, S. & Arvidson, S. (1989) Identification and nucleotide sequence of the 
delta-lysin gene, hid, adjacent to the accessory gene regulator (agr) of Staphylococcus 
aureus. Mol Gen Genet 219: 480-485. 
Jayaraman, R. (2008) Bacterial persistence: some new insights into an old phenomenon. J 
Biosci 33: 795-805. 
Jefferson, K. K., Goldmann, D. A. & Pier, G. B. (2005) Use of confocal microscopy to analyze 
the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob 
Agents Chemother 49: 2467-2473. 
Jefferson, K. K., Pier, D. B., Goldmann, D. A. & Pier, G. B. (2004) The teicoplanin-associated 
locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional 
inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol 186: 2449-2456. 
Ji, G., Beavis, R. C. & Novick, R. P. (1995) Cell density control of staphylococcal virulence 
mediated by an octapeptide pheromone. Proc Nat! Acad Sci USA 92: 12055-12059. 
Jones, H. C., Roth, I. L. & Sanders, W. M., 3rd (1969) Electron microscopic study of a slime 
layer. J Bacteriol 99: 316-325. 
195 
Josefsson, E., McCrea, K. W., Ni Eidhin, D., O'Connell, D., Cox, J., Hook, M., et al. (1998) 
Three new members of the serine-aspartate repeat protein multigene family of 
Staphylococcus aureus. Microbiology 144: 3387-3395. 
Kaplan, J. B. & Fine, D. H. (2002) Biofilm dispersal of Neisseria subflava and other 
phylogenetically diverse oral bacteria. App/ Environ Microbiol 68: 4943-4950. 
Kaplan, S. L., Hulten, K. G., Gonzalez, B. E., Hammerman, W. A., Lamberth, L, Versalovic, 
J., et al. (2005) Three-year surveillance of community-acquired Staphylococcus aureus 
infections in children. Clin Infect Dis 40: 1785-1791. 
Karavolos, M. H., Horsburgh, M. J., Ingham, E. & Foster, S. J. (2003) Role and regulation of 
the superoxide dismutases of Staphylococcus aureus. Microbiology 149: 2749-2758. 
Karpati, F., Malmborg, A. S., Alfredsson, H., Hjelte, L. & Strandvik, B. (1994) Bacterial 
colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient 
population. Infection 22: 258-263. 
Keane, F. M., Loughman, A., Valtulina, V., Brennan, M., Speziale, P. & Foster, T. J. (2007) 
Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding 
protein A, an MSCRAMM of Staphylococcus aureus. Mol Microbiol 63: 711-723. 
Keele, B. B., Jr., McCord, J. M. & Fridovich, I. (1970) Superoxide dismutase from Escherichia 
coli B. A new manganese-containing enzyme. J Biol Chem 245: 6176-6181. 
Keren, I., Shah, D., Spoering, A., Kaldalu, N. & Lewis, K. (2004) Specialized persister cells 
and the mechanism of multidrug tolerance in Escherichia coll. J Bacteriol186: 8172-8180. 
Khardori, N. & Yassien, M. (1995) Biofilms in device-related infections. J Ind Microbiol 15: 
141-147. 
Kim, E. J., Chung, H. J., Suh, B., Hah, Y. C. & Roe, J. H. (1998) Transcriptional and post- 
transcriptional regulation by nickel of sodN gene encoding nickel-containing superoxide 
dismutase from Streptomyces coelicolor Muller. Mol Microbiol 27: 187-195. 
Kinniment, S. L., Wimpenny, J. W., Adams, D. & Marsh, P. D. (1996) Development of a 
steady-state oral microbial biofilm community using the constant-depth film fermenter. 
Microbiology 142 (Pt 3): 631-638. 
Kirisits, M. J., Prost, L., Starkey, M. & Parsek, M. R. (2005) Characterization of colony 
morphology variants isolated from Pseudomonas aeruginosa biofiims. App! Environ 
Microbiol 71: 4809-4821. 
Kluytmans, J., van Belkum, A. & Verbrugh, H. (1997) Nasal carriage of Staphylococcus 
aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10: 
505-520. 
Knobloch, J. K., Bartscht, K., Sabottke, A., Rohde, H., Feucht, H. H. & Mack, D. (2001) 
Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator 
of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J 
Bacteriol 183: 2624-2633. 
196 
Knobloch, J. K., Horstkotte, M. A., Rohde, H., Kaulfers, P. M. & Mack, D. (2002) Alcoholic 
ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J 
Antimicrob Chemother 49: 683-687. 
Knobloch, J. K., Jager, S., Horstkotte, M. A., Rohde, H. & Mack, D. (2004) RsbU-dependent 
regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative 
sigma factor aB by repression of the negative regulator gene icaR. Infect Immun 72: 3838- 
3848. 
Koch, A. L. (1994) Growth Measurement. In: Methods for General and Molecular 
Bacteriology. Gerhardt, P., Murray, R. G. E., Wood, W. A. & Kreig, N. R. (eds). Washington: 
American Society for Microbiology, pp. 248-292. 
Koch, C. & Hoiby, N. (1993) Pathogenesis of cystic fibrosis. Lancet 341: 1065-1069. 
Kogan, G., Sadovskaya, I., Chaignon, P., Chokr, A. & Jabbouri, S. (2006) Biofilms of clinical 
strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS 
Microbiol Lett 255: 11-16. 
Kolodkin-Gal, I., Romero, D., Cao, S., Clardy, J., Kolter, R. & Losick, R. (2010) D-amino acids 
trigger biofilm disassembly. Science 328: 627-629. 
Kono, Y. & Fridovich, I. (1982) Superoxide radical inhibits catalase. J Biol Chem 257: 5751- 
5754. 
Kroukamp, 0., Dumitrache, R. G. & Wolfaardt, G. M. (2010) Nature of inoculum has a 
pronounced effect on biofilm development in flow systems. App! Environ Microbiol 76: 
6025-6031. 
Kumar, S. S., Ghosh, A., Devasagayam, T. P. A. & Chauhan, P. S. (2000) Effect of vanillin on 
methylene blue plus light-induced single-strand breaks in plasmid pBR322 DNA. Mutat Res 
469: 207-214. 
Landry, R. M., An, D. D., Hupp, J. T., Singh, P. K. & Parsek, M. R. (2006) Mucin- 
Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. 
Mol Microbiol 59: 142-151. 
Lapaglia, C. & Hartzell, P. L. (1997) Stress-induced production of biofilm in the 
hype rthermophile Archaeoglobus fulgidus. Appl Environ Microbiol63: 3158-3163. 
Lasa, I. & Penades, J. R. (2006) Bap: a family of surface proteins involved in biofilm 
formation. Res Microbial 157: 99-107. 
Lauderdale, K. J., Boles, B. R., Cheung, A. L. & Horswill, A. R. (2009) Interconnections 
between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. 
Infect Immun 77: 1623-1635. 
Lawrence, J. R., Korber, D. R., Hoyle, B. D., Costerton, J. W. & Caldwell, D. E. (1991) Optical 
sectioning of microbial biofilms. J Bacteriol 173: 6558-6567. 
Lee, C. Y., Sharma, A., Cheong, J. E. & Nelson, J. L. (2009) Synthesis and antioxidant 
properties of dendritic polyphenols. Bioorg Med Chem Lett 19: 6326-6330. 
197 
Lee, S. F., Li, Y. H. & Bowden, G. H. (1996) Detachment of Streptococcus mutans biofilm 
cells by an endogenous enzymatic activity. Infect Immun 64: 1035-1038. 
Lee, Y. K., Lim, C. Y., Teng, W. L., Ouwehand, A. C., Tuomola, E. M. & Salminen, S. (2000) 
Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and 
their competition with enterobacteria. Appl Environ Microbiol 66: 3692-3697. 
Lengfelder, E. & Elstner, E. F. (1979) Cyanide insensitive iron superoxide dismutase in 
Euglena gracilis. Comparison of the reliabilities of different test systems for superoxide 
d ismutases. Z Naturforsch C 34C: 374-380. 
Lew, D. P. & Waldvogel, F. A. (1997) Osteomyelitis. N Eng! J Med 336: 999-1007. 
Lew, D. P. & Waldvogel, F. A. (2004) Osteomyelitis. Lancet 364: 369-379. 
Li, Y. H., Lau, P. C., Lee, J. H., Ellen, R. P. & Cvitkovitch, D. G. (2001) Natural genetic 
transformation of Streptococcus mutans growing in biofilms. J Bacteriol 183: 897-908. 
Lina, G., Jarraud, S., Ji, G., Greenland, T., Pedraza, A., Etienne, J., et at. (1998) 
Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal 
receptor in Staphylococcus aureus. Mol Microbiol 28: 655-662. 
Lindsay, D. & von Holy, A. (2006) Bacterial biofilms within the clinical setting: what 
healthcare professionals should know. J Hosp Infect 64: 313-325. 
Lindsay, J. A. (2010) Genomic variation and evolution of Staphylococcus aureus. Int J Med 
Microbiol 300: 98-103. 
Lindsay, J. A. & Foster, S. J. (2001) zur: a Zn2+-responsive regulatory element of 
Staphylococcus aureus. Microbiology 147: 1259-1266. 
Liu, X., Ng, C. & Ferenci, T. (2000) Global adaptations resulting from high population 
densities in Escherichia coli cultures. J Bacteriol 182: 4158-4164. 
Loiselle, M. & Anderson, K. W. (2003) The use of cellulase in inhibiting biofilm formation 
from organisms commonly found on medical implants. Biofouling 19: 77-85. 
Lowy, F. D. (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532. 
Macfarlane, S. (2008) Microbial biofilm communities in the gastrointestinal tract. J Clin 
Gastroenterol 42: 5142-143. 
Mack, D., Fischer, W., Krokotsch, A., Leopold, K., Hartmann, R., Egge, H., et al. (1996) The 
intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a 
linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 
178: 175-183. 
Mack, D., Nedelmann, M., Krokotsch, A., Schwarzkopf, A., Heesemann, J. & Laufs, R. 
(1994) Characterization of transposon mutants of biofilm-producing Staphylococcus 
epidermidis impaired in the accumulative phase of biofilm production: genetic identification 
of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun 62: 3244- 
3253. 
198 
Mack, D., Siemssen, N. & Laufs, R. (1992) Parallel induction by glucose of adherence and a 
polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence 
for functional relation to intercellular adhesion. Infect Immun 60: 2048-2057. 
MacKintosh, E. E., Patel, J. D., Marchant, R. E. & Anderson, J. M. (2006) Effects of 
biomaterial surface chemistry on the adhesion and biofilm formation of Staphylococcus 
epidermidis in vitro. J Biomed Mater Res A 78: 836-842. 
Maeda, S., Ito, M., Ando, T., Ishimoto, Y., Fujisawa, Y., Takahashi, H., et al. (2006) 
Horizontal transfer of nonconjugative plasmids in a colony biofilm of Escherichia coli. FEMS 
Microbiol Lett 255: 115-120. 
Mah, T. F. & O'Toole, G. A. (2001) Mechanisms of biofilm resistance to antimicrobial 
agents. Trends Microbiol 9: 34-39. 
Mann, E. E., Rice, K. C., Boles, B. R., Endres, J. L., Ranjit, D., Chandramohan, L., et al. 
(2009) Modulation of eDNA release and degradation affects Staphylococcus aureus biofiim 
maturation. PLoS One 4: e5822. 
Marrie, T. J., Nelligan, J. & Costerton, J. W. (1982) A scanning and transmission electron 
microscopic study of an infected endocardial pacemaker lead. Circulation 66: 1339-1341. 
Marshall, K. C. (1985) Bacterial adhesion in oligotrophic habitats. Microbiol Sci 2: 321-322, 
325-326. 
Marti, M., Trotonda, M. P., Tormo-Mas, M. A., Vergara-Irigaray, M., Cheung, A. L., Lasa, 1, 
et al. (2010) Extracellular proteases inhibit protein-dependent biofilm formation in 
Staphylococcus aureus. Microbes Infect 12: 55-64. 
Martinez-Pulgarin, S., Dominguez-Bernal, G., Orden, J. A. & de la Fuente, R. (2009) 
Simultaneous lack of catalase and beta-toxin in Staphylococcus aureus leads to increased 
intracellular survival in macrophages and epithelial cells and to attenuated virulence in 
murine and ovine models. Microbiology 155: 1505-1515. 
Massol-Deya, A. A., Whallon, J., Hickey, R. F. & Tiedje, J. M. (1995) Channel structures in 
aerobic biofilms of fixed-film reactors treating contaminated groundwater. App! Environ 
Microbiol 61: 769-777. 
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., et al. (1998) 
Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the 
pathogenesis of cystic fibrosis airways disease. Cell 95: 1005-1015. 
May, T. B., Shinabarger, D., Maharaj, R., Kato, J., Chu, L., DeVault, J. D., et at. (1991) 
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic 
pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev 4: 191-206. 
Mazmanian, S. K., Skaar, E. P., Gaspar, A. H., Humayun, M., Gornicki, P., Jelenska, J., et al. 
(2003) Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299: 
906-909. 
McBride, T. J., Preston, B. D. & Loeb, L. A. (1991) Mutagenic spectrum resulting from DNA 
damage by oxygen radicals. Biochemistry 30: 207-213. 
199 
McCord, J. M. & Fridovich, 1. (1968) The reduction of cytochrome c by milk xanthine 
oxidase. J Biol Chem 243: 5753-5760. 
McCord, J. M. & Fridovich, I. (1969) Superoxide dismutase. J Biol Chem 244: 6049-6055. 
McDevitt, D., Francois, P., Vaudaux, P. & Foster, T. J. (1995) Identification of the ligand- 
binding domain of the surface-located fibrinogen receptor (clumping factor) of 
Staphylococcus aureus. Mol Microbiol 16: 895-907. 
McKenney, D., Pouliot, K., Wang, Y., Murthy, V., Ulrich, M., Doring, G., et al. (2000) 
Vaccine potential of poly-l-6 beta-D-N-succinylglucosamine, an immunoprotective surface 
polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol 83: 
37-44. 
McLean, R. J., Cassanto, J. M., Barnes, M. B. & Koo, J. H. (2001) Bacterial biofilm formation 
under microgravity conditions. FEMS Microbial Lett 195: 115-119. 
McLean, R. J. C., Bates, C. L., Barnes, M. B., McGowin, C. L. & Aron, G. M. (2004) Methods 
of studying biofilms. In: Microbial Biofilms. Ghannoum, M. & O'Toole, G. A. (eds). 
Washington: ASM Press, pp. 
Merritt, J., Qi, F., Goodman, S. D., Anderson, M. H. & Shi, W. (2003) Mutation of luxS 
affects biofilm formation in Streptococcus mutans. Infect Immun 71: 1972-1979. 
Moisan, H., Brouillette, E., Jacob, C. L., Langlois-Begin, P., Michaud, S. & Malouin, F. 
(2006) Transcription of virulence factors in Staphylococcus aureus small-colony variants 
isolated from cystic fibrosis patients is influenced by SigB. J Bacterial 188: 64-76. 
Morgan, A. R., Cone, R. L. & Elgert, T. M. (1976) The mechanism of DNA strand breakage by 
vitamin C and superoxide and the protective roles of catalase and superoxide dismutase. 
Nucl Acids Res 3: 1139-1150. 
Moyed, H. S. & Bertrand, K. P. (1983) hipA, a newly recognized gene of Escherichia coli K-12 
that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155: 
768-775. 
Nagarajan, V., Smeltzer, M. S. & Elasri, M. 0. (2009) Genome-scale transcriptional profiling 
in Staphylococcus aureus: bringing order out of chaos. FEMS Microbiol Lett 295: 204-210. 
Nallapareddy, S. R., Singh, K. V. & Murray, B. E. (2008) Contribution of the collagen 
adhesin Acm to pathogenesis of Enterococcusfaecium in experimental endocarditis. Infect 
Immun 76: 4120-4128. 
Navarre, W. W. & Schneewind, 0. (1994) Proteolytic cleavage and cell wall anchoring at 
the LPXTG motif of surface proteins in Gram-positive bacteria. Mol Microbiol 14: 115-121. 
Netherwood, T., Bowden, R., Harrison, P., O'Donnell, A. G., Parker, D. S. & Gilbert, H. J. 
(1999) Gene transfer in the gastrointestinal tract. Appl Environ Microbiol 65: 5139-5141. 
Nicholas, R. 0., Li, T., McDevitt, D., Marra, A., Sucoloski, S., Demarsh, P. L., et al. (1999) 
Isolation and characterization of a oB deletion mutant of Staphylococcus aureus. Infect 
Immun 67: 3667-3669. 
200 
Nickel, J. C., Grant, S. K., Lam, K., Olson, M. E. & Costerton, J. W. (1991) Bacteriologically 
stressed animal model of new closed catheter drainage system with microbicidal outlet 
tube. Urology 38: 280-289. 
Nickel, J. C., Olson, M., McLean, R. J., Grant, S. K. & Costerton, J. W. (1987) An ecological 
study of infected urinary stone genesis in an animal model. BrJ Urol59: 21-30. 
Nickel, J. C., Ruseska, I., Wright, J. B. & Costerton, J. W. (1985) Tobramycin resistance of 
Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. 
Antimicrob Agents Chemother 27: 619-624. 
NIH (2002) Research on microbial biofilms. http: //erants. nih. eov/grants/guide/pa-files/PA- 
03-047. html Last Access: 05/09/2010 
Nyholm, S. V., Deplancke, B., Gaskins, H. R., Apicella, M. A. & McFall-Ngai, M. J. (2002) 
Roles of Vibrio fischeri and nonsymbiotic bacteria in the dynamics of mucus secretion 
during symbiont colonization of the Euprymna scolopes light organ. Appl Environ Microbiol 
68: 5113-5122. 
O'Brien, L., Kerrigan, S. W., Kaw, G., Hogan, M., Penades, J., Litt, D., et al. (2002) Multiple 
mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: 
roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and 
protein A. Mol Microbiol 44: 1033-1044. 
O'Gara, J. P. (2007) ica and beyond: biofilm mechanisms and regulation in Staphylococcus 
epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 270: 179-188. 
O'Gara, J. P. & Humphreys, H. (2001) Staphylococcus epidermidis biofilms: importance and 
implications. J Med Microbiol 50: 582-587. 
O'Neill, A. J., Cove, J. H. & Chopra, I. (2001) Mutation frequencies for resistance to fusidic 
acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 47: 647-650. 
O'Neill, E., Pozzi, C., Houston, P., Humphreys, H., Robinson, D. A., Loughman, A., et al. 
(2008) A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin- 
binding proteins, FnBPA and FnBPB. J Bacteriol 190: 3835-3850. 
O'Sullivan, B. P. & Freedman, S. D. (2009) Cystic fibrosis. Lancet 373: 1891-1904. 
O'Toole, G. A. & Kolter, R. (1998) Flagellar and twitching motility are necessary for 
Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304. 
Oh, Y. J., Lee, N. R., Jo, W., Jung, W. K. & Lim, J. S. (2009) Effects of substrates on biofilm 
formation observed by atomic force microscopy. Ultramicroscopy 109: 874-880. 
Otto, M., Sussmuth, R., Jung, G. & Gotz, F. (1998) Structure of the pheromone peptide of 
the Staphylococcus epidermidis agr system. FEBS Lett 424: 89-94. 
Ovchinnikov, Y. A., Monastyrskaya, G. S., Guriev, S. 0., Kalinina, N. F., Sverdlov, E. D., 
Gragerov, A. I., et al. (1983) RNA polymerase rifampicin resistance mutations in Escherichia 
coli: sequence changes and dominance. Mol Gen Genet 190: 344-348. 
201 
Ovchinnikov Yu, A., Monastyrskaya, G. S., Gubanov, V. V., Lipkin, V. M., Sverdlov, E. D., 
Kiver, I. F., et al. (1981) Primary structure of Escherichia coli RNA polymerase nucleotide 
substitution in the beta subunit gene of the rifampicin resistant rpoB255 mutant. Mo/ Gen 
Genet 184: 536-538. 
Parsek, M. R. & Fuqua, C. (2004) Biofilms 2003: Emerging themes and challenges in studies 
of surface-associated microbial life. J Bacteriol 186: 4427-4440. 
Patel, J. D., Ebert, M., Ward, R. & Anderson, J. M. (2007) S. epidermidis biofilm formation: 
effects of biomaterial surface chemistry and serum proteins. J Biomed Mater Res A 80: 742- 
751. 
Patti, J. M., Allen, B. L., McGavin, M. J. & Hook, M. (1994) MSCRAMM-mediated 
adherence of microorganisms to host tissues. Annu Rev Microbiol 48: 585-617. 
Patti, J. M., Jonsson, H., Guss, B., Switalski, L. M., Wiberg, K., Lindberg, M., et al. (1992) 
Molecular characterization and expression of a gene encoding a Staphylococcus aureus 
collagen adhesin. J Biol Chem 267: 4766-4772. 
Perry, A. M., Ton-That, H., Mazmanian, S. K. & Schneewind, 0. (2002) Anchoring of surface 
proteins to the cell wall of Staphylococcus aureus. III. Lipid II is an in vivo peptidoglycan 
substrate for sortase-catalyzed surface protein anchoring. J Biol Chem 277: 16241-16248. 
Petersen, F. C., Tao, L. & Scheie, A. A. (2005) DNA binding-uptake system: a link between 
cell-to-cell communication and biofilm formation. J Bacteriol 187: 4392-4400. 
Pinto, A. V., Mathieu, A., Marsin, S., Veaute, X., lelpi, L, Labigne, A., et al. (2005) 
Suppression of homologous and homeologous recombination by the bacterial MutS2 
protein. Mol Cell 17: 113-120. 
Prosser, B. L., Taylor, D., Dix, B. A. & Cleeland, R. (1987) Method of evaluating effects of 
antibiotics on bacterial biofilm. Antimicrob Agents Chemother 31: 1502-1506. 
Purcell, K. & Fergie, J. (2005) Epidemic of community-acquired methicillin-resistant 
Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital. Arch 
Pediatr Adolesc Med 159: 980-985. 
QIAGEN (2001) Appendix B: Storage, quantitation, and determination of quality of total 
RNA. In: RNeasy Midi/Maxi Handbook. pp. 79-81. 
Que, Y. -A., Haefliger, J. -A., Piroth, L., Francois, P., Widmer, E., Entenza, J. M., et al. (2005) 
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in 
Staphylococcus aureus experimental endocarditis. J Exp Med 201: 1627-1635. 
Rachid, S., Ohlsen, K., Wallner, U., Hacker, J., Hecker, M. & Ziebuhr, W. (2000a) 
Alternative transcription factor sigma(B) is involved in regulation of biofiim expression in a 
Staphylococcus oureus mucosal isolate. J Bacterial 182: 6824-6826. 
Rachid, S., Ohlsen, K., Witte, W., Hacker, J. & Ziebuhr, W. (2000b) Effect of subinhibitory 
antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm- 
forming Staphylococcus epidermidis. Antimicrob Agents Chemother 44: 3357-3363. 
202 
Raimundo, 0., Heussler, H., Bruhn, J. B., Suntrarachun, S., Kelly, N., Deighton, M. A., et al. 
(2002) Molecular epidemiology of coagulase-negative staphylococcal bacteraemia in a 
newborn intensive care unit. J Hosp Infect 51: 33-42. 
Rasmussen, B. (2000) Filamentous microfossils in a 3,235-million-year-old volcanogenic 
massive sulphide deposit. Nature 405: 676-679. 
Rather, P. N. (2005) Swarmer cell differentiation in Proteus mirabilis. Environ Microbiol 7: 
1065-1073. 
Recsei, P., Kreiswirth, B., O'Reilly, M., Schlievert, P., Gruss, A. & Novick, R. P. (1986) 
Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol Gen Genet 
202: 58-61. 
Reisin, 1. L., Prat, A. G., Abraham, E. H., Amara, J. F., Gregory, R. J., Ausiello, D. A., et aL 
(1994) The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride 
channel. J Biol Chem 269: 20584-20591. 
Reisner, A., Holler, B. M., Molin, S. & Zechner, E. L. (2006) Synergistic effects in mixed 
Escherichia coli biofilms: conjugative plasmid transfer drives biofilm expansion. J Bacteriol 
188: 3582-3588. 
Resch, A., Rosenstein, R., Nerz, C. & Gotz, F. (2005) Differential gene expression profiling of 
Staphylococcus aureus cultivated under biofilm and planktonic conditions. App! Environ 
Microbiol 71: 2663-2676. 
Rice, K. C., Mann, E. E., Endres, J. L., Weiss, E. C., Cassat, J. E., Smeltzer, M. S., et al. (2007) 
The cidA murein hydrolase regulator contributes to DNA release and biofllm development 
in Staphylococcus aureus. Proc Natl Acad Sci USA 104: 8113-8118. 
Riddle, J. M., Wang, C. H., Magilligan, D. J., Jr. & Stein, P. D. (1989) Scanning electron 
microscopy of surgically excised human mitral valves in patients over 45 years of age. Am J 
Cardiol 63: 471-477. 
Rindi, S., Cicalini, S., Pietrocola, G., Venditti, M., Festa, A., Foster, T. J., et al. (2006) 
Antibody response in patients with endocarditis caused by Staphylococcus aureus. Eurl Clin 
Invest 36: 536-543. 
Robbins, M. J., Soeiro, R., Frishman, W. H. & Strom, J. A. (1986) Right-sided valvular 
endocarditis: etiology, diagnosis, and an approach to therapy. Am HeartJ 111: 128-135. 
Roche, F. M., Downer, R., Keane, F., Speziale, P., Park, P. W. & Foster, T. J. (2004) The N- 
terminal A domain of fibronectin-binding proteins A and B promotes adhesion of 
Staphylococcus aureus to elastin. J Bio! Chem 279: 38433-38440. 
Rupp, M. E., Fey, P. D., Heilmann, C. & Gotz, F. (2001) Characterization of the importance 
of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the 
pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis 183: 
1038-1042. 
Ryder, V. J., Miller, K., O'Neill, A. J. & Chopra, 1. (2009a) Enhanced mutability in 
staphylococcal biofilms. ARM, Birmingham, UK. 
203 
Ryder, V. J., Miller, K., O'Neill, A. J. & Chopra, I. (2009b) C1-1356 Enhanced mutability of 
Staphylococcus aureus in biofilms results from oxidative damage. ICAAC, San Francisco, 
USA. 
Ryder, V. J., O'Neill, A. J. & Chopra, I. (2010) Phenotypic variants arising in Staphylococcus 
aureus biofilms may promote dissemination during infection Biofilms4, Winchester, UK. 
Sabbuba, N., Hughes, G. & Stickler, D. J. (2002) The migration of Proteus mirabilis and 
other urinary tract pathogens over Foley catheters. BJU Int 89: 55-60. 
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 
Cold Spring Harbour Laboratory Press, New York. 
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W. & Davies, D. G. (2002) 
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J 
Bacteriol 184: 1140-1154. 
Sauer, K., Cullen, M. C., Rickard, A. H., Zeef, L. A., Davies, D. G. & Gilbert, P. (2004) 
Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J 
Bacteriol 186: 7312-7326. 
Schaffer, S. W., Azuma, J. & Mozaffari, M. (2009) Role of antioxidant activity of taurine in 
diabetes. Can J Physiol Pharmacol 87: 91-99. 
Scheid, W. M., Valone, J. A. & Sande, M. A. (1978) Bacterial adherence in the pathogenesis 
of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 61: 1394- 
1404. 
Schembri, M. A., Kjaergaard, K. & Klemm, P. (2003) Global gene expression in Escherichia 
coli biofilms. Mol Microbiol 48: 253-267. 
Scher, K., Kesselman, E., Shimoni, E. & Yaron, S. (2007) Morphological analysis of young 
and old pellicles of Salmonella Typhimurium. Biofouling 23: 385-394. 
Schierle, C. F., De la Garza, M., Mustoe, T. A. & Galiano, R. D. (2009) Staphylococcal 
biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound 
model. Wound Repair Regen 17: 354-359. 
Schmidt, K. A., Manna, A. C., Gill, S. & Cheung, A. L. (2001) SarT, a repressor of alpha- 
hemolysin in Staphylococcus aureus. Infect Immun 69: 4749-4758. 
Schneider, M., Muhlemann, K., Droz, S., Couzinet, S., Casaulta, C. & Zimmerli, S. (2008) 
Clinical characteristics associated with isolation of small-colony variants of Staphylococcus 
aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic 
fibrosis. J Clin Microbiol 46: 1832-1834. 
Schumacher-Perdreau, F., Heilmann, C., Peters, G., Gotz, F. & Pulverer, G. (1994) 
Comparative analysis of a biofilm-forming Staphylococcus epidermidis strain and its 
adhesion-positive, accumulation-negative mutant M7. FEMS Microbiol Lett 117: 71-78. 
Seaver, L. C. & Imlay, J. A. (2004) Are respiratory enzymes the primary sources of 
intracellular hydrogen peroxide? J Biol Chem 279: 48742-48750. 
204 
Shani, S., Friedman, M. & Steinberg, D. (2000) The anticariogenic effect of amine fluorides 
on Streptococcus sobrinus and glucosyltransferase in biofilms. Caries Res 34: 260-267. 
Sharma-Kuinkel, B. K., Mann, E. E., Ahn, J. S., Kuechenmeister, L. J., Dunman, P. M. & 
Bayles, K. W. (2009) The Staphylococcus aureus LytSR two-component regulatory system 
affects biofilm formation. J Bacteriol 191: 4767-4775. 
Shigeta, M., Tanaka, G., Komatsuzawa, H., Sugai, M., Suginaka, H. & Usui, T. (1997) 
Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple 
method. Chemotherapy 43: 340-345. 
Sies, H. (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291-295. 
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. 0., Welsh, M. J. & Greenberg, E. P. 
(2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial 
biofilms. Nature 407: 762-764. 
Singh, R., Ray, P., Das, A. & Sharma, M. (2009) Role of persisters and small-colony variants 
in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in 
vitro study. J Med Microbiol 58: 1067-1073. 
Singh, R., Ray, P., Das, A. & Sharma, M. (2010a) Enhanced production of exopolysaccharide 
matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony 
variant. J Med Microbiol 59: 521-527. 
Singh, R., Ray, P., Das, A. & Sharma, M. (2010b) Penetration of antibiotics through 
Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 
65: 1955-1958. 
Sinha, B., Francois, P. P., Nusse, 0., Foti, M., Hartford, 0. M., Vaudaux, P., et al. (1999) 
Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to 
integrin a5b1. Cell Microbiol 1: 101-117. 
Sitges-Serra, A. & Girvent, M. (1999) Catheter-related bloodstream infections. World J Surg 
23: 589-595. 
Stickler, D. J. (1996) Bacterial biofiims and the encrustation of urethral catheters. Biofouling 
94: 293-305. 
Taddei, F., Matic, I. & Radman, M. (1995) cAMP-dependent SOS induction and mutagenesis 
in resting bacterial populations. Proc Nat/ Acad Sci USA 92: 11736-11740. 
Taylor, C. D., Wirsen, C. 0. & Gaill, F. (1999) Rapid microbial production of filamentous 
sulfur mats at hydrothermal vents. App! Environ Microbiol 65: 2253-2255. 
Tenover, F. C. & Gorwitz, R. J. (2006) The epidemiology of Staphylococcus Infections. In: 
Gram-Positive Pathogens. Fischetti, V. A., Novick, R. P., Ferretti, J. J., Portnoy, D. A. & Rood, 
J. I. (eds). Washington DC: ASM Press, pp. 
Tetz, G. V., Artemenko, N. K. & Tetz, V. V. (2009) Effect of DNase and antibiotics on biofilm 
characteristics. Antimicrob Agents Chemother 53: 1204-1209. 
205 
Thomas, R., Ferguson, J., Coombs, G. & Gibson, P. G. (2011) Community acquired 
methicillin resistant Staphylococcus aureus pneumonia -A clinical audit. Respirology. 
Thurnheer, T., Giertsen, E., Gmur, R. & Guggenheim, B. (2008) Cariogenicity of soluble 
starch in oral in vitro biofilm and experimental rat caries studies: a comparison. J App! 
Microbiol 105: 829-836. 
Timmerman, C. P., Fleer, A., Besnier, J. M., De Graaf, L., Cremers, F. & Verhoef, J. (1991) 
Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates 
attachment to polystyrene. Infect Immun 59: 4187-4192. 
Tkeshelashvili, L. K., McBride, T., Spence, K. & Loeb, L. A. (1991) Mutation spectrum of 
copper-induced DNA damage. J Biol Chem 266: 6401-6406. 
Tojo, M., Yamashita, N., Goldmann, D. A. & Pier, G. B. (1988) Isolation and 
characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J 
Infect Dis 157: 713-722. 
Tormo, M. A., Knecht, E., Gotz, F., Lasa, I. & Penades, J. R. (2005) Bap-dependent biofilm 
formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? 
Microbiology 151: 2465-2475. 
Trotonda, M. P., Tamber, S., Memmi, G. & Cheung, A. L. (2008) MgrA represses biofilm 
formation in Staphylococcus aureus. Infect Immun 76: 5645-5654. 
Tsang, L. H., Cassat, J. E., Shaw, L. N., Beenken, K. E. & Smeltzer, M. S. (2008) Factors 
contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. 
PLoS One 3: e3361. 
Tsuji, B. T., von Eiff, C., Kelchlin, P. A., Forrest, A. & Smith, P. F. (2008) Attenuated 
vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing 
the small-colony-variant phenotype. Antimicrob Agents Chemother 52: 1533-1537. 
Tunkel, A. R. & Mandell, G. L. (1992) Infecting microorganisms. In: Infective endocarditis. 
Kaye, D. (ed). New York: Raven Press, pp. 85-97. 
Uhlen, M. & Abrahmsen, L. (1989) Secretion of recombinant proteins into the culture 
medium by Escherichia coli and Staphylococcus aureus. Biochem Soc Trans 17: 340-341. 
Valderas, M. W., Gatson, J. W., Wreyford, N. & Hart, M. E. (2002) The superoxide 
dismutase gene sodM is unique to Staphylococcus aureus: Absence of sodM in coagulase- 
negative staphylococci. J Bacteriol 184: 2465-2472. 
Valderas, M. W. & Hart, M. E. (2001) Identification and characterization of a second 
superoxide dismutase gene (sodM) from Staphylococcus aureus. J Bacterial 183: 3399-3407. 
Valle, J., Vergara-Irigaray, M., Merino, N., Penades, J. R. & Lasa, I. (2007) oB regulates 
IS256-mediated Staphylococcus aureus biofilm phenotypic variation. J Bacterial 189: 2886- 
2896. 
Valpuesta, V. & Botella, M. A. (2004) Biosynthesis of L-ascorbic acid in plants: new 
pathways for an old antioxidant. Trends Plant Sci 9: 573-577. 
206 
van Loosdrecht, M. C., Lyklema, J., Norde, W. & Zehnder, A. J. (1990) Influence of 
interfaces on microbial activity. Microbiol Rev 54: 75-87. 
Vandecasteele, S. J., Peetermans, W. E., R, R. M., Rijnders, B. J. & Van Eldere, J. (2003) 
Reliability of the ica, cap and atlE genes in the discrimination between invasive, colonizing 
and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related 
infections. Clin Microbiol Infect 9: 114-119. 
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., et al. 
(2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton- 
Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9: 978-984. 
von Eiff, C., Friedrich, A. W., Becker, K. & Peters, G. (2005) Comparative in vitro activity of 
ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. 
Antimicrob Agents Chemother 49: 4372-4374. 
Vuong, C., Kocianova, S., Voyich, J. M., Yao, Y., Fischer, E. R., DeLeo, F. R., et al. (2004) A 
crucial role for exopolysaccharide modification in bacterial biofilm formation, immune 
evasion, and virulence. J Biol Chem 279: 54881-54886. 
Vuong, C., Saenz, H. L., Gotz, F. & Otto, M. (2000) Impact of the agr quorum-sensing 
system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 182: 1688-1693. 
Walters, M. C., 3rd, Roe, F., Bugnicourt, A., Franklin, M. J. & Stewart, P. S. (2003) 
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to 
tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob 
Agents Chemother 47: 317-323. 
Wang, I. W., Anderson, J. M. & Marchant, R. E. (1993) Staphylococcus epidermidis 
adhesion to hydrophobic biomedical polymer is mediated by platelets. J Infect Dis 167: 329- 
336. 
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T. H., Queck, S. Y., Li, M., et al. (2007) 
Identification of novel cytolytic peptides as key virulence determinants for community- 
associated MRSA. Nat Med 13: 1510-1514. 
Wann, E. R., Gurusiddappa, S. & Hook, M. (2000) The fibronectin-binding MSCRAMM 
FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol 
Chem 275: 13863-13871. 
Ward, J. F., Evans, J. W., Limoli, C. L. & Calabro-Jones, P. M. (1987) Radiation and hydrogen 
peroxide induced free radical damage to DNA. Br! Cancer Suppl 8: 105-112. 
Watnick, P. I., Fullner, K. J. & Kolter, R. (1999) A role for the mannose-sensitive 
hemagglutinin in biofilm formation by Vibrio cholerae EI Tor. J Bacteriol 181: 3606-3609. 
Weidenmaier, C., Peschel, A., Xiong, Y. Q., Kristian, S. A., Dietz, K., Yeaman, M. R., et al. 
(2005) Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions 
with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect 
Dis 191: 1771-1777. 
207 
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K., et at. 
(2007) High-level vancomycin-resistant Staphylococcus aureus isolates associated with a 
polymicrobial biofilm. Antimicrob Agents Chemother 51: 231-238. 
Weinstein, L. & Schlesinger, J. J. (1974) Pathoanatomic, pathophysiologic and clinical 
correlations in endocarditis (second of two parts). N Engl J Med 291: 1122-1126. 
Wentland, E. J., Stewart, P. S., Huang, C. T. & McFeters, G. A. (1996) Spatial variations in 
growth rate within Klebsiella pneumoniae colonies and biofilm. Biotechnol Prog 12: 316- 
321. 
Williams, D. L. & Bloebaum, R. D. (2010) Observing the biofilm matrix of Staphylococcus 
epidermidis ATCC 35984 grown using the CDC biofilm reactor. Microsc Microanal 16: 143- 
152. 
Wolgemuth, C., Hoiczyk, E., Kaiser, D. & Oster, G. (2002) How myxobacteria glide. Curr Biol 
12: 369-377. 
Xia, G., Kohler, T. & Peschel, A. (2010) The wall teichoic acid and lipoteichoic acid polymers 
of Staphylococcus aureus. lnt J Med Microbial 300: 148-154. 
Yamada, K. M. & Olden, K. (1978) Fibronectins--adhesive glycoproteins of cell surface and 
blood. Nature 275: 179-184. 
Yamada, S., Sugai, M., Komatsuzawa, H., Nakashima, S., Oshida, T., Matsumoto, A., et al. 
(1996) An autolysin ring associated with cell separation of Staphylococcus aureus. J 
Bacterial 178: 1565-1571. 
Yang, J. A., Park, D. W., Sohn, J. W., Yang, 1. S., Kim, K. H. & Kim, M. J. (2006) Molecular 
analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant 
Staphylococcus aureus with low-level mupirocin resistance. J Korean MedSci 21: 827-832. 
Yang, S. J., Rice, K. C., Brown, R. J., Patton, T. G., Liou, L. E., Park, Y. H., et al. (2005) A LysR- 
type regulator, CidR, is required for induction of the Staphylococcus aureus cidABC operon. 
J Bacterial 187: 5893-5900. 
Yim, L. C., Hongmei, J., Aitchison, J. C. & Pointing, S. B. (2006) Highly diverse community 
structure in a remote central Tibetan geothermal spring does not display monotonic 
variation to thermal stress. FEMS Microbial Ecol 57: 80-91. 
Zheng, Z. & Stewart, P. S. (2002) Penetration of rifampin through Staphylococcus 
epidermidis biofilms. Antimicrob Agents Chemother 46: 900-903. 
Ziebuhr, W., Heilmann, C., Gotz, F., Meyer, P., Wilms, K., Straube, E., et al. (1997) 
Detection of the intercellular adhesion gene cluster (ica) and phase variation in 
Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 65: 
890-896. 
Zobell, C. E. (1943) The effect of solid surfaces upon bacterial activity. J Bacteriol 46: 39-56. 
208 
Zong, Y., Xu, Y., Liang, X., Keene, D. R., Hook, A., Gurusiddappa, S., et a/. (2005) A 
'Collagen Hug' model for Staphylococcus aureus CNA binding to collagen. EMBO J 24: 4224- 
4236. 
209 
